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ABSTRACT

Kinetic, Mechanistic, and Structural Investigation of Features Controlling Stereoselectivity of
(R)- and (S)-Hydroxypropyl CoM Dehydrogenases from Xanthobacter autrophicus Strain Py2
by
Dariusz Adam Sliwa, Doctor of Philosophy
Utah State University, 2010
Major Professor: Dr. Scott A. Ensign
Department: Chemistry and Biochemistry
Enantiopure alcohols are valuable intermediates in fine organic synthesis, in particular for
preparation of biologically active compounds. The necessity of preparing single enantiomer drugs
in an optically pure form has triggered much research, especially in the pharmaceutical industry.
The biocatalytical production of chiral alcohols by alcohol dehydrogenase enzymes is
characterized by the asymmetric reduction of the corresponding ketones, usually with high degree
of stereoselectivity. The commercial value of the enzymes as stereoselective biocatalysts has
been a significant driving force in understanding features that control their mechanism of
catalysis and stereoselectivity. This work focuses on two enantiocomplementary dehydrogenase
enzymes ((R)- and 2-(S)-hydroxypropyl-CoM (HPC) dehydrogenases (DH)) of the epoxide
carboxylation pathway in Xanthobacter autotrophicus strain Py2. The main goal of this
dissertation is to kinetically, mechanistically and structurally characterize S-HPCDH and through
the comparison studies with R-HPCDH reveal the basis for high degree of stereoselectivity
exhibited by both enzymes. Analysis of the molecular structure of R-HPCDH and the homology
model of S-HPCDH suggests a mechanism of substrate specificity in which the binding of the
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substrate sulfonate moiety at distinct sites on each stereoselective enzyme directs the orientation
of the appropriate substrate enantiomer for the hydride abstraction. The positively charged
residues responsible for binding the CoM moiety of the substrate were identified in R-HPCDH
(Arg152 and Arg196), and in S-HPCDH (Arg211 and Lys214). Site-directed mutagenesis
confirmed their importance in binding and orienting physiological substrates, but not the
substrates lacking the CoM moiety. Extensive kinetic and mechanistic characterization of SHPCDH reveals its key catalytic features similar to those of R-HPCDH, but also points out a few
important differences. Furthermore, the role of the methionine residues flanking the substrate in
the active site of both dehydrogenases was investigated. Substitution of these residues to alanine
resulted in enzymes with significantly altered catalytic parameters and suggested their importance
in binding and catalysis. Additionally, the X-ray crystal structures of the Met187Ala and
Met192Ala mutants of R-HPCDH have revealed their role as "gate keepers," protecting the active
site from the surrounding solvent. Kinetic analysis of Met187Leu and Met192Leu mutants
implied a structural, rather than catalytic function of the methionines. It is proposed that steric
clashes of the terminal methyl group of the HPC substrates with the nicotinamide ring of NAD+
are a major determinant of the enantioselectivity in S-HPCDH. This research provides the first
side-by-side characterization of a pair of short-chain dehydrogenase/reductase (SDR) enzymes
expressed simultaneously to act on two enantiomers of the same alcohol produced in a metabolic
pathway. The R-HPCDH and S-HPCDH enzymes are distinguished from all other known
members of the SDR family in using the novel sulfonate functional group of coenzyme M as a
handle for chiral discrimination. These results provide a standard for examining the molecular
basis of stereoselectivity in other such enzyme pairs.
(206 pages)
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CHAPTER 1
INTRODUCTION
BACKGROUND AND SIGNIFICANCE
The increasing dependence of our society on industrial chemical processes results in large
amounts of short-chain (C2 – C4) hydrocarbons being released to the surrounding environment.
The biogenic sources of alkanes and alkenes further increase the global atmospheric non-methane
pool of hydrocarbons. Of these compounds, alkenes, their halogenated counterparts and epoxides
are especially reactive molecules with toxic, mutagenic and potentially carcinogenic properties
that threaten ecosystems and pose serious risks to human health and development (1, 2). Several
bacteria have been isolated over the years that can convert these toxic molecules into usable nonreactive metabolites (3). The current interest in biodegradation is rationalized not only by the
applied aspects, but also by the general need to understand the mechanisms that living systems
utilize to detoxify and/or metabolize these compounds and their biological intermediates. In the
case of applied technologies, both the whole organisms and the homogeneously purified enzymes
that comprise the bacterial pathways of alkane and alkene metabolism have biotechnological
potential. Xanthobacter autotrophicus strain Py2 is one of several bacteria capable of growing on
propylene and epoxypropane as the primary carbon and energy source (4).
The research efforts described in the subsequent chapters of this dissertation have been
focused on the elucidation of the mechanism by which the enzymes of the epoxide degradation
pathway in X. autotrophicus Py2 catalyze the conversion of toxic epoxides to useful metabolites.
Of particular interest are two enantiocomplementary dehydrogenases which allow bacteria to
grow on both the (R)- and (S)- enantiomeric forms of epoxypropane.
Sources of Propylene and Epoxides. Propylene is produced primarily as a by-product of
petroleum refining and of ethylene production by steam cracking of hydrocarbon feedstocks (5).
Propylene is a major chemical intermediate. The most important derivatives of propylene are:
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polypropylene, acrylonitryle, propylene oxide, isopropanol, acetone and cumene. Propylene
oxide, also known as epoxypropane, is a versatile chemical intermediate used in a wide range of
industrial and commercial products (6). By volume, it is among the top 50 chemicals produced in
the world. About 4 billion pounds of epoxypropane is manufactured annually by Dow Chemical
Company (7) as a starting material in the synthesis of versatile products like polyether polyols for
urethanes, propylene glycol (mainly for polyester fibres), polypropylene glycol, dipropylene
glycol, glycol ethers and surfactants (6). In addition, aliphatic epoxides such as epoxyethane and
epoxypropane have been used extensively as sterilizing agents for the medical and food industries
(8). Chlorinated epoxides such as epichlorohydrin (3-chloro-1,2-epoxypropane) are produced in
large quantities as starting materials for the production of glycerol and epoxy resins (9). Epoxides
are also generated in vivo through the epoxidation of alkenes by a number of enzymes with
monooxygenase activity as shown in Scheme 1-1.

H

H
C

H3C

-

+

+ O2 + 2e + 2H

C
H

O

H
C
H3C

H
C

+ H2O

H

Scheme 1-1.

These monooxygenases can be divided into two general categories depending on the
fate of their epoxide products. One consists of enzymes which metabolize epoxides for a source
of carbon and energy, while the other is composed of enzymes converting epoxides for all other
purposes (e.g., detoxification). An example of the monooxygenase-generated epoxides further
metabolized for use as a carbon and energy source are found in alkene-utilizing organisms such
as X. autotrophicus Py2 (10) and R. rhodochrous B-276 (11). In contrast, a number of
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cytochrome P-450 monooxygenases represent enzymes that produce epoxides not metabolized for
use by the organism.

The heme-containing cytochrome P-450 monooxygenase family of

isozymes (found ubiquitously in animals, plants, and microorganisms) are well known to
nonselectively metabolize foreign compounds in the detoxification process (12, 13) . Although
detoxification is an obvious benefit to organisms containing P-450 enzymes, in the case of
alkenes, oxidation results in the generation of more toxic and reactive species, namely epoxides
(14). The other enzymes of this category encompass the non-heme bacterial monooxygenases
such as toluene monooxygenase (15), methane monooxygenase (16), ammonia monooxygenase
(17), and alkane monooxygenase (18).
An interesting example of the biological source of epoxides are found in bacterial
pathways of haloalkane metabolism via the action of halohydrin dehalogenases (19). These
enzymes can convert a halohydrin, such as 1-chloro-2-propanol, into the corresponding epoxide
(epoxypropane) and halide ion with a high enantioselectivity. Moreover, this reaction is thought
to proceed via mechanism strategy similar to that of the SDR superfamily of enzymes, which will
be discussed at a later point in this introduction.

O

H
C
R

H
C
H

H

O-

H

C

C

R

X

H

X-

Scheme 1-2.

Biological Reactivity of Epoxides. Aliphatic epoxides are highly reactive, toxic
compounds with mutagenic and in some cases carcinogenic properties (1, 20). The reactivity of
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these molecules derives from their electrophilic nature and strained three-member ring. The
general mechanism of elecrophilic addition of an epoxide is shown in Scheme 1-2. The biological
nucleophile X- attacks the epoxide, subsequently opening the ring and generating the alkylated
product. Epoxides can react with a variety of cellular nucleophiles abundantly found on DNA,
RNA, and proteins. In DNA and RNA, the principal reactive nucleophiles include the nitrogen
atoms of the purines and pyrimidine bases. In proteins, epoxides react with sterically accessible

GSH

A

O

R

R
H 2O

O

B

CoMSH

O

SG

HO
R

R

C

HO

SG

HO
SCoM

O

O

D
O

OH

E

O
R
O

R
OH
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cysteine thiol groups, methionine sulfurs or the histidine ring nitrogens. Biological systems have
devised numerous strategies for converting epoxides into less detrimental species. Five known
biological strategies have been described to date of epoxides metabolism/detoxification (Figure 11). All cases include opening of the epoxide ring via nucleophilic addition or isomerization, thus
rendering the compounds inactive as electrophiles. The major differences in the examples
described below lay in a type of nucleophile used in the reaction. The enzymes representing
various strategies include: glutathione transferases, found in higher organisms to detoxifiy
epoxides by converting them to less toxic glutathione conjugates (21); epoxide hydrolases,
catalyzing the hydration of epoxides to the corresponding diols (22-24); epoxyalkane:coenzyme
M transferase, an enzyme identified in both X. autotrophicus Py2 (25), and by extension R.
rhodochrous B276 (26, 27), which detoxifies epoxypropane by converting it to a coenzyme M
conjugate for further metabolism; styrene oxide isomerase, that catalyzes isomerization of styrene
oxide to phenylacetaldehyde (28); and finally vitamin K epoxide reductase, a central enzyme in
the vertebrate vitamin K cycle where it functions to regenerate the dihydroquinone form of
vitamin K for use by vitamin K carboxylase (29, 30).
Epoxypropane Metabolism by Propylene-Oxidizing Bacteria. Many biological systems
have developed mechanisms for dealing with epoxides. Among several bacteria capable of
growing on epoxides as the only carbon and energy source are X. autotrophicus Py2 (31), R.
rhodochrous strain B276 (32), and Nocardia strain A60 (33). Previous studies determined that the
first step in the metabolism of propylene by X. autotrophicus Py2 and R. rhodochrous B276
occurs via an oxidative conversion to epoxypropane.

The alkene monooxygenase (AMO)

enzymes from these organisms have been homogenously purified and characterized.

Both

enzymes are NADH-dependent and highly stereoselective in their conversion of propylene to (R)expoxypropane (X. autotrophicus Py2 AMO 95%, R. rhodochrous B276 AMO 92%) (26, 34).
The X. autotrophicus Py2 AMO is a four component complex made up of an epoxygenase with
58-, 38-, and 10-kDa subunits arranged in an α2β2γ2 configuration that contains 4 moles of
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nonheme iron, a 35-kDa monomeric reductase that contains FAD and a 2Fe-2S cluster, a
homodimeric 13-kDa ferredoxin containing two Rieske-type 2Fe-2S clusters, and an 11-kDa
effector protein (35). The R. rhodochrous B276 AMO is a three-component complex made up of
an epoxygenase with 53- and 35-kDa subunits arranged in an αβ quarternary structure and
containing two moles of non-heme iron, a 40-kDa monomeric reductase that contains FAD and a
2Fe-2S cluster, and a 14-kDa effector protein (11).
Overview of Epoxide Carboxylation. The conversion of epoxypropane to acetoacetate in
the organisms X. autotrophicus Py2 is carried out by a four protein enzyme complex known as
the epoxide carboxylase system (26).

This enzyme complex is dependent on CO2, NAD+,

NADPH, and an unusual cofactor, coenzyme M (CoM or 2-mercaptoethanesulfonate). The
discovery of CoM, the smallest known biological cofactor, as being involved in the epoxides
metabolism was both unprecedented and surprising. CoM was previously thought to be
exclusively utilized during methanogenesis in archaebacteria where it plays a central role in
reductive methane production (25, 36, 37). Bromoethanesulfonate (BES), a small molecule which
is a structural analog of 2-mercaptoethanesulfonate (CoM), has been shown to be a potent
inhibitor of methanogenesis (38) (Scheme 1-3 highlights structural similarities of both
molecules). The enzymes involved in epoxide carboxylation utilize CoM to facilitate the opening
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of the reactive epoxide ring and as a carbon carrier in the subsequent reactions as depicted in
Figure 1-2. The thiol moiety of CoM (illustrated in Scheme 1-3) has proven to be a potent
nucleophile capable of efficiently opening the epoxide ring, and the sulfonate moiety has been

CH3

O
(R)-epoxypropane
(95%)

-

H

(S)-epoxypropane
(5%)

H

epoxyalkane:
coenzyme M
transf erase

SH

-

O
*

*

O 3S
mercaptoethanesulf onate
(coenzyme M)

H3C

HO

S

HS

OH

CH3 H3C
*

O 3S

S

*
H

SO3-

H

(R)-hydroxypropyl-CoM (R-HPC)

SO3-

(S)-hydroxypropyl-CoM (S-HPC)
NAD

R-HPCDH

+

S-HPCDH

NADH
O
S

H3C

2-ketopropyl-CoM (2-KPC)
NADPH

SO 3-

CO2

2-KPCC
NADP+
O

O
+
O-

H 3C
acetoacetate

HS

SO3coenzyme M

Figure 1-2. Pathway of aliphatic epoxide carboxylation in X. autotrophicus strain Py2. The
enzymes catalyzing the subsequent reactions are: epoxypropane:CoM transferase, (R)hydroxypropyl-CoM dehydrogenase (R-HPCDH), (S)-hydroxypropyl-CoM dehydrogenase (SHPCDH) and 2-ketopropyl-CoM oxidoreductase/carboxylase (2-KPCC).
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demonstrated to act as an effective binding “handle” for the enzymes (39-42). Recent studies
show that BES is also a strong inhibitor of propylene metabolism in X. autotrophicus Py2 (39).
The inhibitory effect of BES on the individual components of the epoxide carboxylase system is
examined in more detail in Chapter 3 of this dissertation. The first step of the epoxide
carboxylation pathway involves the opening of the epoxide ring, a reaction catalyzed by
epoxyalkane:CoM transferase. In this reaction CoM is conjugated to either (R)- or (S)epoxypropane thus producing the corresponding alcohols, namely (R)- or (S)-hydroxypropylCoM (R-HPC and S-HPC) (25). In the next step, two enantiocomplementary dehydrogenases,
(R)- and (S)-hydroxypropyl-CoM dehydrogenases (R-HPCDH and S-HPCDH, respectively)
catalyze the NAD+ dependant oxidation of enantiomeric alcohols to a common achiral product, 2ketopropyl-CoM (2-KPC) (26). In the final step, a novel carboxylase, 2-ketopropyl
carboxylase/reductase (2-KPCC) catalyzes the NADPH-dependent reduction, cleavage and
carboxylation of 2-KPC, forming acetoacetate and CoM. CoM is thus regenerated and recycled
for the next round of reactions (39).
Enzymes of the Epoxide Degradation Pathway. Recently, the genome of X. autotrophicus
Py2

was

sequenced,

assembled,

and

annotated

(http://genome.jgi-

psf.org/xanau/xanau.home.html). The genes encoding all components of the epoxide
carboxylation pathway have been cloned and the corresponding enzymes purified (26, 27, 39-42).
Amino acid sequence analysis of these enzymes along with biochemical, spectroscopic, and
kinetic studies have helped further elucidate their mechanisms of action. Below is a summary of
each of the enzymes involved in the pathway. The overall pathway is presented in Figure 1-2,
while the stoichiometry of epoxypropane carboxylation is shown in Equation 1:

epoxypropane + CO2 + NADPH + NAD+ Æ acetoacetate + H+ + NADP+ + NAD (Eq. 1)
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Epoxyalkane:CoM Transferase. The first step in epoxide carboxylation is the ring
opening of the epoxide by the nucleophilic addition of CoM catalyzed by epoxyalkane:CoM
transferase (EaCoMT) (25, 42). Multiple sequence alignments have revealed that EaCoMT
contains a characteristic zinc-binding motif similar to that of other zinc enzymes such as
cobalamin-independent methionine synthase (MetE) (43) and methylcob(III)alamin:CoM
methyltransferase-2 (MT2) (42, 44). Both of these homologous enzymes, as well as others within
this family of Zn-containing alkyl-transferase enzymes, catalyze the nucleophilic substitution of
an activated thiolate. Members of the Zn-containing alkyl-transferase family utilize thiols as
nucleophiles that are activated by coordination to a zinc atom (43). In the case of EaCoMT the
sulfhydryl group of CoM is proposed to coordinate zinc. This lowers the pKa of the thiol and thus
activates it for alkylation, as shown in Figure 1-3. Three permanent ligands of the metal center are
Cys and His residues, with the fourth coordination site occupied by an exchangeable ligand that is
removed upon thiol binding.

When the apo EaCoMT was reconstituted with Co2+ for

spectroscopic studies it gave a normal spectrum corresponding to the tetrahedral state of the metal
center. Upon CoM addition to the enzyme, the spectrum was altered dramatically suggesting that
the thiol of CoM directly ligates the Co2+ center, either by displacing an exchangeable ligand or
by increasing the coordination number about Co2+ (45). EaCoMT is an α6 homohexameric protein
with 1 mole of zinc per 41.7-kDa monomer (45). The enzyme has a modest kcat (6.5 sec -1) but a
high affinity for propylene oxide (1.8 μM) (42). The native enzyme is expressed in high
amounts (4% of the cellular protein) when X. autotrophicus Py2 is grown on propylene,
additionally compensating for the modest kcat (40). Regarding the highly reactive nature of
epoxypropane, its accumulation in the cell would likely have a detrimental effect for the
organism. This corresponds with an observation that epoxypropane does not accumulate in the
assay or growth medium of X. autotrophicus Py2. Increased abundance of EaCoMT and its high
affinity for epoxypropane aid in its efficient metabolism by a bacterium, thus preventing
unnecessary and dangerous reactions with the cellular nucleophiles.
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Figure 1-3. Activation of CoM by epoxyalkane-CoM transferase through coordination to a metal
ion and the subsequent addition to propylene oxide.

(R)- and (S)- Hydroxypropyl-CoM Dehydrogenases. In the second step of the epoxide
carboxylation pathway an enantiomeric mixture of (R)- and (S)-alcohols (in 95:5 ratio) is
oxidized in a NAD+ dependent manner to form a common β-keto acid (Figure 1-2). Specifically,
two homologous enzymes R-HPCDH and S-HPCDH catalyze the reversible oxidation of R-HPC
and S-HPC to yield an achiral product 2-KPC (26, 41). The R-HPCDH and S-HPCDH enzymes
are highly stereoselective for their respective substrates, exhibiting only 0.5 to 1% activity with
the opposing enantiomer (26). Biochemical and molecular studies showed that these enzymes
belong to the "classical" short-chain dehydrogenase/reductase family of alcohol dehydrogenases
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(25, 26, 40). The R- and S-HPCDH enzymes share a relatively high degree of sequence identity
(41%) and are composed of subunits with molecular weights of 26 and 25 kDa, respectively (40).
Although R-HPCDH has been cloned and expressed in a fully active form, many trials to purify
S-HPCDH have not been successful due to its tendency to form inclusion bodies in the
heterologous expression

systems.

Therefore,

the

kinetic,

mechanistic

and

structural

characterization of S-HPCDH is lagging behind that of R-HPCDH. Sequence alignments along
with kinetic studies of the site directed mutants have revealed the identity and function of the
catalytic triad residues for R-HPCDH (Tyr155, Lys159, Ser142) (41). Studies of the pH
dependence of the kinetic parameters for R-HPC oxidation indicated a single ionizable residue of
catalytic importance, Tyr155 with a pKa of 6.9 (41). By analogy to other members of the SDR
family, Tyr155 is believed to serve the role of a general acid/base. The oxidation of R-HPC was
found to follow a compulsory-ordered ternary complex mechanism, where coenzymes are the
outer substrates. Inhibition studies showed that the opposite enantiomer S-HPC and the substrate
analog M-HPC are competitive inhibitors of R-HPC with Kic values close to the Km for R-HPC
(41). Interestingly, other molecules containing sulfonate moieties, 2-mercaptoethanesulfonate
(CoM), ethanesulfonate and methanesulfonate, were mixed or non-competitive inhibitors. The
arginine modifying agents (2,3-butadione and phenylglyoxal) were capable of inactivating the
protein in a time-dependent manner (46). These modifications affected the ability of the enzyme
to oxidize R-HPC much more dramatically than similar substrates lacking the sulfonate moiety
(46). These studies suggested that arginine residues in the enzyme active site interact with the
negatively charged sulfonate moiety in order to orient the molecule for catalysis. Indeed, sitedirected mutagenesis of the C-terminal arginine residues of R-HPCDH identified Arg152 and
Arg196 as essential for catalysis of the natural substrates (R-HPC and 2-KPC) but not the
substrates lacking the sulfonate moiety (47). Short-chain alkylsulfonates and CoM were found to
modulate the enantioselectivity and kinetic properties for 2-butanone reduction by R-HPCDH. In
the presence of 1 mM of additives, the enantioselectivity of 2-butanone reduction increased from
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70% (S)-butanol and 30% (R)-butanol (produced in the absence of the additives) to a theoretical
value of 100% (S)-butanol. The strongest modulating effects were observed for ethanesulfonate
and propanesulfonate (47). However, these effects were abolished for the alanine mutants of
Arg152 and Arg196 thereby confirming their role in the sulfonate binding. The length of the
substrate alkyl chain was shown to be important in substrate affinity. When aliphatic alcohols
were substrates for R-HPCDH, the Km value decreased by 1700-fold upon going from 2-propanol
to (R)-2-octanol (47). The (S)-alcohols with the chain length exceeding five carbons were
sufficiently poor substrates that their kinetic parameters could not be determined. This suggested
that the "methyl binding pocket" cannot accommodate groups longer than the propyl group
presumably due to the steric clashes with the active site residues.
The uniqueness of the HPCDH enzymes along with their prospective industrial
applications has prompted more detailed studies on the basis of their enantioselectivity. The
recent successful cloning and expression of the S-HPCDH enzyme has allowed for the
complementary kinetic and mechanistic studies, the results of which are presented in Chapter 2 of
this dissertation.
SDR Family of Enzymes. As mentioned earlier, R- and S-HPC dehydrogenases belong to
the short-chain dehydrogenase/reductase (SDR) family of enzymes. SDR enzymes play a critical
role in amino acid, carbohydrate, cofactor, lipid, hormone and xenobiotic metabolism as well as
in redox sensor mechanisms. Their importance and functional diversity is reflected in the
physiology of various organisms ranging from viruses, archea, bacteria, yeast to eukaryotes and
higher mammals (48). They constitute a large, evolutionarily old protein family of NAD(P)(H)dependent enzymes with over 70 genes found in the human genome (49-52). The SDR enzymes
are 250 - 350 amino acids in length, exist as dimers or tetramers, and carry out catalysis in the
absence of a metal cofactor. The enzymes have three distinct domains: a conserved N-terminal
NAD+ (or NADP+) binding domain, a central domain with three highly conserved catalytic triad
residues (serine, tyrosine, and lysine) and a variable C-terminal domain responsible for substrate
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recognition. Recent mutagenic and structural studies have extended the knowledge of the general
reaction mechanism and have established a catalytic tetrad of the Asn, Ser, Tyr and Lys residues
(53). The SDR enzymes constitute one of the largest enzyme superfamilies with presently over
46,000 members annotated in databases (52). The term "short-chain" alcohol dehydrogenases has
traditionally been used to distinguish members of this family on the basis of primary sequence
length and catalytic mechanism from the classical zinc-dependent "medium-chain" alcohol
dehydrogenases (MDR), such as liver alcohol, glyceraldehyde or lactate dehydrogenases.
Primary Structure of SDR Enzymes. Since SDR family represents one of the oldest
families of enzymes with its members showing early divergence, there is a relatively low
sequence identity between different SDR enzymes (typically 15-30%). Despite that some highly
conserved motifs are observed in their primery sequence (Figure 1-4). The first being a strictly
conserved segment of the YxxxK sequence, known as the active-site motif. In addition to the Tyr
and Lys residues, a Ser residue (13 residues upstream of Tyr) has been shown to be conserved in
some SDR enzymes. Another characteristic motif is the N-terminal GxxxGxG sequence, which
represents the nucleotide binding region (54). Spacing between the glycines is variable and
depends on the specific subfamily. The two main types of SDR enzymes are denoted as
"classical" and "extended." The "classical" type has a chain length of about 250 amino acids,
while the "extended" family has an additional 100-residue domain in the C-terminal region. Three
further types known as "intermediate," "complex" and "divergent" (55), can be distinguished
based on the specific sequence motif of the cofactor and the active site residues (Table 1-1).
Further, frequent sequence motifs are NNAG (around position 86 -89), a single Asn residue
located around position 111, and a single Asp (around position 60) (49, 56-58). The latter is
typical for the NAD+(H)-dependent enzymes and is not present in NADP+(H)-dependent enzymes
(55).
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Table 1-1. Cofactor and active site sequence motifs for the different SDR superfamiliesa. This
table was adopted from Kavanagh et al. (59).
Subfamily
Cofactor binding
Active site
classical
TGxxx[AG]xG
YxxxK
extended
[ST]GxxGxxG
YxxxK
intermediate
[GA]xxGxx[GA]
YxxxK
divergent
GxxxxxxSxA
YxxMxxxK
complex
GGxGxxG
YxxxN
a
Abbrevaiations: x, any amino acid residue; [ ] denote alternatives that can be present or absent.

Figure 1-4. Multiple-sequence alignment of some of the SDR enzymes showing conserved motifs
of the catalytic triad and the nucleotide binding region.
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Tertiary Structure of the Enzymes of SDR Family. Regardless of the low primary
sequence identity, the tertiary structures of the SDR enzymes display high structural similarities.
Comparison of the 3D structures of enzymes representing the SDR family (82 structures
deposited in PDB) reveals that the most common feature among all available structures is of a α/β
folding pattern known as the Rossmann-fold (60). It is a dinucleotide cofactor binding motif
composed of a central, twisted parallel β-sheet (typically consisting of 6-7 β-strands), which is
surrounded by 6-8 α-helices (61) (Figure 1-5). The Gly-rich sequence pattern of this motif plays
an essential role in the structural integrity of the protein and allows for binding of the
pyrophosphate portion of the nucleotide cofactor (61). The NAD(H) specificity of the enzyme is
determined by an acidic residue (typically Asp) binding to the 2’ and 3’ hydroxyls of the adenine
ribose which is located about 20 residues downstream of the Gly-rich motif.

Figure 1-5. General fold of the SDR enzymes with the cofactor bound.
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In contrast NADP(H)-dependent enzymes contain a basic residue (typically Asn) within the Glyrich segment (61). The N-terminal nucleotide binding domain consists of the classic Rossmannfold and the nucleotide binding sequence GxxxGxG (Figure 1-4). The central catalytic domain
contains a strictly conserved catalytic motif YxxxK. The substrate binding domain is the most
variable although various SDR enzymes show some similarities in this region. The substrate
binding domain is generally composed of the loops between the last two β strands (generally βF
and βG) of a subunit on one side and the loop between the previous two β strands (βD and βE) on
the other side (62).
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General Mechanism of SDR Enzymes. Extensive structural, kinetic, and mechanistic
characterization of SDR enzymes has resulted in the formulation of a general mechanism of
action (49, 63-65). Comparison of this mechanism with the corresponding mechanism of the zincdependent MDR enzymes (66-68) is shown Figure 1-6. During oxidation, the Tyr residue of the
catalytic triad is deprotonated and serves as a general base for proton abstraction from the
substrate. The Lys residue binds the sugar moiety of NAD+ and stabilizes the deprotonated
tyrosyl group of the general base. The Ser residue is thought to increase the acidity of the
substrate hydroxyl group through hydrogen bonding and to stabilize the developing charge on the
alcohol oxygen in the transition state. Although present in most SDR enzymes, the Ser residue is
not obligatory as demonstrated for some enzymes where it was either replaced with Thr or absent
(49, 69). Recent studies have extended the catalytic triad by an Asn residue (56, 70), therefore
establishing a tetrad which is thought to form a proton relay system, similar to that previously
reported for horse liver ADH (71).
Enantiocomplementary SDR Enzymes. Among a large number of SDR enzymes
annotated in databases [(46,000 (52)], there are very few examples of enzyme pairs which in a
common pathway catalyzes the same reaction but with opposite stereoselectivity. To our
knowledge, these enzymes are limited to a set of plant tropinone reductases (72, 73) and bacterial
HPC dehydrogenases (26, 41). A multiple sequence alignment containing R- and S- HPC
dehydrogenases from X. autotrophicus Py2 and the two reductases from Datura stramonium is
shown in Figure 1-4. Tropinone reductase I and II (TR-I and TR-II) catalyze the reversible
stereoselective reduction of the 3-keto group of tropinone to form the enantiomers tropine (αhydroxy) and pseudotropine (β-hydroxy), respectively. Kinetic and structural analysis of TR-I
and TR-II has helped establish their mechanism of stereoselectivity. According to this mechanism
electrostatic interaction between the substrates and the charged amino acids underlie substrate
binding and orientation for catalysis (72, 73). A positively charged histidine (His-112) in TR-I
repels the positively charged nitrogen on the tropinone (Figure 1-7). In case of TR-II, the
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negatively charged glutamate carboxylate (Glu-156) attracts the substrate nitrogen and thus fixes
its position (Figure 1-7).

Based on these results it is conceivable that a similar charge

attraction/repulsion mechanism, involving interactions with the negatively charged sulfonate
moiety of the coenzyme M, controls proper binding of R- and S-HPC to the respective
dehydrogenases.
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Figure 1-7. Mechanism of stereoselective discrimination and catalysis of pseudotropine and
tropine by TR-I and TR-II, respectively.

Structural Basis for Stereoselectivity in R-HPCDH and S-HPCDH. The molecular
structure of R-HPCDH has been determined using X-ray diffraction method and refined to 1.8 Å
resolution (74). The overall fold shown in Figure 1-8, is consistent with the structures of the other
members of the SDR family, including mannitol dehydrogenase (75) and halo alcohol
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dehydrogenase (76). Although the previous results of size exclusion chromatography suggested
that R-HPCDH exists as dimer (41), the X-ray structure suggests that it is a tetramer (74). The
NAD+ binding domain consists of a standard Rossmann motif of a large twisted β sheet
surrounded by 7 α helices (Figure 1-8 B). Excellent quality of the electron density maps for the
sulfonate portion of the bound product (2-KPC) helped to identify two arginine residues
interacting with the sulfonate (Arg152 and Arg196). This confirms the results of the previous
biochemical and mechanistic studies proposing that the interactions between the sulfonate of
CoM and the specific arginines are crucial for the high enantioselectivity and catalytic efficiency
of R-HPCDH (47).

Figure 1-8. X-ray structure of R-HPCDH and the homology model of S-HPCDH; (A) The overall
tertiary structure of R-HPCDH with the individual subunits colored differently. (B)
Superimposition of the R-HPCDH structure (grey) with a homology model of S-HPCDH (green).
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Figure 1-9. Comparison of the active sites architecture for R-HPCDH, S-HPCDH and 2-KPCC:
(A) Active site of R-HPCDH with R-HPC. (B) Active site of S-HPCDH with S-HPC based on the
homology model. (C) Superimposed structure of R-HPCDH (grey) with the homology model of
S-HPCDH (green) to show different special orientation of the sulfonate binding site. (D) Active
site of 2-KPCC with CoM.

The active site of R-HPCDH with the substrate bound R-HPC presented in Figure 1-9A
shows that besides the electrostatic interactions of Arg152 and Arg196 with the sulfonate group,
also Trp195 contributes to the substrate binding through hydrogen bonding. This residue is
positioned at the back of the binding pocket and presumably acts as a backstop preventing
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movement of the substrate during catalysis. An interesting feature of the active site is the
presence of two methionines flanking the substrate. The architecture of the CoM binding pocket
in R-HPCDH resembles that of 2-KPCC which also shows two arginines (Arg56 and Arg365)
interacting with the sulfonate moiety, two methionines flanking the substrate (Met140 and
Met361) and Phe57 acting as a backstop (Figure 1-9D). A homology model of S-HPCDH was
constructed based on the structure of R-HPCDH. Superimposition of both structures reveals
differences in the substrate binding region and suggests the reorientation of the sulfonate binding
site with respect to the CoM binding pocket (Figure 1-9C). It is proposed that in S-HPCDH
enzyme two positively charged residues Arg211 and Lys214 are involved in the sulfonate
binding. Similar to R-HPCDH and 2-KPCC the substrate flanking methionines (Met153 and
Met194) are also suggestes in the active site of S-HPCDH (Figure 1-9B).
Kinetic analysis showed that S-HPC is a strong competitive inhibitor of R-HPCDH with
Ki similar to the Km of the R-HPC (41). Although S-HPC binds to R-HPCDH with high affinity,
the activity is only 0.1 % of that with R-HPC. To visualize the binding mode, S-HPC was
modeled in the active site of the R-HPCDH. Positioning of the hydroxyl group of S-HPC exactly
over that of the R-HPC orients the hydrogen atom of the S-HPC away from the NAD+. This
provides the structural basis for the strong inhibition observed with S-HPC (Figure 1-10).
Furthermore, the comparison of the structures of R-HPCDH with the homology model of SHPCDH suggests that the differential placement of the positively charged residues on each of the
stereoselective enzymes is key to the proper orientation of the substrate for hydride abstraction,
and thus brings about chiral discrimination of the R- and S-HPC substrates.
Although R-HPCDH has been extensively characterized up to date, there are still certain
questions regarding its structural features which remain unanswered. For example, nothing is
known about the role of the methionines flanking the substrate in the active site of R-HPCDH.
Chapter 4 presents the efforts aimed towards elucidating their role in substrate binding and
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stereoselective catalysis. The kinetic and mechanistic studies of the R-HPCDH site directed
mutants are complemented by similar studies of the methionine mutants of S-HPCDH.

Figure 1-10. Binding mode of HPC enantiomers in the active site of R-HPCDH: (A) Active site
of R-HPCDH with the substrate R-HPC bound. (B) Active site of R-HPCDH with the inhibitor SHPC bound.

NADPH:2-Ketopropyl-CoM Carboxylase/Oxidoreductase. The final step in the pathway
of reductive epoxide carboxylation is catalyzed by the enzyme NADPH:2-ketopropyl-CoM
carboxylase/oxidoreductase (2-KPCC) (39, 40). This reaction is an NADPH-dependent
carboxylation of 2-ketopropyl-CoM (2-KPC) to regenerate CoM and produce acetoacetate. It is
also the actual CO2 fixation step in epoxide metabolism (40). 2-KPCC is a homodimeric protein
consisting of 57-kDa subunits with one FAD bound per subunit. Amino acid sequence analysis
shows that 2-KPCC is a member of the FAD containing NADPH:disulfide oxidoreductase
(DSOR) family of enzymes (44). Other members of this family include trypanothione reductase,
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glutathione reductase, thioredoxin reductase, mercuric reductase and dihydrolipoamide
dehydrogenase. All members of this family are NADPH and FAD dependent and catalyze the
two-electron reduction of a disulfide bond (44). The exceptions are: mercuric reductase and 2KPCC which catalyze the reduction of the mercuric ion to elemental mercury and the reduction of
a thioether bond, respectively. An important feature of the DSOR enzymes is the presence of two
highly conserved redox cysteines critical in the substrate reduction. The kinetic and structural
characterization of 2-KPCC from X. autotrophicus Py2 resulted in the elucidation of the
mechanism presented in Figure 1-11 (39).

Figure 1-11. Proposed catalytic mechanism for the reductive cleavage and carboxylation of 2KPC by 2-KPCC. The numbers refer to the steps of the cycle of 2-ketopropyl-CoM
carboxylation. This figure was adapted from Ensign (3).
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The catalytic mechanism includes two half-reactions. The first, reductive half is
conserved among all true members of DSOR family and involves transfer of the reducing
equivalents from NADPH to FAD and further to one of the cysteines forming a redox disulfide
bond. In the second half the substrate is reductively cleaved and the enzyme regenerated.
Specifically, in step 1 of the proposed mechanism, NADPH binds to the oxidized enzyme. In step
2 FAD is reduced. In step 3 the redox active disulfide is reduced by FADH2 to form the
interchange thiol-FAD covalent complex. During step 4, the electron transfer from FAD to the
interchange thiol occurs resulting in the formation of the charge-transfer complex with the
negative charge residing on the proximal thiol. At the same time the substrate 2-KPC binds to the
enzyme. In step 5 the thioether bond of 2-KPC is reductively cleaved by the nucleophilically
attack of the thiol of Cys82, forming enolacetone and the heterodisulfide bond between the thiols
of CoM and the distal Cys82. The enolacetone is stabilized through its tautomerization to form
the carbanion which can either attack CO2 forming acetoacetate or a proton forming acetone.
When CO2 is present little or no acetone is formed. In the final step CoM and NADP+ are released
from the enzyme and the redox active disulfide is reconstituted. Experimental evidence indicated
that all six reaction steps are fully reversible. Outlined in Scheme 1-4 are the five different
catalytic activities associated with 2-KPCC, and in each, enolacetone is a proposed intermediate
(39).

(1) H3CCOCH2S-CoM + NADPH + CO2 Æ H3CCOCH2COO- + NADP+ + CoM
(2) H3CCOCH2S-CoM + NADPH + H+ Æ H3CCOCH3 + NADP+ + CoM
(3) H3CCOCH2COO- + NADP+ + CoM Æ H3CCOCH2S-CoM +NADPH + CO2
(4) H3CCOCH2COO- + H+ Æ H3CCOCH3 + CO2
(5) H3CCOCH2COO- + 14CO2 Æ 1-[14C]-H3CCOCH2COO-

Scheme 1-4.
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The molecular structure of 2-KPCC was recently solved and provided further insights
into the mechanism of reductive cleavage of 2-KPC (77). The overall structure of 2-KPCC is
similar to the dimeric structures observed for the classic members of the DSOR family (Figure 112) namely glutathione reductase (78), trypanothione reductase (79) and lipoamide
dehydrogenase (80). Each monomer consists of three domains, including the FAD-binding
domain, the NADPH binding domain, and the dimerization domain, or the interface domain.

Figure 1-12. The overall fold of 2-KPCC with NADP and FAD bound (green). Individual
subunits are depicted in orange and blue.

The FAD and NADPH binding domain consists of the standard Rossmann nucleotide
binding motifs, as observed for the SDR enzymes discussed above. The structure of 2-KPCC with
the substrate bound suggests a conformational change follows binding of 2-KPC, which is belived
to prevent protonation of the substrate (77). In this way the enzyme also assures that there is a
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linear pathway for electron pair transfer between FAD, the redox active disulfide and the
thioether bond of the substrate. Again, as with the R-HPCDH, the substrate is bound and oriented
by two arginines (Arg56 and Arg365) which bind the substrate with both hydrogen bonds and
ionic interactions (81).

The structure of the enzyme with 2-KPC bound revealed a linear

reduction pathway between NADPH, FAD, the distal and proximal cysteine thiols, and the
thioether linkage of 2-KPC. Structural analysis of the native and the substrate bound structures
supports the mechanism of the reaction as proposed by Clark and Ensign (shown in Figure 1-11).
Concluding Remarks.

The central goal of the research presented in the following

chapters of this dissertation was to extend the kinetic, mechanistic and structural characterization
of R- HPCDH and S-HPCDH in the context of their high degree of enantioselectivity. Both
enzymes represent a unique example of the complementary SDR enzymes present in a common
metabolic pathway, thus allowing the organism to utilize enantiomeric mixtures of epoxides as
the carbon and energy source. Since R- and S-HPC dehydrogenases are an integral part of the
epoxide carboxylase system, it is essential to present them in the broader context of the other
enzymes in the pathway. The substrate flow and the physiological background are of great
relevance to understanding both their role and the mechanism of action. Thereby this introduction
has gone into great detail on topics ranging from the biological reactivity of epoxides, propylene
metabolism and biochemical characterization of the enzymes constituting the epoxide
carboxylase system to mechanistic and structural details of the SDR enzymes. This was done in
order to introduce the relevance of this research, orient the reader on the work that has previously
been conducted, and give an extensive introduction to the following chapters. The interested
reader is referred to the many review articles cited in the text for a more in-depth understanding
of the presented topics.
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CHAPTER 2
MOLECULAR BASIS FOR ENANTIOSELECTIVITY IN THE (R)- AND (S)HYDROXYPROPYLTHIOETHANESULFONATE DEHYDROGENASES, A UNIQUE PAIR
OF STEREOSELECTIVE SHORT-CHAIN DEHYDROGENASES/REDUCTASES
INVOLVED IN ALIPHATIC EPOXIDE CARBOXYLATION1
ABSTRACT
(R)- and (S)-2-hydroxypropyl-CoM (R-HPC and S-HPC) are produced as intermediates
in bacterial propylene metabolism from the nucleophilic addition of coenzyme M to (R)- and (S)epoxypropane, respectively. Two highly enantioselective dehydrogenases (R-HPCDH and SHPCDH) belonging to the short-chain dehydrogenase/reductase family catalyze the conversion of
R-HPC and S-HPC to 2-ketopropyl-CoM (2-KPC), which undergoes reductive cleavage and
carboxylation to produce acetoacetate. In the present study, one of three copies of S-HPCDH
enzymes present on a linear megaplasmid in Xanthobacter autotrophicus strain Py2 has been
cloned and overexpressed, allowing the first detailed side by side characterization of the RHPCDH and S-HPCDH enzymes. The catalytic triad of S-HPCDH was found to consist of Y156,
K160, and S143. R211 and K214 were identified as the amino acid residues coordinating the
sulfonate of CoM in S-HPC. R211A and K214A mutants were severely impaired in the oxidation
of R-HPC or reduction of 2-KPC but were largely unaffected in the oxidation and reduction of
aliphatic alcohols and ketones. Kinetic analyses using (R)- and (S)-HPC as substrates revealed
that enantioselectivity in R-HPCDH (value, 944) was dictated largely by differences in kcat while
enantioselectivity for S-HPCDH (value, 658) was dictated largely by changes in Km. S-HPCDH
had an inherent high enantioselectivity for producing (S)-2-butanol from 2-butanone that was Shad an inherent high enantioselectivity for producing (S)-2-butanol from 2-butanone that was
unaffected by modulators that interact with the sulfonate binding site. The tertiary alcohol 2methyl-2-hydroxypropyl-CoM (M-HPC) was a competitive inhibitor of R-HPCDH-catalyzed R1
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HPC oxidation, with a Kis similar to the Km for R-HPC, but was not an inhibitor of S-HPCDH.
The primary alcohol 2-hydroxyethyl-CoM was a substrate for both R-HPCDH and S-HPCDH
with identical Km values. The pH dependence of kinetic parameters suggests that the hydroxyl
group is a larger contributor to S-HPC binding to S-HPCDH than for R-HPC binding to RHPCDH. It is proposed that active site constraints within the S-HPCDH prevent proper binding
of R-HPC and M-HPC due to steric clashes with the improperly aligned methyl group on the C2
carbon, resulting in a different mechanism for controlling substrate specificity and
enantioselectivity than present in the R-HPCDH.
INTRODUCTION
Alcohol dehydrogenases that catalyze the interconversion of secondary alcohols and
ketones are often highly stereoselective with regard to the enantiomer of the alcohol oxidized or
produced during the course of catalysis (1-3). However, there are very few examples of pairs of
alcohol dehydrogenases expressed simultaneously by an organism to deal with both the (R)- and
(S)-enantiomers of an alcohol produced during a metabolic pathway. One such unique pair was
discovered in the pathway of propylene oxidation by the hydrocarbon-oxidizing bacteria
Xanthobacter autotrophicus Py2 and Rhodococcus rhodochrous B276 (4-8). As shown in Figure
2-1, these bacteria initiate propylene oxidation by epoxidation to produce a mixture of the (R)and (S)-enantiomers of epoxypropane.

The atypical thiol cofactor Coenzyme M (2-

mercaptoethanesulfonate, CoM) then acts a nucleophile to convert these epoxides to the chiral
alcohols (R)- and (S)-hydroxypropyl-CoM (R- and S-HPC) (Figure 1-1). R- and S-HPC are the
substrates for the unique pair of dehydrogenases that convert these alcohols to the ketone 2ketopropyl-CoM (2-KPC), which subsequently undergoes reductive cleavage and carboxylation
to produce acetoacetate (4).
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Figure 2-1. Pathway of propylene oxidation in X. autotrophicus Py2. The reactions catalyzed by
R-HPCDH and S-HPCDH are shown in the boxed region.
Biochemical and molecular characterization of the R- and S-HPCDH enzymes showed
that they are members of the "classical" short-chain dehydrogenase/reductase (SDR) family of
alcohol dehydrogenases (4-6). Classical SDR enzymes typically contain a single polypeptide
chain of about 25 kDa and are active as dimers or tetramers (9-13). They are further defined by a
conserved NAD+-binding motif in the N-terminal portion of the protein and a catalytic triad (or
tetrad) within the central portion, with a conserved tyrosine of this tetrad serving as the general
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base (or acid) for alcohol oxidation (or ketone reduction) (9-13). The C-terminal domains of the
SDR families diverge to confer specificity for different substrates. Close to 10,000
dehydrogenases have been assigned to this SDR family, while more than 46,000 have been
annotated in gene databases (10, 12).
The R- and S-HPCDH enzymes from X. autotrophicus are homologous enzymes that
share high sequence identity but with notable sequence differences within their C-terminal
regions (5-8). These enzymes are highly specific for their respective enantiomers of HPC,
exhibiting less that 0.5% activity with the opposite isomer (4). Thus, side by side comparative
studies of this enzyme pair promise to reveal important details into the mechanistic strategies that
confer stereoselectivity for secondary alcohol enantiomers.
The R-HPCDH from X. autotrophicus has been extensively characterized mechanistically
and structurally, culminating in the formulation of a mechanism of catalysis and stereoselectivity
shown on the left side of Scheme 2-1 (14-16). Stereoselectivity is conferred in large part by two
positively charged arginine residues that form salt bridges with the CoM moiety of the substrate
within the CoM-binding pocket of the enzyme (14, 16). This strong ionic interaction orients the
hydroxyl group and hydrogen atom of the alcohol functional group in the proper orientation for
general base abstraction and hydride transfer (Scheme 2-1) (16). By analogy, a similar
mechanistic strategy is believed to operate in the S-HPCDH, wherein the spatial orientations of
the CoM- and methyl-binding pockets are reversed relative to the hydroxyl group and hydrogen
atom to be transferred (Scheme 2-1, right side) (14, 16, 17). To date, this model has not been
tested for the S-HPCDH due to difficulties encountered in attempting to express the enzyme in an
active form in Eschericia coli (14, 15).
Recently, the complete genome of X. autotrophicus was sequenced (http://genome.jgipsf.org/xanau/xanau.home.html). An analysis of the genome reveals that multiple copies of the
genes that encode the key enzymes of epoxide carboxylation are present. These homologs share
high sequence identity but are not identical. In the present work, one of the additional copies of
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the S-HPCDH homologs that had not been identified earlier was successfully cloned and overexpressed in E. coli, providing the necessary system for construction of site-directed mutants and
kinetic and mechanistic studies to test the tenets of Scheme 2-1. Some unexpected and surprising
results have come from these studies, which show that the R- and S-HPCDH enzymes share some
common mechanistic features, but differ significantly in the strategies for controlling
enantioselectivity for the S- and R-HPC natural substrates, as well as nonphysiological aliphatic
alcohols and ketones.

These studies provide the first detailed "side by side" kinetic and

mechanistic analysis of such a novel pair of highly enantioselective dehydrogenases.

Scheme 2-1.
EXPERIMENTAL PROCEDURES
Materials. All commercially available chemicals were purchased from Sigma-Aldrich
Chemicals, Acros Organics or Fisher Scientific, and were of analytical grade. 2-KPC, R-HPC SHPC, HEC and M-HPC were synthesized as described previously (15). Chemical structures of the
compounds were confirmed using 1H NMR. The spectra of HPC enantiomers and 2-KPC were
identical to those reported previously (4, 15). Purity of the synthesized chemicals as determined
by reverse-phase HPLC was estimated to be ≥98%.
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Cloning of the S-HPCDH Genes (xecE1, xecE2, and xecE3). Total genomic DNA was
isolated from propylene-grown cells of X. autotrophicus strain Py2 using the Epicentre
MasterPure DNA purification kit. Each of the three xecE genes was PCR amplified using the
FailSafe PCR PreMix Selection Kit (Epicentre). Primers were designed such that the forward and
reverse primers contained BamHI and SacI restriction site overhangs, respectively. The primers
were as follows:
xecE1: forward, GCAGGATCCAATGCTGGACGCAGAGG; reverse,
CGTGAGCTCTCATATGGCGGTCATCC; xecE2: forward,
TAGGATCCAGTGGCGCGCGCCGCGGT; reverse,
ATGAGCTCTCATATGGCGGTCATCCCTC; xecE3: forward,
GCAGGATCCAATGTCGAATCGCTTGAAG; reverse,
GCAGAGCTCTCATATCGCCGTCATC.
The reactions contained 200 ng of X. autotrophicus genomic DNA, 1.0 µM primers, FailSafe
PCR Enzyme Mix (1.25 Units), and the manufacturers buffer H. PCR was performed using the
following cycling parameters: stage 1, (95 °C x 5 min) x 1; stage 2, (94 °C x 1min, 60 °C x 1
min, 72 °C x 50 s) x 35; stage 3, (72 °C x 10 min) x 1; The PCR products were analyzed on 1%
(w/v) agarose gels, and xecE1,

xecE2

and xecE3 DNA (0.75 kb, 0.69 kb, and 0.77 kb

respectively) were purified using the QIAquick gel extraction kit (Qiagen). Purified DNA along
with pET28-b (Novagen) and pRSFDuet-1 expression vectors were simultaneously subjected to a
double digest with BamHI and SacI, resolved on 1% agarose gel and purified with the QIAquick
gel extraction kit. Digested xecE genes and pET28-b DNA were mixed and ligated with T4 DNA
ligase for 2h at 25ºC. The resulting plasmids were designated: pDS41, pDS42 and pDS43, and
carried the xecE1, xecE2 and xecE3 genes, respectively. Likewise, digested xecE genes and
pRSFDuet-1 DNA were mixed and ligated with T4 DNA ligase for 2h at 25ºC, to result in
pDS51, pDS52 and pDS53 plasmids with xecE1,

xecE2

and xecE3 genes, respectively.
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Subsequent to DNA sequencing, all constructs were transformed into E.coli DH5α for plasmid
maintenance and into E. coli BL21 - (DE3) CodonPlus (Stratagene) cells for protein expression.
Site-Directed Mutagenesis (SDM). All primers used to introduce point mutations were
purchased from IDT. SDM of pDS53 was carried out utilizing the QuickChange Site-Directed
Mutagenesis Kit (Stratagene) according to the manufacturer’s protocols. All mutations were
confirmed by DNA sequencing. The sequences of the mutagenic primer pairs used for each codon
substitution in xecE3 are as follows:
S143A, GATCGTCAATTTTGGCGCCGTCGCTGGCCTC and
GAGGCCAGCGACGGCGCCAAAATTGACGATC; Y156A,
GACCATGGCGGCCGCCTGCGCAGCCAAG and
CTTGGCTGCGCAGGCGGCCGCCATGGTC; Y156F,
CCATGGCGGCCTTCTGCGCAGCCAAGG and
CCTTGGCTGCGCAGAAGGCCGCCATGG; K160A,
CCTACTGCGCAGCCGCGGGCGCAATCGTCA and
TGACGATTGCGCCCGCGGCTGCGCAGTAGG; R211A,
GAAGTTCAGGCTCGCGCGCTGGCGAAATATCC and
GGATATTTCGCCAGCGCGCGAGCCTGAACTTC; K214A,
CTCGCCGGCTGGCGGCATATCCGATCGGGC and
GCCCGATCGGATATGCCGCCAGCCGGCGAG.
DNA Sequencing. Sequencing was performed on an AB 3730 DNA Analyzer at the Utah
State University CIB DNA sequencing laboratory. The following sequencing primers were used
to

confirm

all

mutations

GGATCTCGACGCTCTCCCT

to
and

pDS53;

ACYCDuetUP1

DuetDOWN1

Primer
Primer

(Novagen),
(Novagen),

GATTATGCGGCCGTGTACAA.
Media and Growth of Bacteria. X. autotrophicus was grown on propylene (10% (v/v)
gas phase) in a 15L semicontinuous microferm fermenter as described previously (18). E.coli
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DH5α was grown in standard Luria-Bertani (LB) broth supplemented with kanamycin (50
µg•mL-1). E. coli BL21-(DE3) CodonPlus was grown in LB media that contained both kanamycin
(50 µg•mL-1) and chloramphenicol (50 µg•mL-1). All other procedures were performed as
described previously (15).
Preparation of Cell-Free Extracts. About 60 grams of frozen cell paste was thawed at
room temperature in 2 volumes of lysis buffer (20 mM Tris, 20% glycerol, 500 mM NaCl, 25
mM imidazole, 0.1% (w/v) Tween20, 0.03 mg•mL-1 DNase I, at pH 8.0). Homogenized cell
suspension was passed twice through a French press at 15000 psi and the crude lysate was
clarified by centrifugation at 244,717g for 45 min. The supernatant was further used for
purification.
Purification of S-HPCDH1, rS-HPCDH1, rS-HPCDH3 and rS-HPCDH3 Mutants. SHPCDH was purified from propylene-grown X. autotrophicus as described previously (5). For the
purification of rS-HPCDH1, rS-HPCDH3 and rS-HPCDH3 mutants, clarified cell extract was
applied to a 2.6 x 4.7 cm column of Ni Sepharose 6 Fast Flow (Amersham) at 3.0 mL•min-1 (33.9
cm•h-1). The column was rinsed at 6.0 mL•min-1 (67.8 cm•h-1) with 2 column volumes of lysis
buffer, followed by 80 column volumes of rinse buffer (20 mM Tris, 20% glycerol, 500 mM
NaCl, 50 mM imidazole, 0.1% (w/v) Tween20, pH 8.0). rS-HPCDH was eluted at 4.0 mL•min-1
(45.2 cm•h-1) with a linear gradient of 19.2 column volumes of 0-100% elution buffer (20 mM
Tris, 20% glycerol, 500 mM NaCl, 500 mM imidazole, pH 8.0). Fractions containing rS-HPCDH
were concentrated over a 30000 MW cutoff membrane, diluted in a 1:20 ratio with dialysis buffer
(20 mM Tris, 10% glycerol, 100 mM NaCl, pH 8.2) and concentrated again (this procedure was
repeated twice). Procedures for overnight dialysis against 5L buffer, described previously for rRHPCDH1 (15), couldn’t be followed due to protein precipitation. Dialyzed rS-HPCDH was flash
frozen and stored in liquid nitrogen. All steps were performed at 4 °C, and all buffers used had
the pH adjusted at 4 °C. Protein concentrations were determined on a NanoDrop
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spectrophotometer using theoretical extinction coefficients (ϵ280 = 10033 M-1 cm-1 for SHPCDH3, ϵ280 = 15595 M-1 cm-1 for S-HPCDH1, and ϵ280 = 18512.5 M-1 cm-1 for R-HPCDH1),
with dialysis flow-through buffers as blanks.
SDS-PAGE and Native PAGE Analysis. SDS-PAGE (12% T) and native PAGE (4-20% T
BioRad) were performed according to the Laemmli procedure (19). The apparent molecular
masses of polypeptides on a SDS-PAGE gel were determined by comparison to Rf values of
standard proteins. Migration of rS-HPCDH3 mutants was also compared directly to wild-type rSHPCDH3, wild-type rR-HPCDH1, native S-HPCDH and R-HPCDH (isolated from X.
autotrophicus). The apparent molecular masses of polypeptides on a native PAGE gel were
determined from a standard curve. The standard curve was constructed by plotting Rf values on
against the log of the native molecular mass for the following standards: β-amylase (200 kDa),
alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa) and ovalbumin (43 kDa).
Gel Filtration Chromatography. The native molecular masses of rS-HPCDH3 and rSHPCDH3 mutants were estimated by gel filtration chromatography using HPLC (Shimadzu SLC10A) with a fluorescence detector (Shimadzu RF-10AXL) set up for excitation and emission
wavelengths at 280 nm and 350 nm, respectively. The gel filtration column (BioSep-SEC S-2000,
300 x 7.8 mm, Phenomenex) was equilibrated in 50 mM Na2HPO4, 200 mM NaCl, pH 7.5,
containing 10% glycerol and 1 mM NAD+. The following molecular mass standards were used
for calibration: β-amylase (200 kDa), aldolase (158 kDa), conalbumin (75 kDa), bovine serum
albumin (66 kDa), ovalbumin (43 kDa), carbonic anhydrase (29 kDa), and myoglobin (18.8 kDa).
All separations were performed at 4 ºC, at a flow rate of 0.5 mL min-1. A calibration curve was
constructed by plotting the retention time against the log of the native molecular mass for
standards. This plot was fit using a second order polynomial, and the equation of this line was
used to determine the log native molecular masses for rS-HPCDH3 and rS-HPCDH3 mutants
using their experimentally determined retention times.
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Circular Dichroism (CD). CD spectra were recorded at 25 °C on an AVIV Model 410
CD Spectrophotometer, using 1 nm spectral bandwidth and a 0.1 cm path length. Stock peptide
solutions were desalted on Sephadex G-25 (PD-10) columns and diluted in 10 x buffer to a final
concentration of 10% glycerol, 10 mM KH2PO4 and 100 mM KF at pH 7.0. Total enzyme
concentration was approximately 0.3 mg•mL-1 (10 µM). Typically, five scans were acquired over
the wavelength range 190-260 nm. The residue ellipticity (Ѳ) was calculated using rS-HPCDH3
molecular weight of 27085.5 Da and NA (number of amino acid in the protein) of 268 residues.
Spectrophotometric Enzyme Assays. Assays with 2-KPC, S-HPC, R-HPC and 2-propanol
as substrates were performed in 50 mM glycine, 50 mM NaH2PO4, and 50 mM Tris base (GPT
buffer mix) at a pH of 7.5 (adjusted at 30 °C), as described previously (15). Assays with all other
substrates (C4 to C6 in carbon chain length) were carried out in 50 mM GPT buffer containing
15% (v/v) glycerol. Stock solutions of synthesized substrates were standardized, as described
previously (15) All enzyme assays were performed in triplicates at 30 °C in a Shimadzu model
UV160U spectrophotometer containing a water-jacketed cell holder for thermal control. Alcohol
or ketone production was monitored by measuring the change in absorbance at 340 nm using the
extinction coefficient for NADH (ϵ340 = 6.22 mM-1 cm-1). For alcohol oxidation assays, the
following ranges of alcohol concentrations were used in determining kinetic constants for RHPCDH1: R-HPC, 0.020 – 1.0 mM; S-HPC, 0.074-11 mM; 2-propanol, 65-3900 mM; (S)-2butanol, 10.9-381 mM; (R)-2-butanol, 43.6-490 mM. For S-HPCDH3 the concentrations were:
R-HPC, 0.038-48 mM; S-HPC, 0.016 – 0.310 mM; 2-propanol, (S)-2-butanol and (R)-2-butanol,
the same as for R-HPCDH1. The concentration of NAD+ for all assays was 10 mM (26 x value of
KmNAD+). For assays of ketone reduction, the following concentration ranges were used in
determining kinetic constants: 2-KPC, 0.050-2.6 mM; 2-butanone, 10-300 mM. The
concentration of NADH for these assays was 0.16 mM, (4.4 x value of KmNADH). On average,
seven concentrations of substrates within the ranges indicated were chosen for the kinetic
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analyses. All samples were degassed/flushed with nitrogen and incubated at 30 ºC water-bath for
5 min prior to the enzyme addition. To determine kinetic parameters (apparent Km and Vmax)
initial rate values were plotted as a function of substrate concentration and data points were fitted
to the Michaelis-Menten equation using SigmaPlot 11.0.
pH Dependence of Kinetic Parameters. All assays were performed in GPT buffer mix or
APT buffer mix (50 mM CH3COONa, 50 mM NaH2PO4, and 50 mM Tris base) at ten different
pH values (5.0 – 10.0) adjusted to the desired pH at 30 ºC, as described previously (15). The
assay results were used to construct a plot of kcat/Km vs pH, which was then fit to Equation 1:

log kcat/Km = log(C/(1 + [H+]/ Ka))

(Eq1)

where C is the maximal log kcat/Km value and Ka is the acid dissociation constant of the
catalytically important ionizing residue. Plots of log kcat and log Km vs pH were constructed in a
point-to-point manner. Stability of the enzyme at a pH 5.0 and 10.0 was tested according to the
pH-jump method (20). The stock solution of rS-HPCDH3 was diluted to 0.1 mg•mL-1 in 10 mM
APT or GPT buffer mix containing 15% glycerol, at pH values of 5.0 and 10.0, respectively. The
enzyme was equilibrated on ice at the desired pH (adjusted at 4 ºC) for 5 min prior to its addition
to the reaction mixture (total of 0.3 µg of rS-HPCDH3). Activity assays were performed for 30
sec in 100 mM GPT buffer mix, pH 7.5, at 30 °C.
Inhibition Studies. All assays were performed in GPT buffer mix at pH 7.5 with
saturating concentration of NAD+ (5 mM). Inhibition assays for R-HPCDH1 were performed at
variable concentrations of R-HPC (31, 72, 144, 287 and 615 µM) or HEC (0.8, 2.0, 4.0, 8.0 and
1.6 mM). Each assay was performed at several fixed concentrations of M-HPC: (0, 0.2, 0.4, 0.8
and 1.6 mM). Initial rate data for rR-HPCDH1 were fit to Equation 2 describing competitive
inhibition of enzymatic activity:
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υ = Vmax[S]/(αKm + [S])

(Eq 2)

where S is the substrate, I is the inhibitor, α = 1 + ([I]/Kis). The type of inhibition exhibited by MHPC was determined by graphing initial rate data in the form of double reciprocal plots (1/υ vs
1/[S] at various [I]). Numerical value of Kis was calculated from equation 2 using SIGMA-PLOT.
Inhibition assays for S-HPCDH3 were performed at varying concentrations of S-HPC (16, 31, 62,
155 and 310 µM) or HEC (0.4, 0.8, 2.0, 4.0, 8.0, and 1.6 mM) and three fixed concentrations of
M-HPC: (0, 1.2 and 4.9 mM). Initial rate data were fit to a rectangular hyperbola described by the
standard form of the Michaelis-Menten equation.
Chiral Gas Chromatographic Assay for 2-Butanone Reduction. All assays were
performed in GPT buffer mix, pH 7.5 (adjusted at 30 ºC), containing 15% (v/v) glycerol. Assay
components in 1 mL reaction volume were: NADH (15 mM), 2-butanone (56 mM), and 0.64 mg
of enzyme. Serum vials (3 mL) were crimp-sealed and degassed/flushed with nitrogen three times
and allowed to equilibrate for 20 min at 30 ºC in a shaking water-bath (200 rpm). The assay was
initiated by adding enzyme. After 1 h incubation 250 µL of headspace gas was removed and
injected into a Shimadzu GC-8A gas chromatograph outfitted with a Supelco β-Dex 225 (30 m ×
0.53 mm) column. GC parameters used were as previously described (14).
RESULTS AND DISCUSSION
Genetic and Bioinformatic Analysis of the Enzymes of Alkene and Epoxide Metabolism.
A previous study demonstrated that the genes of alkene and epoxide metabolism are present on a
320 kb linear megaplasmid in X. autotrophicus Py2 (21). Furthermore, the genes encoding the
enzymes of epoxide carboxylation were found to be clustered in an operon where xecA, xecC,
xecD, and xecE encode the key enzymes shown in Figure 2-1 (5, 22). Of significance to the
present work, xecD encodes R-HPCDH, while xecE encodes S-HPCDH. All four of the enzymes
of epoxide carboxylation were purified and characterized in some detail from the native
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bacterium (4-6, 23). Of relevance to our interest in determining the molecular basis for
enantioselectivity in the dehydrogenation reactions of Figure 2-1, the xecD gene was successfully
cloned into an E. coli expression vector and the enzyme was over-expressed and purified in a
fully active state (15). This allowed for the production of the necessary amounts of protein for
kinetic, mechanistic, and structural characterization, and the construction of site-directed mutants
that provided valuable insights into the catalytic mechanism and the roles of key amino acid
residues in catalysis and controlling enantioselectivity (14-16). Unfortunately, all attempts to
clone and express the counterpart S-HPCDH in a soluble and active form were unsuccessful
despite numerous attempts (15), and the mechanistic and structural characterization of this
enzyme has thus lagged behind that of the R-HPCDH.
Recently, the genome of X. autotrophicus Py2 was sequenced, assembled, and annotated
(http://genome.jgi-psf.org/xanau/xanau.home.html). Unexpectedly, an analysis of the linear
megaplasmid of X. autotrophicus shows the presence of multiple copies of the xec genes, as well
as for the putative enzymes of coenzyme M biosynthesis. In contrast, only a single copy of the
genes encoding the alkene monooxygenase multicomponent enzyme system that converts
propylene to epoxypropane (xamoABCDEF) are present. The xec paralogs are distributed among
three apparent operons and share high identities. The xecD and xecE genes whose protein
sequences were reported previously (5, 22) are those located in an operon approximately 10.4 kbp
downstream of the xamo operon, while the additional copies are located about 197 and 223 kbp
downstream of this first operon. For naming purposes, these copies are now referred to as xecD1
and xecE1, to designate they are found in the first gene cluster, while the additional copies are
referred to as xecD2, xecE2, xecD3 and xecE3 based on which of the additional two clusters they
are found within. Since the abbreviations R- and S-HPCDH has been used previously, these
proteins will also be affixed with the numbers 1, 2, and 3 for naming purposes (i.e., XecD1 is RHPCDH1 while XecD2 is R-HPCDH2 and so on).
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The identification of multiple copies of the xec genes in the linear plasmid genome
rationalizes some previous unexplained observations. Most notably, we were unsuccessful in
using a highly efficient transposon mutagenesis system optimized for X. autotrophicus to obtain
mutants defective in growth with epoxides as the carbon source, although the same system
allowed for the identification of the enzymes of carotenoid biosynthesis, acetone metabolism, and
alkene oxidation (24, 25). Since the transposon mutagenesis system relies on insertional
inactivation of a single gene with a kanamycin cassette, no phenotype will be observed where
multiple redundant copies are present in the genome, which the sequence of the linear
megaplasmid has now revealed is the case for the genes and enzymes of epoxide carboxylation
(but not alkene oxygenation).
Cloning, Expression, and Biochemical Characterization of xecE Homologs. Each of the
three S-HPCDH homologs identified on the linear megaplasmid was expressed using an
optimized expression system with the inclusion of N-terminal six-histidine tags. Only small
amounts (<0.1 mg/g cell paste) of the XecE1 (S-HPCDH1) protein were present in the soluble
fraction, with most of the protein being in inclusion bodies. The small amount of soluble protein,
when purified, had a specific activity nearly identical to the native enzyme, demonstrating that the
enzyme can be expressed in an active form, albeit at levels too low for detailed biochemical and
structural characterization. The second copy, XecE2 (S-HPCDH2), contained apparent mutations
in the N-terminal region, most notably the lack of the classic GXXXGXG cofactor sequence
motif that is found within the Rossman fold (10). This protein was expressed with more protein
in the soluble fraction (~50%), but was completely inactive, as expected due to the lack of key
NAD+-binding residues. The third copy, XecE3 (S-HPCDH3), was very similar to xecE1, with
74% identity, and with all of the conserved SDR sequences intact (Figure 2-2). XecE3 was
expressed in high yields in a soluble form (>4 mg enzyme/g cell paste), and when purified, had a
specific activity nearly identical to that of S-HPCDH1 and S-HPCDH purified from X.
autotrophicus.
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Figure 2-2. Multiple-sequence alignment of S-HPCDH1, S-HPCDH3 and R-HPCDH1 enzymes
from X. autotrophicus Py2. Abbreviations: Cons.S1&3, consensus amino acid alignment for SHPCDH1 and S-HPCDH3; Cons.all, consensus of S-HPCDH1, S-HPCDH3 and R-HPCDH1
Letter designations: a, Classic GXXXGXG glycine-rich NAD+ binding motif. b, Catalytic tetrad
residues of Asn, Ser, Tyr and Lys. c, Positively charged residues that have been shown (RHPCDH1) or are proposed (S-HPCDH) to interact with the sulfonate group of CoM in the
substrate. The alignment was generated using MULTALIN with default parameters, while the
consensus was derived using ClustalW2. The following symbols mean that the residues are: (*)
identical; (:) conserved ; (.) semi-conserved.

The rS-HPCDH3 was subjected to gel filtration chromatography and eluted as a single
peak with an apparent molecular mass of 70.2 kDa. By comparison, native S-HPCDH and rRHPCDH1 eluted from the same column with apparent molecular masses of 49.6 kDa and 64.7
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kDa, respectively, results that are identical to those reported previously when the proteins were
analyzed using a different (Superose-12) gel filtration column (5, 15). The molecular masses of
the R- and S-HPCDH polypeptides are all in the 25-26 kDa range, and each of the native SHPCDH, rR-HPCDH1, rS-HPCDH1, and rS-HPCDH3 proteins migrated as single bands on
SDS-PAGE gels at the expected positions based on their molecular masses.
It is unclear why rS-HPCDH3 elutes with a higher apparent molecular weight on the gel
filtration column than native S-HPCDH and more similarly to how R-HPCDH migrates. The
discrepancy could be due to the likelihood that the S-HPCDH we purified from the native
organism is a homogeneous (or nearly homogeneous) preparation of the XecE1 homolog (SHPCDH1), and that this protein elutes differently from that of XecE3. This idea is supported by
the results of N-terminal sequence analysis of native S-HPCDH by Edman degradation, which
provided the sequence MLDNEVIAIT (5). As shown in Figure 2-2, XecE1 is identical at the Nterminus to that sequence except for one amino acid (the N at position 4). In contrast, the Nterminus of XecE3 has the N-terminal sequence MSNRLKN before converging with XecE1 at
EVIAIT (Figure 2-2). Clearly, the presence of three homologs of each of the HPCDH enzymes
emphasizes the importance of expressing specific enzymes in a defined expression system.
Originally, both R- and S-HPCDH were proposed to be dimers based on their elution
profiles on gel filtration (5). However, the crystal structure of rR-HPCDH1 clearly showed a
tetrameric structure (16), as has been seen for some other members of the SDR family of enzymes
(26-28). Thus, as for many proteins, the HPCDH enzymes may migrate anonymously on gel
filtration columns and we are hesitant to predict the quaternary state of rS-HPCDH3 based on the
gel filtration results.
Native PAGE, gel filtration chromatography, and CD spectrapolarimetric analyses were
performed with wild-type rS-HPCDH3 and the mutants described subsequently (S143A, Y156A,
Y156F, K160A, R211A, K214A). Native PAGE and gel filtration revealed that all of the rSHPCDH3 mutants migrated in a similar manner to that of the wild-type rS-HPCDH. CD analysis
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of the rS-HPCDH3 mutants generated spectra that are indistinguishable from that of the wild-type
enzyme. Collectively, these data suggest that elimination or alteration of the activity of rSHPCDH3 mutants is not due to major structural changes in the protein, but a result of a change in
the chemical environment surrounding substituted residues.
Kinetic Parameters for rS-HPCDH1, rS-HPCDH3, and rR-HPCDH with Physiological
Substrates. Native S-HPCDH1 was previously shown to be highly specific for S-HPC as the
substrate, exhibiting only 0.5% activity when R-HPC was used as the substrate, but the kinetic
parameters for the enzyme were not investigated (4). In the present work, the kinetic analysis of
rR-HPCDH1 performed previously (14) was repeated in side by side experiments with the two
active XecE homologs so that the three enzymes can be compared directly. Although expressed
only at very low levels, rS-HPCDH1 was included in these analyses in order to see if the two
XecE homologs had any significant differences in catalytic properties. For these analyses, varying
concentrations of R-HPC, S-HPC, or 2-KPC and fixed concentrations of NAD+ and NADH
several times higher than Km were used to determine the apparent Km, Vmax, and kcat values for
each enzyme in the forward (oxidative) and reverse (reductive) directions under conditions
identical to those done previously (14). These results are presented in Table 2-1.
The apparent kcat and Km values determined for R-HPC and S-HPC oxidation, and 2-KPC
reduction, by rR-HPCDH1 are similar to those reported previously (14). With regard to rSHPCDH1 and rS-HPCDH3, the apparent kcat values for S-HPC oxidation are nearly identical to
each other, while the apparent Km is seven-fold lower for rS-HPCDH3. For 2-KPC reduction, rSHPCDH1 exhibits a two-fold higher kcat but nearly identical Km relative to rS-HPCDH3. As
noted above, S-HPCDH1 and S-HPCDH3 share high identity (74%) but are not identical
enzymes, so it is not surprising that some differences in kinetic parameters are observed.
The most surprising results of the kinetic analyses are the large relative differences in kcat
and Km for the opposite enantiomers when characterized as substrates for the R- and Sdehydrogenases. As shown in Table 2-1, rR-HPCDH1 catalyzed the oxidation of S-HPC with a

Table 2-1. Kinetic Parameters for R- and S-HPCDH with physiological substrates in the forward and reverse directionsa
rR-HPCDH1
rS-HPCDH1
rS-HPCDH3
Km
kcat
kcat /Km
Km
kcat
kcat /Km
Km
kcat
kcat /Km
(µM)
(s-1)
(M-1 s-1)
(µM)
(s-1)
(M-1 s-1)
(µM)
(s-1)
(M-1 s-1)
R-HPC
95.5 ± 7.5
47.9 ± 1.1
5.0 x 105
5230 ± 350
2.41 ± 0.057
4.6 x 102
9110 ± 1120
5.48 ± 0.23
1.2 x 103
2
5
S-HPC
224 ± 72 0.119 ± 0.0099
5.3 x 10
222 ± 23
28.2 ± 0.80
1.3 x 10
31.4 ± 0.89
24.8 ± 0.17
7.9 x 105
5
4
2-KPC
67.9 ± 12
28.9 ± 1.6
4.2 x 10
241 ± 11
20.0 ± 0.24
8.3 x 10
275 ± 13
10.8 ± 0.15
3.9 x 104
a
Assay for R-HPC and S-HPC oxidation by rR-HPCDH1 contained 1.0 µg and 46 µg of enzyme, respectively. Assay for R-HPC and S-HPC
oxidation by rS-HPCDH1 and rS-HPCDH3 contained 5.0 µg and 1.0 µg of enzyme, respectively. Assay for 2-KPC reduction contained 1 µg of
enzyme. Apparent kcat and Km values are reported as means ± standard deviations. All assays were performed in triplicates at 30 ˚C with fixed
concentrations of NAD+ (10 mM) or NADH (0.17 mM). Apparent kinetic constants were determined by fitting experimental data to the standard
form of the Michaelis-Menten equation.
Substrate
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kcat that is 402-times less than that for R-HPC. In contrast, rS-HPCDH1 and rS-HPCDH3
catalyzed the oxidation of R-HPC with kcat values only 11 and 4.5-times less than that for S-HPC,
but with substantially higher Km values (24 and 290-times higher) (Table 2-1).
A comparison of the catalytic efficiencies (kcat/Km) of the three enzymes for the (R)- and
(S)-enantiomers provides additional insights.

The catalytic efficiencies for the “natural”

enantiomers for each enzyme are in the range of 1 to 8 x 105. By comparison, the catalytic
efficiencies for the opposite enantiomers are about three orders of magnitude lower. When
enantioselectivity (E) is defined as the ratio of kcat/Km for the natural enantiomer to kcat/Km for the
opposite enantiomer, the following values are obtained: ERHPCDH1 = 944, ESHPCDH1 = 283, and
ESHPCDH3 = 658. Thus, the HPCDH enzymes are highly efficient at discriminating between the
HPC enantiomers, with enantioselectivity controlled largely by differences in kcat for R-HPCDH,
and predominantly by differences in Km for the two S-HPCDH enzymes.
The rS-HPCDH1 and rS-HPCDH3 homologs are similar but not identical in terms of
their catalytic properties, verifying that the homologs are redundant S-HPC specific enzymes. The
subsequent studies of S-HPCDH are focused on rS-HPCDH3, since only this protein could be
expressed in sufficient amounts for the detailed analyses described below.
The apparent Km values for NAD+ and NADH with R-HPC and 2-KPC as substrates were
determined for rS-HPCDH3 and gave the following values: Km for NAD+, 191 ± 21 µM; Km for
NADH, 8.42 ± 1.58 µM. By comparison, the Km values for rR-HPCDH1 using a complete
bisubstrate kinetic analysis were previously reported to be 457 μM and 36.6 μM for NAD+ and
NADH, respectively (15).
pH Dependence of the Kinetic Parameters for rS-HPCDH3. Kinetic parameters were
determined for the oxidation of S-HPC by rS-HPCDH3 at a range of pH values and plotted as log
kcat vs pH, log kcat/Km vs pH and log Km vs pH as was done previously for oxidation of R-HPC by
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rR-HPCDH1 (15). These results are presented in Figure 2-3. The overall trends are similar to
those reported for rR-HPCDH1 but with some important differences (15) suggesting a similar
fundamental chemical mechanism for substrate oxidation. The differences in the pH analyses for
the two enzymes are highlighted below.
Figure 2-3A shows a fairly steady increase in log kcat as the pH increases (slope 0.08)
suggesting that isomerization of the enzyme-NAD+ complex could be a major rate-determining
step, as described for other dehydrogenases (29). The same effect was seen for rR-HPCDH1 (15),
although the change in kcat was more pronounced (over six-fold increase vs. three-fold increase
for rS-HPCDH3). Linear regression of the plot of log kcat/Km vs. pH from pH 5.0 – 8.0 (Figure 23B) gave a slope of 0.998 with an R2 value of 0.980, suggesting the importance of a single
ionizable residue that must be deprotonated for catalysis. A fit of the data in Figure 2-3B to
Equation 1 provides a pKa value for this residue of 7.9. Based on pH studies of other SDR
enzymes, the ionizable residue most likely represents the tyrosine of the catalytic triad, which
serves as the general acid/base for catalysis. For comparison, the pKa value for the corresponding
ionizable group of rR-HPCDH1 was reported to be a lower value of 6.9 (15), while the prototype
alcohol dehydrogenases from Drosophila melanogaster and D. lebanonensis were reported to be
7.1 and 7.6, respectively (30, 31).
The data presented in Figure 2-3C show a dramatic decrease in Km (321-fold decrease
from pH 5.0 to pH 9.0) as the pH is increased. Taken together with the above results, this
suggests that the deprotonated tyrosine general base plays an important role in both alcohol
binding (Km effect) and catalysis (kcat and kcat/Km effects). The increase in Km from pH 9 to pH 10
could reflect deprotonation of another functional group important in coordinating the sulfonate of
CoM (K214, as described below). The decrease in Km for rS-HPCDH3 was much greater than
that observed for rR-HPCDH1, where only a 14-fold decrease in Km was observed (15). This
suggests that the general acid/base of S-HPCDH3 is more important for binding of the alcohol
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substrate in the (S)-dehydrogenase than the (R)-dehydrogenase, an idea that is supported by the
further studies described below.

Figure 2-3. Changes of kinetic parameters with pH for rS-HPCDH3 catalyzed oxidation of SHPC. (A) kcat vs. pH, (B) kcat/KmS-HPC vs. pH, (C) KmS-HPC vs. pH, represented in log scale. The
plots in (A) and (C) are shown as simple line plots. The line in plot (B) was generated by a fit of
the experimental data to equation 1.
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Site-Directed Mutagenesis of the Catalytic Triad. As noted in the Introduction, members
of the SDR family of enzymes contain a catalytic triad consisting of a serine, a tyrosine, and a
lysine (or, as more recently described, a tetrad, with the fourth residue being an asparagine) (10,
11). As shown in Figure 2-2, the positions of these residues in the primary sequences are
conserved between the R- and S-HPCDH enzymes. To confirm the importance of the key
residues, site-directed mutants were constructed. As shown in Table 2-2, the Y156F and K160A
mutants were completely inactive. The S143A mutant exhibited a small amount of activity but
with a catalytic efficiency that was reduced by more than five orders of magnitude relative to
wild-type. Interestingly, the Y156A mutant exhibited a kcat that was 2.6% of the activity of the
wild-type enzyme, with a Km value 60-fold higher than wild-type. The observation that the
Y156A, but not Y156F mutant retains some activity suggests that the removal of the bulky phenyl
group allows the enzyme to facilitate hydrogen atom abstraction from the hydroxyl group by
another mechanism. An analysis of the primary sequences of the HPCDH enzymes shows that a
cysteine residue is next to the tyrosine base in the S-enzymes but not the R-enzyme (Figure 2-2).
A cysteine is also adjacent to the catalytic triad in the SDR 17β-hydroxysteroid dehydrogenase,
and the Y to A substitution in that enzyme also exhibits a small amount of activity (32). It is
conceivable that C157 substitutes as the general base in the Y156A mutant, albeit with a reduced
catalytic efficiency, although this possibility has not been pursued further in this study.
Identification and Site-Directed Mutagenesis of the Sulfonate Binding Residues. For rRHPCDH1, two arginine residues, R156 and R196, were shown to interact with the sulfonate of
CoM via ionic interactions (Scheme 1, left side) (14, 16). Site-directed mutagenesis of either of
these residues to alanine resulted in substantially reduced kcat values and increased Km values for
2-KPC reduction. Importantly, the same amino acid substitutions did not significantly alter kcat or
Km when 2-butanone, a non-physiological substrate lacking the sulfonate, was used as the
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substrate (14). Thus, the sulfonate-coordinating arginine residues of R-HPCDH1 are only
required for effective catalysis with the natural substrate. By analogy, positively charged residues
within a pocket are believed to interact with the sulfonate moiety of 2-KPC and S-HPC in SHPCDH, but with differential placement relative to the methyl binding pocket such that the
hydroxyl group and hydrogen atom of the substrate are oriented properly for catalysis (14, 16).
To facilitate the identification of these residues, a homology model was constructed for SHPCDH3 based on the R-HPCDH1 structure, as was done previously for S-HPCDH1 (at the time
it was thought that there was only one copy of this enzyme) (16). The physiological substrates for
each enzyme were modeled into the active sites of the enzymes using the crystal structure that
was obtained for rR-HPCDH1 bound to S-HPC (16). As shown in Figure 2-4A, the positioning of
the catalytic triad residues, verified for S-HPCDH3 by the mutational analyses in Table 2-2, are
conserved between the two S-HPCDH enzymes. As predicted, the active sites of the enzymes
differ in the spatial orientations of the CoM and methyl groups, with the positions of the
hydrogen atom and hydroxyl group being fixed relative to NAD+ and the tyrosine general base.
Figure 2-4B shows a different view of the active sites, highlighting the interactions known (for
rR-HPCDH1) and proposed (for rS-HPCDH3) to be important in binding the sulfonate of CoM.
While two arginines coordinate the sulfonate within R-HPCDH1, the model suggests coordination
by an arginine and a lysine for S-HPCDH3 (as well as S-HPCDH1 as seen in the multiple
sequence alignment of Figure 2-2). To verify the importance of these residues, they were mutated
to alanines, and the effects on enzymatic activity were determined. As shown in Table 2-3,
substitution of either R211 or K214 by alanine resulted in substantially reduced catalytic
efficiencies for S-HPCDH3 with the natural substrates in both the forward (oxidative, S-HPC as
substrate) and reverse (reductive, KPC as substrate) directions. Interestingly, the most dramatic
effects of the mutations were on Km values, which were 50-74 times higher in the oxidative

Table 2-2. Summary of Amino Acid Substitutions Made to the Putative rS-HPCDH35 Catalytic Residues Using Site-Directed Mutagenesis a

amino acid

postulated catalytic role(s) b

substitution

Vmax

Km

kcat

kcat /Km

(units•mg-1)

(µM S-HPC)

(s-1)

(M-1 s-1)

none

54.8 ± 0.37

31.4 ± 0.89

24.8

7.49 x 105

S143

H-bond donor to substrate/charge
stabilization of the transition state

S143A

0.0290 ±
0.0030ca

9480 ± 2500

0.0131

1.38 x 100

Y156

general acid/base

Y156A

1.44 ± 0.045ca

1850 ± 180

0.652

3.52 x 102

Y156F

no activityd

K160A

no activityd

K160

lowers pKa of Y156/coenzyme binding

a

Abbreviations: S-HPC, 2-[(S)-2-hydroxypropylthio]ethanesulfonate. bPostulated catalytic roles are based on a general trend found in
most SDR enzymes (including R-HPCDH). cAssays contained 66 μg of S143A or 20 μg of Y156A, 5 mM NAD+ and variable
concentration of S-HPC. dNo activity was defined as no measurable change in the absorbance at 340 nm (for NADH) in assays containing
100 μg of the protein, 2.5 mM of S-HPC and 20 mM NAD+. Apparent Vmax and Km values are reported as means ± standard deviations. All
other values are reported as means only. All assays were performed in triplicate at 30 ºC with fixed concentrations of NAD+. Apparent
kinetic constants were determined by fitting experimental data to the standard form of the Michaelis-Menten equation.
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Figure 2-4. Superimposed active sites of R-HPCDH1 and S-HPCDH3 based on the crystal
structure of R-HPCDH1 and a homology model of S-HPCDH3. The cartoon structures and carbon
atoms of amino acid residues of R-HPCDH1 (pdb ID 2cfc) and the homology model for SHPCDH3 are colored grey and green, respectively. NAD+ is shown in magenta. R-HPC and SHPC were modeled using the crystal structure for S-HPC bound at the active site of R-HPCDH1
as described previously (16). In both views, R-HPC (grey carbon atoms) and S-HPC (green
carbon atoms) are modeled at the active sites such that the positions of the hydroxyl group and
hydrogen atom occupy the same positions. The methyl groups and the methylene groups linking
the hydroxypropyl groups to CoM are overlayed on top of each other to highlight the different
spatial orientations of these groups in R- and S-HPC. Panel A, Superimposed structures
highlighting the interactions of substrates with the catalytic triads. Panel B, Superimposed
structures highlighting the interactions of substrates with the amino acids that coordinate the
sulfonate of CoM.
direction and 41-43 times higher in the reductive direction. There was a significant (40-80%)
decrease in kcat due to the mutations for the forward reaction, but very little change for the
reductive direction. By comparison, 2-KPC reduction by the R152A and R196A mutants of RHPCDH1 were impaired sizably in both Km and kcat values (14). The kcat and Km values measured
for the reduction of the aliphatic ketone 2-butanone and the oxidation of the aliphatic alcohol 2propanol were largely unaffected by the amino acid changes in S-HPCDH3 (Table 2-3). These
aliphatic substrates had dramatically higher Km values and lower kcat values relative to the natural
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substrates, highlighting the importance of the CoM moiety in catalysis. The fact that the kinetic
parameters did not change substantially in the site-directed mutants demonstrates that the

Table 2-3. Kinetic Parameters for wild-type rS-HPCDH3 and R211A and K214A with various
substrates a
Enzyme

wild-type

Km

Change in

kcat

Change in

kcat /Km

(mM)

Km (x-fold)

(s-1)

kcat (x-fold)

(M-1 s-1)

1.0

7.9 x 105

0.0314 ± 0.00089

Substrate: S-HPC
1.0
24.8 ± 0.17

R211A

1.55 ± 0.12

49

16.0 ± 0.42

0.64

1.0 x 104

K214A

2.30 ± 0.094

73

5.78 ± 0.090

0.23

2.5 x 103

wild-type

0.275 ± 0.013

Substrate: 2-KPC
1.0
10.8 ± 0.15

1.0

3.9 x 104

R211A

11.4 ± 0.48

41

8.59 ± 0.18

0.80

7.5 x 102

K214A

11.8 ± 0. 94

43

9.62 ± 0.34

0.89

8.1 x 102

1.0

3.7 x 102

Substrate: 2-butanone
1.0
0.0438 ± 0.00086

wild-type

118 ± 5.3

R211A

179 ± 26

1.5

0.0718 ± 0.054

1.6

4.0 x 102

K214A

71.9 ± 6.1

0.61

0.0387 ± 0.0012

0.90

5.4 x 102

wild-type

1410 ± 59

1.0

1.4 x 103

R211A

724 ± 36

0.51

1.72 ± 0.035

0.85

2.4 x 103

K214A

951 ± 18

0.67

1.73 ± 0.19

0.86

1.8 x 103

a

Substrate: 2-propanol
1.0
2.02 ± 0.54

Assay for S-HPC oxidation contained 0.20 μg of wild-type rS-HPCDH3, or 4.0 μg of R211A
and K214A while assay for 2-KPC reduction contained 0.20 μg of wild-type rS-HPCDH3, 5.0 μg
of R211A and 2.0 μg of K214A. Assay for 2-butanone reduction contained 197 μg of enzyme
while assay for 2-propanol oxidation contained 8.0 μg of enzyme. Apparent kcat and Km values are
reported as means ± standard deviations. All other values are reported as means only. All assays
were performed in triplicates at 30 ºC with fixed concentrations of NAD+ (10 mM) or NADH
(0.17 mM). Apparent kinetic constants were determined by fitting experimental data to the
standard form of the Michaelis-Menten equation.
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sulfonate-binding residues are not important for aliphatic substrates where no favorable
interaction with the positively charged residues would occur. Similar results were obtained when
2-butanone was analyzed as a substrate for wild-type R-HPCDH1 and the R152A and R196A
mutants (14).
S-HPCDH3 Has an Inherent Stereoselectivity for 2-Butanone Reduction not Present in
R-HPCDH1. To gain further information on the stereoselectivity of S-HPCDH3, the chiral
products of 2-butanone reduction ((R)- and (S)-2-butanol) were quantified. As shown in Table 24, S-HPCDH3 has a very high inherent stereoselectivity, producing (S)-2-butanol with a 98.4%
enantioexcess (ee). These results are dramatically different than those observed for R-HPCDH1,
where (S)-2-butanol is also produced in higher amounts than (R)-2-butanol, but in only a 44%
enantioexcess (Table 2-4 and (14)). Thus, even though the R- and S-HPCDH enzymes are highly
specific for production of R-HPC and S-HPC from 2-KPC reduction, they both form excesses of
(S)-2-butanol from 2-butanone, a result that seems contradictory to what one might expect from
the stereoselectivity observed for the natural substrates and products.
An interesting feature of the R-HPCDH1 is that the enantioselectivity of 2-butanone
reduction can be "modulated" to produce higher amounts of (S)-2-butanol by including CoM,
methanesulfonate,

ethanesulfonate,

or

propanesulfonate

in

the

assay

(14).

These

"enantioiselective modulators" modulated stereospecificity in a saturable fashion, with a
theoretical yield of 100% (S)-2-butanol at the saturation points (14).

The effects of these

enantioselective modulators were abolished in mutants in the sulfonate-coordinating arginines
(R152A and R196A) (14). These results were interpreted as follows: the alkylsulfonates bind in
the CoM binding pocket, constraining 2-butanone to bind in the active site with the methyl group
rather than the ethyl group oriented towards the bound alkylsulfonate to prevent steric clashes. In
this orientation, the sp2 hybridized carbonyl of 2-butanone is necessarily constrained for hydride
transfer

to

the

plane

that

produces

(S)-2-butanol

(14).

Table 2-4. Enantioselectivity of 2-butanone reduction by wild-type rS-HPCDH3, rS-HPCDH3 mutants, and rR-HPCDH1a
no additions

+ 1 mM ethanesulfonate
ee

ee

% (S)-2-

% (R)-2-

(S)-2-

% (S)-2-

% (R)-2-

(S)-2-

butanol

Butanol

butanol

butanol

butanol

butanol

rS-HPCDH3

99.18 ± 0.15

0.82 ± 0.15

98.36

98.03 ± 0.08

1.97 ± 0.08

96.06

rS-HPCDH3 R211A

99.42 ± 0.22

0.58 ± 0.22

98.84

99.36 ± 0.15

0.64 ± 0.15

98.72

rS-HPCDH3 K214A

91.59 ± 0.31

8.41 ± 0.31

83.18

90.88 ± 0.20

9.12 ± 0.20

81.76

rR-HPCDH1

71.94 ± 1.34

28.06 ± 1.34

43.88

92.67 ± 0.05

7.33 ± 0.05

85.34

Enzyme

All assays were performed in triplicate at 30 °C using 0.64 mg enzyme, 15 mM NADH, and 56 mM 2-butanone. Percent yields
are reported as means ± standard deviations.
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Table 2-5. Kinetic Parameters for rS-HPCDH3 and rR-HPCDH1 catalyzed oxidation of 2-butanola

Substrate

Km

Vmax

kcat

kcat /Km

Change in Change in enantiokcat
Km
selectivity

(mM)

(units/mg)

(s-1)

(M-1 s-1)

(x-fold)

(x-fold)

(E)

rS-HPCDH3
(R)-2-butanol

67.6 ± 3.4

2.23 ± 0.03

1.00

14.8

1.00

1.00

0.16

(S)-2-butanol

28.1 ± 1.5

5.77 ± 0.07

2.60

92.8

2.60

0.42

6.27

rR-HPCDH1
(R)-2-butanol

215 ± 11

3.77 ± 0.06

1.87

8.69

1.00

1.00

0.33

(S)-2-butanol

353 ± 45

18.8 ± 0.9

9.34

26.4

4.99

1.64

3.04

a

All assays were performed in triplicate at 30 ˚C with fixed concentrations of NAD+ (10 mM). Assays of 2butanol oxidation catalyzed by rS-HPCDH3 and rR-HPCDH1 contained 25 and 21 μg of enzyme,
respectively. Apparent kinetic constants were determined by fitting experimental data to the standard form of
the Michaelis-Menten equation. Apparent Vmax and Km values are reported as means ± standard deviations. All
other values are reported as means only. Enantioselectivity was defined as (kcat/Km)R-enantiomer/(kcat/Km)S-enantiomer
for (R)-2-butanol oxidation and as (kcat/Km)S-enantiomer/(kcat/Km)R-enantiomer for (S)-2-butanol oxidation.
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As shown in Table 2-4, the addition of 1 mM ethanesulfonate to rS-HPCDH3 had very little
effect on the stereochemical outcome of 2-butanone reduction relative to the effect observed with
rR-HPCDH1. No effect of ethanesulfonate was seen in the rS-HPCDH3 wild-type or R211A
mutant. Interestingly, the enantioselectivity decreased somewhat for the rS-HPCDH3 K214A
mutant, an effect that was not changed when ethanesulfonate was added. Perhaps the substitution
of lysine by the smaller alanine opens the active site to allow 2-butanone to bind in an orientation
producing more of the (R)-product.

In any event, the high inherent stereoselectivity for

production of (S)-2-butanol from 2-butanone reduction by rS-HPCDH3, the same enantiomer
produced in excess by rR-HPCDH1 and that can be increased by the addition of alkysulfonates,
highlights a significant difference in how the two enzymes act on non-physiological aliphatic
ketones.
Dehydrogenation of 2-Butanol Enantiomers by rR- and rS-HPCDH Enzymes.

The

studies of 2-butanone reduction were expanded to examine the kinetic parameters for the reverse
reaction, i.e., (R)- and (S)-2-butanol oxidation to 2-butanone. These results are summarized in
Table 2-5. Both enzymes exhibited a preference for (S)-2-butanol as the substrate, with
enantioselectivity values of 6.23 and 3.04 for rS-HPCDH3 and rR-HPCDH1, respectively. These
results are in agreement with the studies showing (S)-2-butanol to be the preferred product of 2butanone reduction for both enzymes. The Km values for 2-butanone reduction were about 1000times higher than for 2-KPC. Clearly, the sulfonate of CoM is a determining factor in the
exquisite stereoselectivity for (R)- and (S)- enantiomers for the natural substrates.
2-(2-methyl-2-hydroxypropylthio)ethanesulfonate is a Competitive Inhibitor of Natural
Substrate Oxidation by rR-HPCD1H but not rS-HPCDH3. Referring back to the studies of Table
2-1, rR-HPCDH1 exhibits a Km for S-HPC in the same range as R-HPC, while rS-HPCDH3
exhibits a Km for R-HPC that is nearly 300-times higher than for S-HPC. If Km is a measure of
binding affinity, these results indicate that rR-HPCDH1 is able to bind either enantiomer with
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high affinity, although for the improper enantiomer, the hydroxyl and hydrogen of the substrate
are misaligned, resulting in lower turnover (Table 2-1). In contrast, the high Km value for R-HPC
with rS-HPCDH3 suggests that the other enantiomer does not bind well in the first place, possibly
due to steric constraints when the methyl group is misaligned. As shown in Chart 2-1, 2-(2methyl-2-hydroxypropylthio)ethanesulfonate (M-HPC) is an achiral analog of both R-HPC and SHPC where the hydrogen atoms of each alcohol are replaced by a methyl group, resulting in a
tertiary alcohol that cannot undergo oxidation. M-HPC is thus an equivalent mimic of both HPC
enantiomers and can be studied as a possible inhibitor of both enzymes to shed light on the Km
differences for the opposite enantiomers discussed above.
As shown in Figure 2-5A, M-HPC was a competitive inhibitor of R-HPC oxidation by
rR-HPCDH1, with a Kis of 289 ± 14 μM. This value is in the range of the Km for the natural
substrate R-HPC (96 μM) and the opposite enantiomer S-HPC (224 μM), demonstrating that all
three compounds bind rR-HPCDH1 with comparable affinities. In marked contrast to these
results, no detectable inhibition was observed for M-HPC vs. the natural substrate S-HPC with rSHPCDH3 (Figure 2-5B). This result correlates with the observation that R-HPC has a
dramatically higher Km for S-HPCDH3 relative to the natural substrate (9110 vs. 31.4 μM). This
experiment was repeated with rS-HPCDH1 and the same result was obtained: no detectable
inhibition was seen with M-HPC (Figure 2-5C). Thus, the addition of the methyl group in the
improper position relative to the CoM and hydroxyl groups has profound effects on binding
affinity for the R- and S-specific dehydrogenases, further highlighting an important distinction
between these enzymes.
2-(2-hydroxyethylthio)ethanesulfonate (HEC) is a Substrate for Both the R- and SHPCDH Enzymes with Identical Km Values. As shown in Chart 2-1, HEC is an achiral mimic of
both R-HPC and S-HPC in which the methyl group is replaced by a hydrogen. HEC was found to
be a substrate for both rR-HPCDH1 (kcat = 0.55 ± 0.015 μM, Km = 959 ± 107 μM) and rS-
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HPCDH3 (kcat = 3.8 ± 0.25 μM, Km = 975 ± 248 μM). Thus, the loss of the methyl groups
imparting chirality resulted in an enzyme substrate with identical (within experimental error) Km
values for both enzymes, suggesting that for this substrate, the CoM moiety and hydroxyl group
have become equal determinants in binding affinity (assuming Km approximates affinity). As a
final experiment, M-HPC was investigated as an inhibitor of HEC oxidation to see if the result of
Figure 2-5 would hold with the achiral substrate. As shown in Figure 2-6, M-HPC was a
competitive inhibitor of HEC oxidation by rR-HPCDH1 with a Kis of 114 ± 12 μM, but was not
an inhibitor of HEC oxidation by rS-HPCDH3, further highlighting the specificity of M-HPC as a
reversible competitive inhibitor of only the (R)-dehydrogenase.
Different Strategies of Controlling Enantioselectivity in the R- and S-HPCDH Enzymes.
To summarize, the results presented above demonstrate that enantioselectivity in rR-HPCDH1 is
controlled largely by differences in kcat for the two HPC enantiomers, while enantioselectivity in
rS-HPCDH3 is controlled by differences in Km (Table 2-1). In the opposite direction, both
enzymes reduce 2-KPC with comparable efficiencies.

The tertiary alcohol M-HPC is a

competitive inhibitor that binds to rR-HPCDH1 with an affinity similar to R-HPC and S-HPC, but
does not bind to rS-HPCDH3. The primary alcohol HEC exhibits an identical Km value for both
enzymes. The simplest interpretation of these results is that rR-HPCDH1 can bind either
enantiomer of HPC with the CoM moiety oriented properly in the sulfonate-binding pocket
consisting of R152 and R196 (Figure 2-4), but that rS-HPCDH3 is unable to bind R-HPC in this
fashion, presumably due to steric clashes imposed by the presence of the misaligned methyl
group on the C2 atom. Both enzymes bind HEC with identical affinities since no methyl group is
present. Thus, a high affinity ternary complex of S-HPC, NAD+, and rR-HPCDH1 forms, but the
misalignment of the hydrogen and hydroxyl groups on C2 relative to NAD+ and the tyrosine
general base results in a 403-fold lower turnover rate. Indeed, this model has been confirmed by
the x-ray crystal structure of the complex of S-HPC and NAD+ with rR-HPCDH1 (16).
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Chart 2-1.
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Figure 2-5. Effects of 2-(2-methyl-2-hydroxypropylthio)ethanesulfonate (M-HPC) on R- and SHPC oxidation by R-HPCDH1, S-HPCDH3, and S-HPCDH1. Panel A, Competitive inhibition of
R-HPCDH1-catalyzed R-HPC oxidation by M-HPC. The double reciprocal plots for assays
performed in the presence of different concentrations of M-HPC are shown in the main diagram.
Data points represent the average of triplicate experiments. The solid lines were generated by
nonlinear least-square fits of the v vs. S data, shown in the inset, to the equation for a rectangular
hyperbola using Sigmaplot. M-HPC concentrations: (●) 0 mM, (○) 0.2 mM, (▼) 0.4 mM, (∆) 0.8
mM, (■) 1.6 mM. Panels B and C, v vs. S plots for S-HPC oxidation by S-HPCDH3 and SHPCDH1, respectively, in the presence of different concentrations of M-HPC. The lines were
generated by fitting the data to the standard form of the Michaelis-Menten equation. M-HPC
concentrations: (●) 0 mM, (○) 1.2 mM, (▼) 4.9 mM
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Figure 2-6. Effects of 2-(2-methyl-2-hydroxypropylthio)ethanesulfonate (M-HPC) on 2-(2hydroxyethylthio) ethanesulfonate (HEC) oxidation by R-HPCDH1 and S-HPCDH3. Panel A,
Competitive inhibition of R-HPCDH1-catalyzed HEC oxidation by M-HPC. The double
reciprocal plots for assays performed in the presence of different concentrations of M-HPC are
shown in the main diagram. Data points represent the average of triplicate experiments. The solid
lines were generated by nonlinear least-square fits of the v vs. S data, shown in the inset, to the
equation for a rectangular hyperbola using Sigmaplot. M-HPC concentrations: (●) 0 mM, (○) 0.2
mM, (▼) 0.4 mM, (∆) 0.8 mM, (■) 1.6 mM. Panel B, v vs. S plots for HEC oxidation by SHPCDH3 in the presence of different concentrations of M-HPC. The lines were generated by
fitting the data to the standard form of the Michaelis-Menten equation. M-HPC concentrations:
(●) 0 mM, (○) 1.2 mM, (▼) 4.9 mM.

68
In contrast to rR-HPCDH1, rS-HPCDH3 apparently cannot bind S-HPC analogs (R-HPC
and M-HPC) with CoM oriented properly in the sulfonate-binding pocket that consists of R122
and K214. The most logical explanation for this is that the misaligned methyl groups on C2
required for this high affinity binding are not accommodated due to steric clashes with amino acid
side chain(s). Thus, R-HPC binds to rS-HPCDH3 with a 290-fold lower affinity, but in an
orientation where the hydroxyl and hydrogen on C2 can be more properly aligned with tyrosine
156 and NAD+, such that kcat only decreases by 4.5-fold relative to the natural substrate S-HPC.
The limited studies done with the other S-HPCDH homolog (rS-HPCDH1) support a similar
strategy for controlling enantioselectivity.
The results of the pH studies further indicate that the hydroxyl group at C2 is a larger
determinant in the binding of S-HPC to rS-HPCDH3 than for binding of R-HPC to rR-HPCDH1.
Note that the Km for the natural substrate is three-fold lower for S-HPCDH3 than for rRHPCDH1, which could be due to higher affinity binding of the hydroxyl group. However, the Km
values for HEC, lacking the methyl group, are identical for both enzymes. Thus, the methyl
group of S-HPC may facilitate the alignment of the hydroxyl group in this higher affinity
position.
While the homology model of rS-HPCDH3 proved useful for predicting the catalytic
triad and sulfonate-binding residues verified experimentally in this paper, it is not sufficient for
testing the tenets of this model by definitively identifying steric clashes with a modeled substrate
or inhibitor. The verification of this model for differential control of enantioselectivity will
require solving the three-dimensional structure of rS-HPCDH3, work that is currently in progress,
followed by further biochemical, mutational, and kinetic characterization of the enzyme.
Physiological Implications of These Studies. The differential control of enantioselectivity
in the R- and S-HPCDH enzymes may have evolved to reflect the roles these enzymes play in
propylene metabolism. As shown in Figure 2-1, alkene monooxygenase from X. autotrophicus
produces a mixture of (R) and (S)-epoxypropane, although (R)-epoxypropane is produced in a
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90% enantioexcess (4). Both (R)- and (S)-epoxypropane are substrates for epoxyalkane:CoM
transferase, which results in the production of R- and S-HPC, respectively.

Although (S)-

epoxypropane (and by extrapolation, S-HPC) are the minor products of the metabolic pathway, it
is still essential for these compounds to be further metabolized by the bacterium, since epoxides
are highly toxic. While epoxyalkane:CoM transferase detoxifies (S)-epoxypropane by conversion
to S-HPC, S-HPC must proceed through the pathway of epoxide carboxylation to regenerate free
CoM; if it did not, the CoM pool would be wastefully sequestered. Since R-HPC is the more
abundant enantiomer, R-HPCDH will still operate efficiently even with a similar Km value for the
opposite enantiomer, since S-HPC is predicted to be produced at about 20-fold lower
concentrations. In contrast, in order for S-HPCDH to be efficient at the lower concentrations of
S-HPC encountered in the cell, it needs to have a lower Km for the natural substrate and
substantially higher Km for the opposite enantiomer to work efficiently. To summarize, the
different amounts of R- and S-HPC that accumulate in the cells due to the inherent
stereoselectivity of the alkene monooxygenase appears to have led to the evolution of different
strategies for controlling efficient substrate flux through the pathway. R-HPC oxidation is
controlled by kcat, since R-HPCDH does not need to discriminate substrate binding at the much
lower concentrations of the opposite enantiomer present, while control of S-HPC oxidation is
controlled by Km, since discrimination of substrate binding is crucial with the higher
concentrations of the inhibitory enantiomer present.

In the context of this physiological

discussion it should be noted that R- and S-HPCDH were found to have comparable specific
activities in cell extracts of X. autotrophicus when grown on propylene, with each predicted to
account for about 1% of soluble cell protein (4-6). This observation reiterates that substrate flux is
controlled by differences in mechanisms of these enzymes and not by differences in levels of
expression.
The fact that X. autotrophicus has redundant copies of the dehydrogenases (as well as the
other enzymes of epoxide metabolism) further highlights the importance of these enzymes to the
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bacterium. The results of Table 2-1 suggest some differences in the kinetic properties for two of
the redundant S-enzymes. It will be interesting to see if there are any kinetic differences in the
redundant R-enzymes, as well as to determine at what relative levels the individual enzymes are
expressed. The copies we purified from X. autotrophicus in our previous studies (4-6, 18, 23)
consisted primarily (or wholly) of the enzymes in the first operon based on yields from the
purification schemes and their biochemical properties. Now that we have a greater understanding
of the organization of the epoxide carboxylation genes we can apply molecular genetics to
determine how important the individual copies are to bacterial growth and survival under
different conditions.
Summary. To our knowledge, this paper provides the first side by side characterization of
a pair of SDR enzymes expressed simultaneously to act on two enantiomers of the same alcohol
produced in a metabolic pathway. These dehydrogenases are distinguished from all other known
members of the SDR family in using the novel sulfonate functional group of coenzyme M as a
handle for chiral discrimination. The differential control of enantioselectivity by kcat vs. Km is a
surprising yet explainable result in the context of cellular metabolism. These results provide a
standard for examining the molecular basis of stereoselectivity in other such enzyme pairs.
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CHAPTER 3
THE ENANTIOSELECTIVITY AND KINETIC PROPERTIES OF (R) - AND (S) –
HYDROXYPROPYL COM DEHYDROGENASES FROM XANTHOBACTER
AUTOTROPHICUS STRAIN PY2
ABSTRACT
The 2-(R)- and 2-[(S)-2-hydroxypropylthio]ethanesulfonate (HPC) dehydrogenases (DH)
represent a unique set of enantioselective short-chain dehydrogenase/reductase (SDR) enzymes,
catalyzing

the

reversible

oxidation

of

R-HPC

and

S-HPC

to

produce

2-(2-

ketopropylthio)ethanesulfonate (2-KPC). Recent successful cloning and expression of rSHPCDH3 allowed for the comparison studies with the previously characterized rR-HPCDH1
counterpart. Both enzymes are highly enantioselective for their corresponding substrates,
exhibiting 0.14% to 1.0% activity with the opposite enantiomer. The enantioselectivity was
shown to be controlled differently in the HPCDH enzymes, either through changes in the Km or
the kcat (1). The kinetic and mechanistic studies of R- and S-HPCDH enzymes in the context of
their high degree of enantioselectivity are reported. The reduction of 2-butanone by rR-HPCDH1
produced 30% (R)-2-butanol and 70% (S)-2-butanol, while in the same reaction rS-HPCDH3
produced 99% (S)-2-butanol. The enantioselectivity and the kinetic parameters in the reduction of
the aliphatic ketones can be modulated by the addition of the short-chain alkylsulfonates as
observed for rR-HPCDH1. This modulating effect was abolished for rS-HPCDH3, regardless of
the direction of the reaction and the chain-length of the additive. The absolute enantioselectivity
towards the (S)-alcohol is observed for rS-HPCDH3 in the reduction of 2-butanone, 2-pentanone
and 2-hexanone. The ability of rS-HPCDH3 to oxidize the (R)- and (S)-enantiomers the longchain aliphatic alcohols (C4-C8) suggests that chirality of the alcohol is not a sufficient
determinant for the high degree of enantioselectivity displayed by rS-HPCDH3. There is a clear
requirement for the sulfonate moiety on the substrate to provide strong binding affinity and the
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proper orientation of the substrate for the hydride abstraction. Inhibitors were investigated as
probes of the molecular features of the substrate contributing to its binding. Ethanesulfonate,
propanesulfonate and butanesulfonate were found to be uncompetitive inhibitors of S-HPC
oxidation by rS-HPCDH3, while methanesulfonate and CoM were mixed inhibitors. This
suggested that the length of the substrate carbon chain is an important determinant in the
recognition by the HPCDH enzymes. Bromoethanesulfonate (BES) is a structural analog of CoM
and has been shown to be a potent inhibitor of methanogenesis. The effect of BES on the
oxidation of S-HPC by rS-HPCDH3 was examined to complement the previous studies with other
enzymes of the epoxide carboxylation pathway. BES was found to be a strong uncompetitive
inhibitor with respect to S-HPC. This study provides an important insight into the mechanism of
enantioselectivity among the SDR enzymes, with emphasis of on rS-HPCDH3.
INTRODUCTION
Chiral alcohols are valuable intermediates in the synthesis of a large number of fine
chemicals and pharmaceuticals. Thus, the production of optically pure alcohols by the reduction
of the corresponding ketones represents one of the most fundamental and practical chemical
transformations. The biocatalytic approach to these transformations is finding an increasing
number of industrial applications (2) due to its efficiency, high optical purity of resulting products
and low environmental impact (3, 4). For this reasons biocatalysis offers an attractive alternative
to chemical synthesis. Alcohol dehydrogenases (ADHs) are of special interest due to their high
degree of enantioselectivity and substrate specificity (5). Since their early use in the biocatalytic
production of secondary (S)- and (R)-alcohols (6), screening efforts have been made towards
isolation and characterization of novel ADHs with high thermostability and chemo-, regio- and
stereoselectivity. Of particular demand are enantiocomplementary enzymes, which catalyze the
same reaction, but with an opposite stereoselectivity. A unique example of such enzymes
constitute a pair of 2-(R)- and 2-[(S)-2-hydroxypropylthio]ethanesulfonate (HPC) dehydrogenases
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(DH) from Xanthobacter autotrophicus strain Py2. The R- and S-HPCDH are an integral part of
the three step epoxide degradation pathway in X. autotrophicus Py2, where they act in concert to
catalyze the reversible oxidation of R- and S-HPC to a common achiral product 2-(2ketopropylthio)ethanesulfonate (2-KPC) (Scheme 3-1) (7, 8). This pathway requires CoM as a
cofactor for the epoxide ring opening and as a carrier of 2-hydroxypropyl- and 2-ketopropyl-CoM
intermediates (9). R- and S-HPCDH belong to the short-chain dehydrogenase/reductase (SDR)
superfamily. The X-ray structures determined for members of this family display highly similar
α/β folding pattern with a Rossmann-fold for nucleotide binding. The SDR enzymes represent
one of the oldest protein families found in all forms of life, where they display great functional
diversity (10-12).
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Scheme 3-1.

Among a large number of SDR enzymes annotated in databases (13), there are very few
stereoselective enzymes present in a common pathway that catalyze the same reaction but with an
opposite stereoselectivity. The only known examples include a pair of tropinone reductases (14,
15) and the R- and S-HPC dehydrogenases (8, 16). The uniqueness of the HPCDH enzymes,
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along with their prospective industrial applications has prompted more detailed studies on the
basis of their enantioselectivity. Besides biocatalytical implications of this research for the
production of enantiopure alcohols, in its broader context this study may also prove useful in the
bioremediation of toxic compounds such as alkenes, ketones and epoxides. Furthermore,
understanding the mechanism of enantioselectivity may prove useful in engineering other
stereoselective enzymes for biocatalytical purposes, either through the rational design or directed
evolution.
The central goal of the research presented in this chapter is to extend the kinetic and
mechanistic characterization of HPCDH enzymes in the context of their high degree of
enantioselectivity. This work is complementary to the research described in Chapter 2 and is
intended to investigate in the greater detail differences in the enantioselectivity observed for rSHPCDH3 and rR-HPCDH1. Side by side kinetic experiments in the presence of short-chain
alkylsulfonates as potential modulators of the enzyme activity and enantioselectivity were carried
out to aid better understanding of the mechanism of chiral discrimination. Results of the
inhibition studies supported by the structural analysis further define similarities and differences
between rS-HPCDH3 and rR-HPCDH1. As reported previously, the amino acid sequence
comparison of both enzymes revealed a number of differences in their respective C-terminal
domains. The most striking being the differential placement of positively charged residues (Arg,
Lys) that play an important role in binding of the sulfonate of CoM (1, 16). Based on the
available kinetic and structural data for rR-HPCDH1 and rS-HPCDH3 a model has been proposed
in which the differential placement of the sulfonate binding residues and the steric clashes of the
terminal methyl group of the substrate are responsible for proper binding and orientation of RHPC and S-HPC alcohols to their respective enzymes. This hypothesis has been investigated by
examining the catalytic properties and stereoselectivity of the HPCDH enzymes with their
physiological substrates (R-HPC, S-HPC, and 2-KPC) and non-physiological substrates (aliphatic
alcohols and ketones lacking the sulfonate moiety). The effect of linear alkylsulfonates on the
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kinetic parameters of the aliphatic ketone reduction catalyzed by rS-HPCDH3 was also
investigated.
EXPERIMENTAL PROCEDURES
Materials. All commercially available chemicals were purchased from Sigma-Aldrich
Chemicals, Acros Organics or Fisher Scientific, and were of analytical grade. Substrates for
enzymatic assays: 2-KPC, R-HPC and S-HPC were synthesized as described previously (16).
Chemical structures of the compounds were confirmed using 1H NMR. The spectra of HPC
enantiomers and 2-KPC were identical to those reported previously (16, 17). Purity of the
synthesized chemicals was estimated by reverse-phase HPLC to be ≥98%.
Cloning of the rR-HPCDH3 and rS-HPCDH1 Genes (xecD1 and xecE3). As described
previously (1), three sets of genes encoding R- and S-HPCDH enzymes were identified on the
linear megaplasmid of X. autotrophicus Py2. The operon in which they occur were designated as
1, 2 and 3, accordingly to order in which they appear in the DNA sequence and with respect to
the first discovered and characterized operon of the epoxide degradation pathway genes (assigned
with number 1). The xecD1 gene encoding R-HPCDH1 (from the first operon) and xecE3 gene
encoding S-HPCDH3 (from the third operon) were amplified using genomic DNA of propylenegrown X. autotrophicus Py2 as a template. The PCR primers and cloning procedures were
identical to those described previously (1). Plasmids pXD28 and pDS53 containing xecD1 and
xecE3 genes, respectively, were transformed into Escherichia coli BL21 - (DE3) CodonPlus
(Stratagene) cells for protein expression.
DNA Sequencing. All the sequencing was performed on an AB 3730 DNA Analyzer at
the Utah State University CIB DNA sequencing laboratory with the following primers: for
pXD28; T7 promoter primer, TAATACGACTCACTATAGGG (Novagen), and T7 terminator
primer, GCTAGTTATTGCTCAGCGG (Novagen), and for pDS53; ACYCDuetUP1 Primer
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(Novagen),

GGATCTCGACGCTCTCCCT

and

DuetDOWN1

Primer

(Novagen),

GATTATGCGGCCGTGTACAA.
Media and Growth of Bacteria. E. coli BL21- (DE3) CodonPlus was grown in a 15L
semicontinuous microferm fermenter with LB media that contained both kanamycin (50 µg mL-1)
and chloramphenicol (50 µg mL-1). All other procedures were performed as described previously
(16).
Purification of rR-HPCDH1 and rS-HPCDH3. The recombinant enzymes rR-HPCDH1
and rS-HPCDH3 were purified on IMAC column with Ni Sepharose 6 Fast Flow (Amersham)
resin as described previously (1). Protein concentrations were determined on a NanoDrop
spectrophotometer using theoretical extinction coefficients (ϵ280 = 10033 M-1 cm-1 for S-HPCDH3
and ϵ280 = 18512.5 M-1 cm-1 for R-HPCDH1), with dialysis flow-through buffers as blanks.
Molecular Mass of rR-HPCDH1 and rS-HPCDH3, and Native State Evaluation. The
apparent molecular masses of polypeptides were determined on a SDS-PAGE gel (12% T) by
comparison to Rf values of standard proteins. The native molecular masses of rR-HPCDH1 and
rS-HPCDH3 were estimated by native PAGE (4-20% T BioRad) and gel filtration
chromatography using HPLC (Shimadzu SLC-10A) with a fluorescence detector (Shimadzu RF10AXL) adjusted for excitation at 280 nm and emission 350 nm. The gel filtration column
(BioSep-SEC S-2000, 300 x 7.8 mm, Phenomenex) was used in conditions described previously
(1). SDS-PAGE and native PAGE were performed according to the Laemmli procedure (18).
Circular dichroism (CD) spectrapolarimetric analysis were performed to ensure that the tertiary
structure of the proteins remains intact. CD spectra were recorded at 25 °C on an AVIV Model
410 CD Spectrophotometer, as described previously (1).
Spectrophotometric Enzyme Assays. Assays with 2-KPC, S-HPC and R-HPC as substrates
were performed in 50 mM glycine, 50 mM NaH2PO4, and 50 mM Tris base (GPT buffer mix) at
pH 7.5, as described previously (16). Assays with all other substrates (C4 to C8 in carbon chainlength) were carried out in 50 mM GPT buffer containing 15% (v/v) glycerol. Stock solutions of
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synthesized substrates were standardized, as described previously (16). All assays were
performed at 30 °C in a Shimadzu model UV160U spectrophotometer containing a waterjacketed cell holder for thermal control. Alcohol or ketone production was monitored by
measuring the change in absorbance at 340 nm using the extinction coefficient for NADH (ϵ340 =
6.22 mM-1 cm-1). For alcohol oxidation assays, the following ranges of alcohol concentrations
were used in determining kinetic constants: R-HPC, 0.035-1.4 mM; S-HPC, 0.096-1.9 mM; (S)-2butanol, 10.9-381 mM; (R)-2-butanol, 43.6-490 mM. The oxidation of 2-butanol in the presence
of 1 mM alkylsulfonates was carried out with 227 mM of (R)-2-butanol or 174 mM of (S)-2butanol (Table 2-4). Activity assay of rS-HPCDH3 with (S)- and (R)-enantiomers of C4 to C8
alcohols was performed at concentrations ranging from 50 mM to 74 mM (Table 2-5). The
concentration of NAD+ for all assays was 10 mM (26 x value of KmNAD+). For assays of ketone
reduction, the following concentration ranges were used in determining kinetic constants: 2-KPC,
0.050-2.6 mM; 2-butanone, 10-300 mM; 2-pentanone, 47-470 mM; 3-pentanone, 18.8-564 mM;
2-hexanone, 16.2-162 mM. In the assay of 2-ketone reduction catalyzed by rS-HPCDH3 all
additives tested for their ability to modify kinetic parameters were present at an overall
concentration of 1 mM (Table 2-7). All assays contained the following concentrations of the
substrate: 558 μM of 2-butanone; 225 mM of 2-pentanone and 122 mM of 2-hexanone. The
concentration of NADH for these assays was 0.16 mM, (4.4 x value of KmNADH). On an average,
seven concentrations of the substrates within the ranges indicated were chosen for the kinetic
analyses. The assays were performed in duplicates or triplicates, unless otherwise stated. All
samples were degassed/flushed with nitrogen and incubated in the 30 ºC water-bath for 5 min
prior to the enzyme addition. To determine kinetic parameters (apparent Km and Vmax) initial rate
values were plotted as a function of substrate concentration and data points were fitted to a
Michaelis-Menten equation using SigmaPlot 11.0.
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Standardization of Stock Solutions. Stock solutions of R-HPC and 2-KPC were
standardized with rR-HPCDH1, whereas stock solutions of S-HPC were standardized by use of
rS-HPCDH3. Standardization assays for R-HPC and S-HPC oxidation were performed in GPT
buffer (50 mM glycine, 50 mM NaH2PO4, and 50 mM Tris base) at pH 11.0 with 50 μg of
enzyme and 10 mM of NAD+. Standardization assay for 2-KPC reduction was performed in GPT
buffer at pH 7.5 with 50 μg of enzyme and 0.2 mM of NADH. All assays were carried out at 30
ºC for 2 min and repeated 3 to 6 times. The average absorbance measured at 340 nm was
correlated with micromoles of the substrate used in the assay using the extinction coefficient for
NADH (ϵ340 = 6.22 mM-1 cm-1). Calculations of the final stock concentration of 2-KPC were done
using the equilibrium constant determined from the Haldane equation, as described previously
(16). Calculations of the final stock concentration of R-HPC and S-HPC were based on
assumption that the reactions went to completion, since pH 11.0 renders both enzymes
irreversible. Stock solutions of NAD+ and NADH were standardized by measuring absorbance of
aliquoted solutions at 260 nm and 340 nm, respectively, using the appropriate extinction
coefficients (NAD+ ϵ260 = 18.0 mM-1 cm-1 and NADH ϵ340 = 6.22 mM-1 cm-1).
Inhibition Studies. All assays were performed in GPT buffer mix at pH 7.5 with
saturating concentration of NAD+ (10 mM). Inhibition assays for rR-HPCDH1 were performed at
variable concentrations of R-HPC (31, 72, 144, 287 and 615 µM). Each assay was performed at
several fixed concentrations of propanesulfonate (0, 1, 2, 4 and 8 mM) or butanesulfonate (0,
0.25, 0.5, 1.0 and 2.0 mM). Inhibition assays for S-HPCDH3 were performed at variable
concentrations of S-HPC (16, 31, 62, 155, 310 and 645 µM) and several fixed concentrations of
the inhibitor: R-HPC (0, 1.2, 2.4, 4.9 and 9.7 mM), methanesulfonate (0, 40, 80, 160 and 300
mM), ethanesulfonate (0, 10, 20, 50 and 100 mM), propanesulfonate (0, 10, 20, 40 and 80 mM),
butanesulfonate (0, 1.25, 2.5, 5, and 10 mM), 2-mercaptoethanesulfonate (0, 1, 2, 4 and 8 mM),
bromoethanesulfonate (BES) (0, 0.5, 1.0, 1.5 and 3.0) and Na2SO4 (0, 10, 20, 50, 100, 200 and
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300 mM). Assay with BES was carried out in the presence of 1 mM EDTA. Initial rate data for
each inhibitor were fitted to the following equations describing enzyme activity in the presence of
competitive (Eq 1), uncompetitive (Eq 2) and mixed (Eq 3) inhibitors:

υ = Vmax[S]/(αKm + [S])

(Eq 1)

υ = Vmax[S]/( Km + α’[S])

(Eq 2)

υ = Vmax[S]/(αKm + α’[S])

(Eq 3)

where S is the substrate, I is the inhibitor, α = 1 + ([I]/Kis) and α’= 1 + ([I]/Kii). The type of
inhibition exhibited by each compound was determined based on the visual evaluation of the lines
pattern displayed on the double reciprocal plots (1/υ vs 1/[S] at various [I]) and by fitting data to
each of the inhibition models described by equations 1 – 3. All calculations and graphing were
done in SigmaPlot 11.0. Final inhibition mode was decided upon the best data fit defined by the
smallest value of standard deviation for Kis and/or Kii following the appropriate graphical pattern.
Initial rate data were fit to a rectangular hyperbola described by the standard form of MichaelisMenten equation.
Chiral Gas Chromatographic Assay for 2-Ketone Reduction. All assays were performed
in GPT buffer mix, pH 7.5 (adjusted at 30 ºC), containing 15% (v/v) glycerol. Assay components
in 1ml reaction volume were: 15 mM NADH, 0.64 mg of enzyme (wild-type or mutant rSHPCDH3) and 56 mM of the substrate (2-butanone, 2-prentanone or 2-hexanone). Additionally,
assays examining the ability of alkylsulfonates to modulate the enantioselectivity of rS-HPCDH3
contained

1

mM

of

additives

(methanesulfonate,

butanesulfonate or 2-mercaptoethanesulfonate).
described previously (1).

ethanesulfonate,

propanesulfonate,

All other procedures were performed as
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RESULTS AND DISCUSSION
Genetic Analysis of Genes Encoding Enzymes Involved in Aliphatic Epoxide
Carboxylation. It was reported previously that the genes encoding the key enzymes of the
epoxide carboxylase system were clustered in a single operon located on a 320 kbp linear
megaplasmid (19). The DNA analysis of the recently published genome of X. autotrophicus Py2
(http://genome.jgi-psf.org/xanau/xanau.home.html) revealed the presence of two additional
operons shown in Figure 3-1. For the naming purposes the previously characterized operon was
designated as number one, while the newly discovered operons are designated as two and three,
according to the order of appearance in the DNA sequence. The additional operons are not
complete and contain genes which are highly homologous, but not identical. Interestingly, the
genes appearing in all three operons are those encoding R-HPCDH and S-HPCDH enzymes
(xecD1- xecD3 and xecE1 - xecE3, respectively) (1).

Figure 3-1. Fragment of 320 kb linear megaplasmid of X. autotrophicus Py2 showing multiple
copies of xecD and xecE genes encoding R- and S-HPCDH, respectively.
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Figure 3-2. Multiple sequence alignment of S-HPCDH and R-HPCDH enzymes homologs from
X. autotrophicus Py2. Letter designations: a, classic GXXXGXG glycine-rich NAD+ binding
motif; b, catalytic tetrad residues of Asn, Ser, Tyr and Lys; c, substrate flanking Met residues; d,
positively charged residues that have been shown in R-HPCDH1 and S-HPCDH3 to interact with
the sulfonate group of the substrate. The alignment was generated using MULTALIN with default
parameters, while consensus was derived using ClustalW2. The following symbol means that the
residues are: (*) identical; (:) conserved ; (.) semi-conserved.
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Production of rR-HPCDH1 and rS-HPCDH3. The presence of multiple copies of genes
encoding R- and S-HPCDH could explain the previous results showing that R-HPCDH1 isolated
from X. autotropicus Py2 migrated in a form of two bands on the SDS-PAGE gels, despite many
efforts of their chromatographic separation (20). The calculated molecular weights of the proteins
encoded by xecD1, xecD2 and xecD3 are 26.1 kDa, 29.5 kDa and 26.2 kDa, respectively. Mixture
of all homologs resolved on the SDS-PAGE gel could therefore account for the appearance of
two bands. With regard to S-HPCDH enzymes, further analysis show that S-HPCDH1, SHPCDH2 and S-HPCDH3 (encoded by xecE1, xecE2 and xecE3 genes, respectively) share 76%
to 88% of amino acid identity. The S-HPCDH2 lacked the NAD+ binding motive GXXXGXG
and when purified was found to be inactive (data not shown). The catalytic triad residues (Ser,
Tyr, Lys), the CoM binding residues (Arg and Lys) as well as two substrate flanking methionines
were highly conserved between all homologs of S-HPCDH (Figure 3-2). Amino acid sequence
alignment of the S-HPCDH homologs and R-HPCDH1 reveal only 40% to 41% identity. This is
not surprising given that low sequence identity is common among SDR enzymes and typically
ranges between 15% to 30% (21). Examination of the codon usage in xecE genes shows that
xecE1 and xecE3 contain 7 and 10 rare codons, respectively. This suggests that codon usage
could have contributed to even more troublesome expression of rS-HPCDH1 than of its
counterpart rR-HPCDH1. Indeed, the expression of rS-HPCDH1 was minimal (< 0.1 mg/g of cell
paste), as most of the protein remained insoluble. The highest expression was obtained for the rSHPCDH3 homolog cloned in pRSF Duet vector and expressed in BL21-CodonPlus(DE3) strain
(1). Therefore, only rR-HPCDH1 and rS-HPCDH3 were used in the subsequent kinetic and
structural studies. Purification of the native form of S-HPCDH1 from X. autotrophicus Py2
allowed for comparison studies which showed that the specific activity of rS-HPCDH3 and SHPCDH1 are nearly identical (1).
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Molecular Mass of rR-HPCDH1 and rS-HPCDH3, and Native State Evaluation. The rSHPCDH3 was subjected to gel filtration chromatography and eluted as a single peak with an
apparent molecular mass of 70.2 kDa. By comparison, native S-HPCDH1 and recombinant RHPCDH1 eluted from the same column with apparent molecular masses of 49.6 kDa and 64.7
kDa, respectively. These results are identical to those reported previously when the proteins were
analyzed using a different (Superose-12) gel filtration column (22, 23). It is unclear why rSHPCDH3 elutes with a higher apparent molecular weight on the gel filtration column than native
S-HPCDH1 and more similarly to how rR-HPCDH1 migrates. The discrepancy could be due to
the likelihood that the S-HPCDH we purified from the native organism is a homogeneous (or
nearly homogeneous) preparation of the S-HPCDH1 homolog, and that this protein elutes
differently from that of S-HPCDH3. This idea is supported by the results of N-terminal sequence
analysis of native S-HPCDH by Edman degradation, which provided the sequence
MLDNEVIAIT (22). As shown in Figure 3-2, S-HPCDH1 is identical at the N-terminus to that
sequence except for one amino acid (the N at position 4). In contrast, the N-terminus of SHPCDH3 has the N-terminal sequence MSNRLKN before converging with S-HPCDH1 at
EVIAIT (Figure 3-2). Clearly, the presence of three homologs of each of the HPCDH enzymes
emphasizes the importance of expressing specific enzymes in a defined expression system.
Originally, both R- and S-HPCDH were proposed to be dimers based on their elution
profiles on gel filtration (16, 20). However, the crystal structure of rR-HPCDH1 clearly showed a
tetrameric structure (22), as has been reported for other members of the SDR family (23-25).
Thus, as for many enzymes, the HPCDH homologs can migrate anonymously on gel filtration
columns and we are hesitant to predict the quaternary state of rS-HPCDH3 based on the gel
filtration results.
SDS-PAGE analysis of rR-HPCDH1 and rS-HPCDH3 mutants estimated the average
purities of the enzymes used in this work to be ≥98%. All proteins migrated on a SDS-PAGE gel
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as single bands with the predicted molecular masses. Results of gel filtration chromatography and
CD analysis suggested that the oligomerization state of the recombinant proteins is unaffected.
Spectrophotometric Enzyme Assays. Difficulties in the heterologous expression of a
soluble and an active form of rS-HPCDH1 resulted in cloning and purification of the rS-HPCDH3
homolog. Both enzymes share a high amino acid identity (78%) and high structural similarities,
based on their homology models. All kinetic parameters in the reaction with S-HPC, 2-KPC and
R-HPC were very similar (1). As revealed in Chapter 2, the rS-HPCDH3 and rR-HPCDH1
enzymes control their enantioselectivity via different mechanisms. The enantioselectivity of rRHPCDH1 was shown to be dictated by changes in kcat, while the enantioselectivity of rSHPCDH3 was mostly controlled by changes in Km (1).
Activity assays for rS-HPCDH3 performed with varied concentrations of NAD+ and
NADH, when HPC and 2-KPC were saturating, respectively, revealed the following kinetic
parameters: Km for NAD+, 191 ± 21 µM; Km for NADH, 8.42 ± 1.58 µM. The equilibrium
constant (Keq) determined using the Haldane relationship for a bisubstrate reaction (Eq 4) was
88.9 x 10-2 at 30 ºC and pH 7.5. By comparison Keq determined in the same conditions for rRHPCDH1 was 7.5 x 10-2 (16).

Keq = (VfmaxKmNADHKm2-KPC)/( VrmaxKmNAD+KmS-HPC)

(Eq 4)

where Vfmax and Vrmax are the maximal rates for the forward and reverse reactions, respectively,
when substrates are at saturating concentration.
The product inhibition studies for the oxidation of R-HPC by rR-HPCDH1 demonstrated
that NADH was a competitive inhibitor for NAD+, while 2-KPC was found to be a mixed
inhibitor. This suggests that only coenzymes can productively bind to the free enzyme (16). The
same was observed for other members of the SDR family and is believed to apply also for rSHPCDH3. If that is the case, then based on the Km values for the cofactors it appears that NADH
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is a stronger inhibitor for NAD+ in rS-HPCDH3, as compared to rR-HPCDH1. The difference in
the Km values between the two cofactors increased significantly and was 23-fold for rS-HPCDH3,
and 12-fold for rR-HPCDH1. Additionally, with respect to rS-HPCDH3, lower Km values for
NAD+ (457 vs. 191 µM) and NADH (37 vs. 8 µM) indicated that the formation of the binary
enzyme complex might be easier in case of rS-HPCDH3 than for rR-HPCDH1.
Chiral Gas Chromatographic Assay for 2-Butanone Reduction by rR-HPCDH1 and rSHPCDH3 in the Presence of Short-Chain Alkylsulfonates. Chiral gas chromatography was
employed to analyze enantiomeric products of 2-butanone reduction. Since, short-chain
alkylsulfonates were found to modulate kinetic parameters and product distribution of 2-butanone
reduction in rR-HPCDH1 enzyme (with ethanesulfonate having the strongest effect) (26), this
possibility was also examined for rS-HPCDH3. Results of 2-butanone reduction presented in
Table 3-1 indicate that rS-HPCDH3 is highly enantioselective in oxidizing 2-butanone to (S)-2butanol, exhibiting 98% enantiomeric excess (ee). Interestingly, the same reaction catalyzed by
rR-HPCDH1 also results in an excess of (S)-2-butanol, however at a lower value of ee (44%).
While the presence of 1 mM ethanesulfonate in the reaction mixture increases ee for rR-HPCDH1
to 85%, no effect on the enantioselectivity of 2-butanone reduction is observed for rS-HPCDH3.
The enantioselectivity of rS-HPCDH3 remains unaffected even at higher concentrations of the
alkylsulfonates (up to 5 mM) as close to 100% of (S)-2-butanol is produced in the reduction of 2butanone. It was previously proposed (26) that binding of ethanesulfonate in the CoM binding
pocket of rR-HPCDH1 influences both the orientation in which 2-butanone binds and the rate of
the reaction. Thus, the presence of ethanesulfonate could result in the substrate binding
preferentially in the orientation that leads to the formation of (S)-2-butanol, due to steric clashes
between the bound alkylsulfonate and the ethyl side chain of 2-butanone. If the proposed
mechanism holds true for rS-HPCDH3, one would expect the reverse preference for 2-butanone
binding in the presence of ethanesulfonate, namely a change in the enantioselectivity towards the
production of (R)-2-butanol. This would be expected especially with longer chain alkylsulfonates,
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which would introduce increasing steric hindrance and in turn increasing selectivity for (R)-2butanol. To test this possibility, the rS-HPCDH3 catalyzed reduction of 2-butanone was
performed with the addition of C1 to C4 alkylsulfonates and with CoM (at a total concentration of
1 mM). For comparison, the same assay was carried out with rR-HPCDH1. As reported
previously (1) (Table 2-6), the amount of (S)-2-butanol produced by rS-HPCDH3 remain
unchanged and close to 100% of the (S)-enantiomer regardless of the used additive. At the same
time, total concentration of 2-butanol produced in the assay decreases with the increasing carbon
chain-length of the modulator molecule, and is the lowest for butanesulfonate (21% less than the
control reaction without the additive). Although alkylsulfonates had no effect on modulating
enantioselectivity of rS-HPCDH3, change in the product yield for 2-butanone reduction suggests
binding of the modulator molecule at the active site of rS-HPCDH3. In contrast, rR-HPCDH1
exhibits a significant increase in the enantioselectivity in the presence of a modulator molecule,
enhancing the production of (S)-2-butanol from 70% for the control reaction (without the
additive) to 91% with 1 mM of ethanesulfonate. This was accompanied by up to 3.7-fold increase
in the total amount of 2-butanol produced in the assays containing methanesulfonate or
ethanesulfonate. The modulating effect of the effector molecule on the product distribution and
yield of rR-HPCDH1 was decreasing with an increase in its chain-length. This trend was
observed only for alkylsulfonates longer than ethanesulfonate. Thus, 2-butanone reduction in the
presence of propanesulfonate and butanesulfonate resulted in a decreasing amount of the (S)enantiomer (although still higher than without the additive) and decreasing total yield of 2butanol. Free CoM used in the assay gave similar results to the same chain-length
propanesulfonate. Structural studies of the active site of rR-HPCDH1 and rS-HPCDH3 revealed a
differential spatial orientation of the positively charged residues in the CoM binding pocket. In
rS-HPCDH3 these residues (Arg211 and Lys214) are found to occupy one side of the substrate
binding pocket rather than approach the sulfonate group from both sides, as in the case of rRHPCDH1 (Arg152 and Arg196). Additionally, the active site of rR-HPCDH1 shows a presence

Table 3-1. Additives tested for their ability to modulate enantioselectivity of rR-HPCDH1 and rS-HPCDH3 in the asymmetric reduction of 2butanone – GC assaya
rS-HPCDH3
modifier

rR-HPCDH1

% (S)-2butanol

% (R)-2butanol

Total conc.
[mM]

Change in
total conc.
(x-fold)

% (S)-2butanol

% (R)-2butanol

Total conc.
[mM]

Change in
total conc.
(x-fold)

None

99.18 ± 0.2

0.82 ± 0.2

1.49 ± 0.2

1.00

70.21 ± 1.0

29.79 ± 1.0

1.65 ± 0.4

1.00

methanesulfonate

99.50 ± 0.5

0.50 ± 0.5

1.59 ± 0.1

1.07

90.84 ± 0.4

9.16 ± 0.4

5.32 ± 0.3

3.22

ethanesulfonate

98.03 ± 0.1

1.97 ± 0.1

1.38 ± 0.1

0.93

91.46 ± 0.1

8.54 ± 0.1

6.05 ± 0.2

3.67

propanesulfonate

99.25 ± 0.2

0.75 ± 0.2

1.41 ± 0.2

0.95

89.96 ± 0.5

10.04 ± 0.5

2.09 ± 0.3

1.27

butanesulfonate

100.0 ± 0.00

0.00 ± 0.00

1.18 ± 0.1

0.79

79.75 ± 1.0

20.25 ± 1.0

1.08 ± 0.01

0.65

CoM

100.0 ± 0.00

0.00 ± 0.00

1.32 ± 0.1

0.89

88.90 ± 0.4

11.10 ± 0.4

2.92 ± 0.1

1.77

a

All additives were used at the overall concentration of 1mM. All assays were performed in triplicate at 30 °C using 0.64 mg rS-HPCDH3 or rRHPCDH1, NADH (15 mM), and 2-butanone (56 mM). Assay time was 60 min. All values are given as means ± standard deviations.
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Table 3-2. Enantioselectivity of 2-ketone reduction by rS-HPCDH3 and rR-HPCDH1- GC assaya
rS-HPCDH3
Substrate

% (S)alcohol

% (R)alcohol

Total conc.
[mM]

2-butanone

98.80

1.20

1.49

2-pentanone

100.0

0.00

2-hexanone

100.0

0.00

rR-HPCDH1
Change in total
conc. (x-fold)

% (S)alcohol

% (R)alcohol

Total conc.
[mM]

Change in total
conc. (x-fold)

1.00

71.94

28.06

2.13

1.00

4.92

3.30

36.30

63.70

5.24

2.46

2.94

1.97

37.22

62.78

14.66

6.88

a

All substrates were used at the overall concentration of 56 mM. All assays were performed in 50 mM GPT buffer with 15% glycerol at 30°C
using 0.64 mg rS-HPCDH3 or rR-HPCDH1 and NADH (15 mM). Assay time was 60 min. A single assay was performed for each of the
substrates.
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Figure 3-3. Active site of rR-HPCDH1 with the bound substrate R-HPC showing the catalytic
tetrad (Asn114, Ser142, Tyr155, Lys159) and residues interacting with the sulfonate moiety of
the substrate (Arg152, Arg196 and Trp195).

Figure 3-4. Active site of rS-HPCDH3 (homology model) with the bound substrate S-HPC,
showing the catalytic tetrad (Asn115, Ser143, Tyr156, Lys160) and positively charged residues
(Arg211, Lys214) proposed to coordinate the sulfonate moiety of the substrate.
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of the Trp195 residue, missing in rS-HPCDH3, which not only serves as a back-stop to prevent
the substrate from further translation, but also contributes to binding of the sulfonate group
(Figure 3-3). This spatially even distribution of Arg152, Arg196 and Trp195 residues could
provide a larger contact surface and thus allow rR-HPCDH1 to orient the substrate more precisely
than is observed for rS-HPCDH3 (Figure 3-4). It is somewhat intriguing why such different
effects of "modulating" enantioselectivity of 2-butanone reduction by alkylsulfonates are
observed for rR-HPCDH1 and rS-HPCDH3. Although both enzymes are highly homologous,
with many structural and mechanistic similarities, they are clearly not identical. Careful analysis
of the molecular structure of rS-HPCDH3, once available, may aid in better understanding of this
phenomena.
Chiral Gas Chromatographic Assay for 2-Penatone and 2-Hexanone Reduction by rRHPCDH1 and rS-HPCDH3. Chiral gas chromatography studies of 2-butanone reduction were
expanded to examine if the distribution of products observed for 2-butanone reduction also holds
for longer chain ketones, namely 2-pentanone and 2-hexanone. As shown in Table 3-2, rSHPCDH3 exhibits absolute enantioselectivity in the reduction of 2-pentanone and 2-hexanone
producing only the (S)-enantiomer of the respective alcohols (within detection levels). In contrast,
reduction of the same ketones by rR-HPCDH1 results in a mixture of about 36% of the (S)alcohol and 64% of the (R)-alcohol. This is an unexpected change from the results observed for 2butanone reduction where 72% of the produced alcohol is in form of the (S)-enantiomer (Table 32). Comparison of the total product concentration shows that both enzymes are more efficient (by
at least two-fold) in reducing aliphatic ketones with longer than C4 carbon chains (Table 3-2). An
interesting observation made during the course of 2-hexanone reduction assay with rR-HPCDH1
is that the product distribution of resulting 2-hexanol seems to be time dependent (Table 3-3).
Specifically, it was noticed that the ratio of S/R enantiomers is changing over time towards 1:1
ratio with a concurrent decrease in the total concentration of the products. Although the
concentration of (S)-2-hexanol remains relatively constant, the amount of (R)-2-hexanol
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Table 3-3. Time dependent asymmetric reduction of 2-hexanone by rS-HPCDH3 and rRHPCDH1- GC assaya
Assay
time

peak area [units]

conc. [mM]

total conc.
[mM]

(S)-2(R)-2(S)-2(R)-22-hexanol
hexanol
hexanol
hexanol
hexanol
rS-HPCDH3
a
1
29403
ND
100.00
0.00
2.94
NDa
2.94
a
a
2
65472
ND
100.00
0.00
6.55
ND
6.55
a
a
3
94885
ND
100.00
0.00
9.49
ND
9.49
rR-HPCDH1
1
54586
92054
37.22
62.78
5.46
9.21
14.66
2
54099
75593
41.71
58.29
5.41
7.56
12.97
3
51358
55191
48.20
51.80
5.14
5.52
10.65
a
All assays were performed in 50 mM GPT buffer with 15% glycerol at 30 °C and contained 15
mM NADH, 56 mM 2-hexanone and 0.64 mg rS-HPCDH3 or rR-HPCDH1. Single point
measurements were taken at various time intervals for each of the assays.
[h]

(S)-2hexanol

peak area [%]

(R)-2hexanol

decreases by 40% within a 2h period. It is unclear what causes this change, however it appears
that (R)-2-hexanol gets further converted to a compound other than 2-hexanone or (S)-2-hexanol.
Interestingly enough, a similar observation was made for the reduction of 2-butanone by rRHPCDH1 (unpublished data).
Aliphatic Alcohols as Substrates for rR-HPCDH1 and rS-HPCDH3. It was shown
previously that electrostatic interactions between the sulfonate moiety of the substrate and the
positively charged residues within the C-terminal substrate binding domain of rR-HPCDH1 and
rS-HPCDH3 are major determinants of binding affinity and chiral discrimination (1, 22, 26).
Moreover, kinetic assays with (R)- and (S)-2-butanol revealed that both enzymes are
stereoselective towards (S)-2-butanol (1). Although enantioselectivity of rR-HPCDH1 for (S)-2butanol is lower than that observed for rS-HPCDH3 (E = 3.0 vs. 6.2), it remains somewhat
surprising that rR-HPCDH1 selects in favor of the (S)-enantiomer as a substrate, with five-fold
higher kcat value. To further investigate high enantioselectivity of rS-HPCDH3 for (S)-2-butanol
observed in 2-butanone reduction, complementary studies were carried out in the reverse
direction where (R)- and (S)-2-butanol oxidation was monitored in the presence of short-chain
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alkylsulfonates (Table 3-4). First of all, specific activity of (S)-2-butanol oxidation by rSHPCDH3 was 2.8-times higher than for (R)-2-butanol which confirms previously reported results
of 2-butanol oxidation showing 2.6-fold ratio of (S)-2-butanol/(R)-2-butanol (1).

Table 3-4. Additives tested for their ability to modify kinetic parameters for rS-HPCDH3
catalyzed 2-butanol oxidation
(S)-2-butanol
(R)-2-butanol
Additive
Specific
Activity
Specific
Activity
Relative
Activity
change (xActivity
change (xchange S/R
(U/mg)
fold)
(U/mg)
fold)
(x-fold)
none
4.92 ± 0.13
1.00
1.74 ± 0.010
1.00
2.83
methanesulfonate 4.97 ± 0.20
1.01
1.80 ± 0.013
1.04
2.76
ethanesulfonate
4.93 ± 0.15
1.00
1.87 ± 0.029
1.08
2.63
propanesulfonate
4.71 ± 0.13
0.96
1.72 ± 0.025
0.99
2.74
butanesulfonate
4.24 ± 0.085
0.86
1.62 ± 0.024
0.93
2.61
CoM
4.33 ± 0.076
0.88
1.52 ± 0.010
0.88
2.84
propionate
4.83 ± 0.022
0.98
1.75 ± 0.040
1.00
2.77
a
All assays were performed at 30 ˚C in UV spectrophotometer with fixed concentrations of NAD+
(10 mM). All additives were present at an overall concentration of 1 mM. All assays contained 25
μg of enzyme and 227 mM of (R)-2-butanol or 174 mM of (S)-2-butanol. All values are reported
as means ± standard deviations.

Moreover, this ratio remains fairly constant regardless of the alkylsulfonate used in the
assay, which corroborates well with the results of the 2-butanone reduction assay where identical
additives had no effect on the stereochemical outcome of the reaction. Comparison of the results
presented in Table 3-4 reveals that methanesulfonate and ethanesulfonate have no effect on the
overall activity of rS-HPCDH3 at 1 mM concentration used in the assay. Beginning with
propanesulfonate the enzyme activity decreases as the carbon chain of the “modulator” increases.
The lowest value is observed for CoM for which the specific activity declines by 12% as
compared to the control reaction without the additives. It is plausible that binding of the
"modulator" molecule in the active site of rS-HPCDH3, determined by strong electrostatic
interactions with its sulfonate group, affects the relatively weaker binding of the alcohol equipped
with a single functional group. Thus prior binding of the alkylsulfonates with longer than C3
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carbon chain is thought to impose steric restrictions on the substrate. Interestingly, although this
has no effect the overall enantioselectivity of rS-HPCDH3, it does change the enzyme’s activity.
In conclusion, these results suggest that the enantioselectivity of rS-HPCDH3 for (S)-2-butanol
cannot be modulated regardless of the additive and the direction of the reaction (oxidative vs.
reductive). Therefore the phenomena of modulating enantioselectivity by incorporating nonreactive molecules containing sulfonate moiety remains a unique feature limited only to rRHPCDH1.

Table 3-5. Comparison of rS-HPCDH3 activity with (S)- and (R)-enantiomers of various chiral
alcohols
(S)-enantiomer
(R)-enantiomer
Specific
Specific
Activity
Activity
Substrate
Activity
Activity
change
difference
[U/mg]
[U/mg]
x-fold (S/R)
[%]
2-butanol
3.65
1.10
3.3
232
2-pentanol
7.11
1.74
4.1
308
2-hexanol
5.11
1.16
4.4
341
2-heptanol
4.38
0.91
4.8
380
2-octanol
3.45
0.66
5.3
425
a
All assays were performed at 30 ˚C in UV spectrophotometer with fixed concentrations of NAD+
(10 mM). All assays contained 25 μg of enzyme. Single assays were performed for each of the
substrates.

It was shown previously that rS-HPCDH3 is capable of oxidizing non-physiological
substrates, such as short-chain secondary aliphatic alcohols (2-propanol, 2-butanol), although
high concentrations of alcohols were required to give rates significantly lower than that observed
for S-HPC (1). To further extend kinetic characterization of rS-HPCDH3 and to gain more insight
into the mechanism of the enantioselectivity, the oxidation of long-chain chiral alcohols lacking
the sulfonate moiety was investigated. In side by side experiments both enantiomers of each of
the alcohols ranging from 2-butanol to 2-octanol were tested. As expected, (S)-alcohols are better
substrates for rS-HPCDH3 with three- to five-fold higher activity than that of the corresponding
(R)-alcohols (Table 3-5). Interestingly, the specific activity with longer chain (S)-alcohols (C5 to
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C7) is greater than that with (S)-2-butanol, presumably due to their increasing affinity for the
enzyme which in turn could aid in their better positioning for catalysis. Similar assays performed
for rR-HPCDH1 revealed the importance of the alkyl chain-length of tested alcohols in binding
affinity. Specifically, it was shown for rR-HPCDH1 that the Km decreases significantly (1700fold) when (R)-2-octanol is used as a substrate in place of 2-propanol rR-HPCDH1 (26).
Interestingly, rS-HPCDH3 exhibits comparable activity for (S)-2-butanol and (S)-2-octanol,
despite the 550-fold difference in the solubility (in aqueous solutions used in the assay).
Furthermore, comparison of the results determined for (R)- and (S)-enantiomers of C4 to C8
alcohols reveals that the enantioselectivity (defined as specific activity of (S)-alcohol/ specific
activity of (R)-alcohol) of rS-HPCDH3 towards the (S)-alcohol increases with an increasing
chain-length of the substrates. This is a consequence of decreasing activity of rS-HPCDH3 with
(R)-enantiomers and simultaneously increasing activity with (S)-enantiomers upon going from 2butanol to 2-octanol. Although, the activity of rS-HPCDH3 towards (R)-alcohols lowers with
each additional carbon in the substrate’s chain, (R)-alcohols remain the relatively good substrates
with activities comparable to those of the (S)-alcohols. This is an unexpected result given that in
similar studies of rR-HPCDH1 the opposite enantiomers of alcohols longer than C5 were
sufficiently poor substrates that their kinetic parameters could not be determined (26). In case of
rS-HPCDH3 the efficient catalysis of (R)-enantiomer requires its hydroxyl group and the
hydrogen atom to be properly aligned with respect to NAD+ and Tyr156. This can be
accomplished when the position of the terminal methyl group and the remaining carbon chain are
switched. How rS-HPCDH3 can accommodate up to six-carbon long aliphatic chain in a methyl
binding pocket remains unknown. At this point rS-HPCDH3 is thought to be highly
enantioselective only towards alcohols containing the sulfonate moiety and much more versatile
in oxidizing enantiomeric mixtures of secondary alcohols lacking such a moiety.
Aliphatic Ketones as Substrates for rS-HPCDH3 and rR-HPCDH1. Results of the assays
performed for rS-HPCDH3 with various aliphatic ketones, ranging from 2-butanone to 2-
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hexanone, summarized in Table 3-6, confirm the trend previously observed for the aliphatic
alcohols. Namely, the Km value decreases as the alkyl chain-length increases, roughly two-fold
for every additional carbon, thus suggesting again that hydrophobic interactions play an important
role in binding of aliphatic ketones by rS-HPCDH3. Also in case of rR-HPCDH1 the Km value
decreases in a similar manner, however with a simultanous increase in the kcat value (14-fold)
upon going from 2-butanone to 2-hexanone. This increase in kcat is likely due to the increasing
binding affinity which in turn could result in the limited rotational motion of the substrate. Less
degree of freedom could thus aid in proper alignment of the substrate for catalysis. Interestingly
in case of rS-HPCDH3, the increase in kcat is observed only in the reduction of 2-pentanone, while
in the reduction of 2-hexanone the kcat remains the same as in the reduction of 2-butanone. This
was despite five-fold increase in affinity of 2-hexanone for the enzyme (assuming that Km
represents binding affinity of the substrate). Changes in the kinetic parameters for the reduction
of 2-pentanone and 3-pentanone by rR-HPCDH1 and rS-HPCDH3 suggest that geometry of the
substrate might be an important determinant of efficient catalysis. Both enzymes display about
6.5-fold higher catalytic efficiency (kcat/Km) for 2-pentanone relative to 3-pentanone. Interestingly
this was accomplished differently for rR-HPCDH1 and rS-HPCDH3. While rR-HPCDH1
controls its specificity mostly through changes in Km (2.3-fold increase from 2-pentanone to 3pentanone), the specificity of rS-HPCDH3 is largly dictated by difference in the kcat values for
both substrates (five-fold decrease from 2-pentanone to 3-pentanone). It was shown previously
that although a "methyl binding pocket" of rR-HPCDH1 can accommodate ethyl and propyl
groups, their binding comes with a significant increase in the Km values. Accordingly, similar
increase in the Km values for 3-pentanone is presumably a result of the ethyl group being forced
to occupy the "methyl binding pocket" in the HPCDH active site. This in turn could cause steric
hindrance and necessary misalignment of the carbonyl group of the substrate with respect to
NAD+ and the catalytic triad residues. Regardless of these differences, 3-pentanone proves to be
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a better substrate than 2-butanone for rR-HPCDH1 (but not for rS-HPCDH3) with 2.4-fold
specificity ratio for 3-pentanone as indicated by kcat/Km values (Table 3-6).

Table 3-6. Kinetic Parameters for rS-HPCDH3 – Catalyzed reduction of 2-ketonesa
Substrate

Km

Vmax

kcat

kcat /Km

Change Change
in kcat
in Km

(mM)

(units/mg)

(s-1)

(M-1 s-1)

(x-fold) (x-fold)

0.401
1.981
0.305
1.821

1.00
1.95
0.37
0.97

rS-HPCDH3
2-butanone
2-pentanone
3-pentanone
2-hexanone

156.5 ± 13.8
62.13 ± 6.04
76.81 ± 8.68
33.69 ± 3.72

0.14 ± 0.00
0.27 ± 0.01
0.05 ± 0.00
0.14 ± 0.00

0.063
0.123
0.023
0.061

1.00
0.40
0.49
0.22

rR-HPCDH1
2-butanone
51.9 ± 0.50
0.05 ± 0.00
0.027
0.520
1.00
1.00
2-pentanone
16.01 ± 1.68 0.25 ± 0.01
0.125
7.804
4.63
0.31
3-pentanone
47.18 ± 7.38 0.13 ± 0.00
0.058
1.229
2.15
0.91
2-hexanone
9.57 ± 0.54
0.79 ± 0.01
0.391
4.086
14.48
0.18
a
All assays were performed in triplicates at 30 ˚C in UV spectrophotometer with fixed
concentrations of NADH (0.17 mM). All assays contained 191 μg of enzyme. Apparent kinetic
constants were determined by fitting experimental data to the standard form of Michaelis-Menten
equation. Apparent Vmax and Km values are reported as means ± standard deviations. All other
values are reported as means only.

Reduction of Aliphatic Ketones by rS-HPCDH3 in the Presence of Short-Chain
Alkylsulfonates. As demonstrated above, short-chain alkylsulfonates were unable to modulate
enantioselectivity of 2-butanone reduction catalyzed by rS-HPCDH3. The amount of produced
(S)-2-butanol remained unchanged and close to 100% regardless of the used additive. It was also
proposed that the steric clashes of the alkylsulfonate chain and the ethyl group of 2-butanone
were responsible for the modulating effect of the 2-butanone reduction revealed by rR-HPCDH1.
To examine the possibility of such steric effects in rS-HPCDH3, longer chain ketones (2petnanone and 2-hexanone) were used in the assay along with the previously tested
alkylsulfonates. For comparison purposes the reduction of 2-butanone was carried out under
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identical conditions. In general, the results presented in Table 3-7 suggest that the longer the
carbon chain of the sulfonate compound, the greater the effect it has on the specific activity of the
enzyme in the reduction reaction. This effect is however minimal and noticeable only for longer
than three carbon chain alkylsulfonates with the largest change (12%) observed for 2-pentanone
reduction in the presence of butanesulfonate. As was shown in Table 3-2, rS-HPCDH3 is highly
stereospecific in 2-ketone reduction producing exclusively (S)-2-alcohol as the final product.
Thus it is plausible that any steric constraints introduced in the active site could only lower this
stereospecificity. Since the production of (R)-enantiomer by rS-HPCDH3 would likely proceed
with a lower activity (Table 3-5), any variation in the product ratio (less than 100% of (S)enantiomer) should result in a decrease of the specific activity. Accordingly, if the addition of the
alkylsulfonates can modulate enantioselectivity of the enzyme, as observed for rR-HPCDH1 then
it would reflect in the values of the specific activity for the reduction of 2-ketones. Surprisingly,
in the most extreme example of the reduction of 2-hexanone in the presence of 1 mM
butanesulfonate or CoM, the specific activity exhibited by rR-HPCDH1 remains almost
unchanged. It is unclear how both molecules can be simultaneously accommodated in the active
site without causing additional steric restrictions. Undoubtly, crystallographic data of the rSHPCDH3 structure with both molecules bound would be of great help. Nevertheless, these results
provide further evidence for the unusual characteristics of rS-HPCDH3 which might be of special
interest for the biocatalytical production of enantiopure secondary alcohols.
Inhibition Studies. It is generally accepted that the data from inhibition experiments can
give a significant insight into an enzyme’s kinetic mechanism. Determination of the inhibition
constants for the analyzed compounds can also help to define the enzyme’s active site and the
relative contribution of the groups involved in substrate binding. As shown in Table 3-8, R-HPC
was found to be an uncompetitive inhibitor of S-HPC oxidation catalyzed by rS-HPCDH3, with a

Table 3-7. Additives tested for their ability to modify kinetic parameters for rS-HPCDH3 catalyzed reduction of
2-ketonesa
Additive
2-butanone
2-pentanone
2-hexanone
Specific Activity Activity
Specific Activity
Activity Specific Activity Activity
(U/mg)
change
(U/mg)
change
(U/mg)
change
(x-fold)
(x-fold)
(x-fold)
None
0.1115 ± 0.0021
1.00
0.2008 ± 0.0005
1.00
0.0975 ± 0.0008
1.00
methanesulfonate 0.1122 ± 0.0045
1.01
0.1984 ± 0.0165
0.99
0.1031 ± 0.0013
1.06
ethanesulfonate
0.1078 ± 0.0007
0.97
0.2073 ± 0.0003
1.03
0.0960 ± 0.0024
0.98
propanesulfonate 0.1019 ± 0.0062
0.91
0.1905 ± 0.0053
0.95
0.1008 ± 0.0101
1.03
butanesulfonate
0.1074 ± 0.0033
0.96
0.1777 ± 0.0081
0.88
0.0936 ± 0.0003
0.96
CoM
0.1068 ± 0.0010
0.96
0.1829 ± 0.0053
0.91
0.0925 ± 0.0042
0.95
a
All assays were performed at 30 ˚C in UV spectrophotometer with fixed concentrations of NADH (0.17 mM).
All additives were present at an overall concentration of 1 mM. All assays contained 191 μg of enzyme and the
following concentrations of the substrate: 558 μM of 2-butanone; 225 mM of 2-pentanone and 122 mM of 2hexanone. All values are reported as means ± standard deviations.
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Table 3-8. Inhibition studies of rS-HPCDH3 and rR-HPCDH1-catalyzed oxidation of S-HPC and R-HPC, respectivelya
rS-HPCDH3 with S-HPC
rR-HPCDH1 with R-HPC
inhibitor
Type of
Kis [µM]
Kii [µM]
Type of
Kis [µM]
Kii [µM]
inhibition
inhibition
R-HPC
Uncompetitive
NAb
13490 ± 1784
NAb
NAb
NAb
b
b
b
c
S-HPC
NA
NA
NA
Competitive 156 ± 7
NAb
methanesulfonate Mixed
222300 ± 23610 830000 ± 91280 Mixedc
147800 ± 2600 122700 ± 5100
b
c
ethanesulfonate
Uncompetitive
NA
180308 ± 10257 Mixed
26700 ± 800
38900 ± 2300
propanesulfonate Uncompetitive
NAb
11020 ± 640.8
Mixed
3131 ± 578
2981 ± 255
butanesulfonate
Uncompetitive
NAb
1264 ± 54.68
Mixed
264.8 ± 26.96 1685 ± 251
c
CoM
Mixed
1319 ± 204.70
1369 ± 101.30
Mixed
2250 ± 130
3620 ± 170
BES
Uncompetitive
NAb
656 ± 33.66
Mixedd
1710 ± 280
2300 ± 200
Na2SO4
NDe
NDe
NDe
NDce
NDce
NDce
a
Abbreviations: BES, bromoethanesulfonate; All assays were performed at 30 °C, pH 7.5, with variable concentrations of SHPC or R-HPC, 0.64 mg rS-HPCDH3 or rR-HPCDH1 and 10 mM NAD+. All values are given as means ± standard
deviations. bNA – not applicable. cDetermined by Clark et al. (16). dDetermined by Boyd, J.M. (29) eND – not detected;
Na2SO4 did not exhibit inhibitory effects at concentrations up to 300 mM.
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Figure 3-5. Effect of R-HPC on rS-HPCDH3 catalyzed oxidation of S-HPC at pH 7.5. (A) 1/v as a
function of the inverse S-HPC concentration determined at several fixed concentrations of RHPC: (●) 0 mM, (○) 1.2 mM, (▼) 2.4 mM, (∆) 4.9 mM, (■) 9.7 mM. (B, C) Secondary plots of
(A) illustrate data quality and fit to equation 1. (B) Slopes from plot A as a function of the R-HPC
concentration. (C) Intercepts from plot A as a function of the R-HPC concentration. Data points
represent the average of triplicate experiments. Shown in the inset is the nonlinear least-square fit
of the v vs. S data to the equation for a rectangular hyperbola using SigmaPlot. In all cases lines
represent theoretical data generated from experimental values by SigmaPlot.

Kii value (13490 ± 1784 μM) 435-times higher than the Km for S-HPC (31 ± 0.9 μM) but close to
the Km for R-HPC (9100 ± 1100 μM) (1). Because the fit of the initial rate data in a double
reciprocal form (shown in Figure 3-5) does not reveal a typical pattern for uncompetitive
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Figure 3-6. Effect of methanesulfonate on rS-HPCDH3 catalyzed oxidation of S-HPC at pH 7.5.
(A) 1/v as a function of the inverse S-HPC concentration determined at several fixed
concentrations of methanesulfonate: (●) 0 mM, (○) 40 mM, (▼) 80 mM, (∆) 160 mM, (■) 300
mM. (B, C) Secondary plots of (A) illustrate data quality and fit to equation 1. (B) Slopes from
plot A as a function of the methanesulfonate concentration. (C) Intercepts from plot A as a
function of the methanesulfonate concentration. Data points represent the average of triplicate
experiments. The inset represents the nonlinear least-square fit of the v vs. S data to the equation
for a rectangular hyperbola using SigmaPlot. In all cases lines represent theoretical data generated
from experimental values by SigmaPlot.

inhibition, other models were also considered. The only reasonable alternative fit was observed
for competitive inhibition, although the determined value of Kis carried a significantly larger error
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(5155 ± 1424 μM). It should be noted here that R-HPC is also a substrate for rS-HPCDH3
(typified by 290-fold higher Km and 4.5-fold lower kcat than those of S-HPC) and as such cannot
be considered as a “true” inhibitor. Therefore, any conclusions drawn from this study should be
as a substrate (400-times lower kcat than that of R-HPC). As determined previously, S-HPC is a
strong competitive inhibitor with a Kis value close to the Km for R-HPC (105 ± 2 μM) (16). With
regard to alkylsulfonates, methanesulfonate was found to be a mixed inhibitor of S-HPC
oxidation catalyzed by rS-HPCDH3 which agrees with the pattern observed in Figure 3-6.
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Figure 3-7. Effect of ethanesulfonate on rS-HPCDH3 catalyzed oxidation of S-HPC at pH 7.5.
(A) 1/v as a function of the inverse S-HPC concentration determined at several fixed
concentrations of ethanesulfonate: (●) 0 mM, (○) 10 mM, (▼) 20 mM, (∆) 50 mM, (■) 100 mM.
The inset represents the nonlinear least-square fit of the v vs. S data to the equation for a
rectangular hyperbola using SigmaPlot. In all cases lines represent theoretical data generated
from experimental values by SigmaPlot.
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An ambiguous situation is observed for ethanesulfonate as the double reciprocal plot of
the inhibition assay does not reveal any distinct pattern, but rather resembles a combination of
multiple inhibition models (Figure 3-7). Calculations performed in SigmaPlot 11.0 show the best
fit of the experimental data to the uncompetitive model with 18% standard deviation on the
determined value of Kii, followed by the competitive model with 37% error for calculated value
of Kis. Mixed inhibition, somewhat suggested by the graphical representation of the experimental
data, was typified by 7% and 27% error of Kis and Kii value, respectively. Propanesulfonate is an
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Figure 3-8. Effect of propanesulfonate on rS-HPCDH3 catalyzed oxidation of S-HPC at pH 7.5.
(A) 1/v as a function of the inverse S-HPC concentration determined at several fixed
concentrations of propanesulfonate: (●) 0 mM, (○) 10 mM, (▼) 20 mM, (∆) 40 mM, (■) 80 mM.
The inset represents the nonlinear least-square fit of the v vs. S data to the equation for a
rectangular hyperbola using SigmaPlot. In all cases lines represent theoretical data generated
from experimental values by SigmaPlot.

uncompetitive inhibitor with respect to S-HPC as determined by fitting the experimental data to
the equation 2. This result agrees with the graphical pattern displayed on the double reciprocal
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plot (Figure 3-8). Likewise, butanesulfonate is an uncompetitive inhibitor of S-HPC oxidation by
rS-HPCDH3 showing the appropriate line pattern, although somewhat distorted as the slope
values are not identical (Figure 3-9). In contrast, propanesulfonate and butanesulfonate were
found to be mixed inhibitors of R-HPC oxidation by rR-HPCDH1 showing a very clear and
characteristic pattern typically observed for this type of inhibition (Figure 3-11 and 3-12). Also
CoM is a mixed inhibitor with values comparable to the inhibition constants determined for both
enzymes (Table 3-8 and Figure 3-10). Comparison of the Kii values shown in Table 3-8 reveals
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Figure 3-9. Effect of butanesulfonate on rS-HPCDH3 catalyzed oxidation of S-HPC at pH 7.5.
(A) 1/v as a function of the inverse S-HPC concentration determined at several fixed
concentrations of butanesulfonate: (●) 0 mM, (○) 1.25 mM, (▼) 2.5 mM, (∆) 5.0 mM, (■) 10
mM. The inset represents the nonlinear least-square fit of the v vs. S data to the equation for a
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from experimental values by SigmaPlot.
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Figure 3-10. Effect of CoM (mercaptoethanesulfonate) on rS-HPCDH3 catalyzed oxidation of SHPC at pH 7.5. (A) 1/v as a function of the inverse S-HPC concentration determined at several
fixed concentrations of CoM: (●) 0 mM, (○) 1.0 mM, (▼) 2.0 mM, (∆) 4.0 mM, (■) 8.0 mM.
Data points represent the average of triplicate experiments. The inset represents the nonlinear
least-square fit of the v vs. S data to the equation for a rectangular hyperbola using SigmaPlot. In
all cases lines represent theoretical data generated from experimental values by SigmaPlot.

that the addition of a single methyl group to methanesulfonate increases its binding affinity to rSHPCDH3 by five-fold. Similarly, the addition of a methyl group to ethanesulfonate increases its
binding affinity by 16-fold, while the addition of the ethyl group to ethanesulfonate results in a
more significant increase (143-fold). Together, these results suggest that the length of the
substrate carbon chain is an important determinant in the recognition by rS-HPCDH3. Although a
similar trend is observed for rR-HPCDH1, where the Kii value decreases upon going from
methanesulfonate to butanesulfonate by 73-fold, this change is not as pronounced as for rS-
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HPCDH3 where the corresponding Kii values decrease by 657-fold. Moreover, it appears that the
addition of a thiol group to ethanesulfonate also increases recognition by rR-HPCDH1 and rSHPCDH3 as the Kii values for CoM (2-mercaptoethanesulfonate) decrease by 11- and 132-fold,
respectively. This contribution, however, is difficult to extrapolate to any added affinity afforded
by the S- or R-HPC thioether, because of the possibility that CoM is binding directly with the
deprotonated Tyr residue of the catalytic triad through the thiol. In an attempt to estimate the
binding contribution of the sulfonate group alone, sodium sulfonate was used in the assay,
however no inhibitory effect was detected at concentrations up to 300 mM. Comparison of the
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generated by nonlinear least-square fits of the v vs. S data (shown in the inset) to the equation for
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reciprocal plot illustrating mixed inhibition is shown in the main diagram. The solid lines were
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results summarized in Table 3-8 and the double reciprocal plots for different carbon chain-length
alkylsulfonates reveals a trend for rS-HPCDH3 enzyme, where the type of inhibition “transitions
smoothly” from a mixed inhibition determined for methanesulfonate through an uncompetitive
inhibition and back to the mixed inhibition for CoM. Note that the best fit of the experimental
data for an uncompetitive model is observed for propanesulfonate, while both ethanesulfonate
and butanesulfonate show an uncompetitive fit with traits of a mixed inhibition. Interestingly, all
alkylsulfonates (but not S-HPC) were found to be mixed inhibitors for R-HPC oxidation by rRHPCDH1, which indicates that they can bind to multiple forms of the enzyme. Conversely,
uncompetitive inhibitors (ethanesulfonate, propanesulfonate and butanesulfonate with respect to
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S-HPC oxidation by rS-HPCDH3) can only bind to the enzyme•subtrate binary complex and
affect the Vmax of the reaction rather than the substrate’s Km. In summary, if these inhibitors bind
in a manner similar to that of the mercaptoethanesulfonate (CoM) portion of the substrate (R-HPC
or S-HPC), then these results provide an insight to the binding contribution of the substrate’s
CoM moiety methylenes.
Effect of 2-Bromoethanesulfonate on rS-HPCDH3. Bromoethanesulfonate (BES), a
structural analog of CoM, is a well known inhibitor of methanogenesis (28) and bacterial growth
on propylene and propylene oxide (27). Both BES and CoM contain a sulfonate moiety which has
proven to be a powerful binding determinate in all four epoxide carboxylase enzymes (1, 16, 22,
29, 30). The electrophilic bromine moiety of BES also makes it a potent alkylating agent or
affinity label. Therefore, BES has been shown to affect the activity of two out of the four
enzymes involved in epoxide metabolism, namely rR-HPCDH1 and 2-KPCC (27). Both enzymes
were non-competitively inhibited by BES with respect to their sulfonate containing substrates. In
addition to being a rapid equilibrium non-competitive (mixed) inhibitor, BES was demonstrated
to be a reversible inhibitor of rR-HPCDH1 and an irreversible inactivator of 2-KPCC (31). As
demonstrated previously, BES is not an inhibitor of the first enzyme in epoxypropane
metabolism, epoxyalkane:CoM transferase (EaCoMT) (31). This study examines the inhibitory
effect of BES on rS-HPCDH3, thereby complementing the previous studies and completing the
picture of the overall effect of BES on all enzymes involved in CoM-dependent bacterial epoxide
carboxylation. To determine which type of inhibition occurs, the rate of S-HPC oxidation was
measured at different concentrations of BES. The experimental data was fit to equations 1 – 3,
and double reciprocal plots were constructed (Figure 3-13). The results presented in Table 3-8
indicate that BES is an uncompetitive inhibitor with respect to S-HPC with the Kii value of 656 ±
33.7 μM. The line pattern observed in Figure 3-13 is consistent with this type of inhibition. The
parallel lines with an identical slope are observed for all different concentrations of BES
examined in the assay with an exception of the line representing 3 mM BES. Even when this line
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Figure 3-13. Effect of BES (bromoethanesulfonate) on rS-HPCDH3 catalyzed oxidation of SHPC at pH 7.5. (A) 1/v as a function of the inverse S-HPC concentration determined at several
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Data points represent the average of duplicate experiments. The inset represents the nonlinear
least-square fit of the v vs. S data to the equation for a rectangular hyperbola using SigmaPlot. In
all cases lines represent theoretical data generated from experimental values by SigmaPlot.

is excluded from the calculations of the theoretical values (using Eq 1) the determined value of Kii
remains very similar (693.4 ± 26.1 μM). By way of comparison, the BES inhibition assay of RHPC oxidation by rR-HPCDH1 revealed non-competitive (mixed) inhibition suggesting that BES
can bind to any form of the enzyme thus altering its activity. Furthermore, the inhibition constants
(Kii and Kis) determined for rR-HPCDH1 were significantly higher than that of rS-HPCDH3. The
3.5-fold difference in the Kii value indicates that BES has a greater inhibitory effect on S-HPC
oxidation carried out by rS-HPCDH3. Because of the close similarities between BES and CoM, it
is not surprising that both the HPCDH enzymes are inhibited by its presence. However, since
HPC substrates also contain the sulfonate moiety it was thought that inhibition of BES and CoM
would be competitive. As shown in Table 3-8, this is not the case for either of the enzymes. The
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rR-HPCDH1 exhibited mixed inhibition with both BES and CoM showing similar values of the
inhibition constants, whereas rS-HPCDH3 revealed uncompetitive and mixed inhibition,
respectively, with significantly different Kii values. Considering the latter, it is intriguing why
such different mechanisms of rS-HPCDH3 inhibition are observed for the two similar molecules
and why the HPCDH enzymes exhibit such different inhibitory effects in the presence of the
same set of alkylsulfonate compounds.
Summary and Concluding Remarks. Although biocatalysis holds a tremendous potential
particularly for the pharmaceutical and agriculture industry, it has not been spared from its own
weaknesses. One of them is the lack of enantiocomplementary enzymes to produce a desired
enantiomer in an asymmetric synthesis. There are however examples of naturally occurring
enantioselective enzymes catalyzing the same reaction in a common pathway but with opposite
stereospecificity. One obvious evolutionary advantage of this approach is the ability to use both
enantiomers as a carbon and energy source, and prevent wasteful, and in case of toxic compounds
dangerous, accumulation of the other enantiomer. Epoxide carboxylation pathway of X.
autotrophicus Py2 is one of very few examples where a pair of enantioselective enzymes is found
to be integrated in the same pathway allowing the organism to individually metabolize both
enantiomeric forms of epoxypropane. Moreover, since R-HPCDH and S-HPCDH represent one of
only two known pairs of the SDR enzymes, they can be considered as an excellent model for
studying enantioselectivity within the SDR family. The results presented in this chapter can aid in
a better understanding of the mechanism underlying the high degree of chiral discrimination
observed for R- and S-HPCDH.
The results of the chiral gas chromatography assay for 2-butanone reduction confirmed
the previous results (26), showing again that the enantioselectivity and the product yield of rRHPCDH1 can be significantly enhanced by the presence of short-chain alkylsulfonates in the
assay reaction. This is a novel and unprecedented phenomenon in the biocatalytic production of
chiral alcohols. In contrast, the modulating effect of the alkylsulfonates was abolished for 2-
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butanone reduction catalyzed by rS-HPCDH3, as the enzyme revealed nearly absolute
enantioselectivity towards (S)-2-butanol (ee 98 %) regardless of the additive used. A similar
observation was made for the reduction of higher ketones, namely 2-penatnone and 2-hexanone.
Moreover, results presented in Table 3-3 show that the reduction of 2-hexanone to 100% of (S)-2hexanol is consistent throughout the time of the assay and not affected by the increasing
concentrations of the product. This appears as an important and valuable feature of a good
biocatalyst, not exhibited by rR-HPCDH1. The results of the oxidation of (R)- and (S)-2-butanol
show that the enantioselectivity of rS-HPCDH3 cannot be modulated regardless of the additive
used and the direction of the reaction (oxidative vs. reductive). Thus the phenomena of
modulating enantioselectivity of rR-HPCDH1 by incorporating non-reactive molecules
containing CoM moiety remains a unique feature limited only to rR-HPCDH1.
The assay with the long-chain aliphatic alcohols (C4-C8) revealed that rS-HPCDH3 is
capable of oxidizing both (R)- and (S)-enantiomers of tested alcohols, which is not observed for
rR-HPCDH1. Additionally, these results demonstrate that chirality of the alcohol is not a
sufficient determinant of the high degree of enantioselectivity displayed by rS-HPCDH3, and to
some extent by rR-HPCDH1. Clearly, there is a requirement for the sulfonate moiety on the
substrate which provides a strong binding affinity and more importantly serves as a useful handle
in orienting the substrate for hydride abstraction. This is consistent with a 1000-fold increase in
the Km value and an over 100-fold decrease in the enantioselectivity value (E) for (R)- and (S)-2butanol, as compared to the corresponding natural substrates (R-HPC, S-HPC). Lack of
negatively charged groups on 2-butanol allows it to assume one of two possible orientations with
either a methyl or an ethyl group residing in a "methyl binding pocket", thus leading to poor
enantioselectivity. Results of the kinetic assays performed for rS-HPCDH3 with various aliphatic
alcohols and ketones showed that substrate affinity increases with the increasing chain-length of
the substrate. This could suggest that hydrophobic interactions play an important role in substrate
binding for both HPCDH enzymes. The position of the carbonyl group on the substrate is also of
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some importance, given that 2-pentanone was demonstrated to be a better substrate than 3pentanone for both enzymes. Results of activity assays of the aliphatic ketone reduction catalyzed
by rS-HPCDH3 and rR-HPCDH1 (Table 3-8) indicated that both enzymes were up to 230-fold
more active in the oxidation of 2-butanol than in the reduction of 2-butanone. This is in
agreement with the corresponding reactions of HPC oxidation and 2-KPC reduction, where
kcat/Km values were lower for the reduction reaction catalyzed by rS-HPCDH3 and rR-HPCDH1
(1). The Km value exhibited by rS-HPCDH3 for the reduction of 2-butanone was two- to six-times
higher than the Km values for 2-butanol, suggesting that the hybridization state (planar sp2 vs.
tetrahedral sp3) of the substrate can have an effect on its binding affinity for the enzyme. In
contrast, rR-HPCDH1 showed an opposite correlation, where Km value for 2-butanol was four- to
seven-fold higher, as compared to 2-butanone. Inhibitors were investigated as probes of the
molecular features of R- and S-HPC that contribute to substrate binding. Ethanesulfonate,
propanesulfonate and butanesulfonate were found to be uncompetitive inhibitors of S-HPC
oxidation by rS-HPCDH3 suggesting that they can only bind to the enzyme•subtrate binary
complex and affect the Vmax of the reaction rather than the substrate’s Km. Methanesulfonate and
CoM were mixed inhibitors with respect to S-HPC, the result similar to that determined for the
oxidation of R-HPC by rR-HPCDH1. Mixed inhibition was also observed for propanesulfonate
and butanesulfonate in the oxidation of R-HPC by rR-HPCDH1, thus showing that all short-chain
alkylsulfonates are mixed inhibitors with respect to R-HPC and can bind to any form of the
enzyme. Together, these results provide an insight to the binding contribution of the
mercaptoethanesulfonate methylenes of the substrates and suggest that the length of the substrate
carbon chain is an important determinant in recognition by the HPCDH enzymes (more for rSHPCDH3 than for rR-HPCDH1). Finally, the effect of BES on the oxidation of S-HPC by rSHPCDH3 was examined completing the picture of the overall effect of BES on all enzymes
involved in CoM-dependent bacterial epoxide carboxylation. BES was found to be an
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uncompetitive inhibitor with respect to S-HPC. The determined values of the inhibition constants
suggest that BES has a greater inhibitory effect on rS-HPCDH3 than on rR-HPCDH1.
Although both enzymes share a high degree of structural homology and are highly
stereoselective for their respective substrates, they differ in many aspects. The most significant
differences are observed in the inhibition studies and in the reaction with the non-physiological
substrates (aliphatic alcohols and ketones lacking the CoM moiety). Most importantly, they
employ different mechanisms of controlling their enantioselectivity. Although both enzymes are
highly enantioselective and hold high potential for the biocatalytic production of optically pure
alcohols, the rS-HPCDH3 is especially noteworthy for its near absolute stereospecificity towards
(S)-alcohols.
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CHAPTER 4
ROLE OF THE ACTIVE SITE METHIONINES IN THE SUBSTRATE RECOGNITION AND
THE CATALYTIC MECHANISM OF THE (R)- AND (S)HYDROXYPROPYLTHIOETHANESULFONATE DEHYDROGENASES; KINETIC AND
STRUCTURAL STUDIES
ABSTRACT
The novel epoxide carboxylase pathway of Xanthobacter autotrophicus strain Py2 is
characterized by a three-step, four enzyme conversion of a highly reactive epoxypropane to
acetoacetate. Structural analysis of three of these enzymes (R-HPCDH, S-HPCDH and 2-KPCC)
revealed striking similarities in their active site architecture. Highly conserved positively charged
residues (Arg/Lys) lining the CoM binding pocket and two methionine residues flanking the
substrate are a common feature. While, Arg and Lys residues were shown to be important in
binding of the sulfonate moiety of the substrate through electrostatic interactions, the role of
methionines remains unknown. The present study investigates the importance of the active site
methionines in the R- and S-HPCDH enzymes. Site-directed mutagenesis of Met187 and Met192
of R-HPCDH1 to alanine and subsequently to leucine, followed by kinetic analysis with various
substrates was carried out. Similar substitutions and kinetic studies were performed on Met153
and Met194 of S-HPCDH3. The most significant change in the kinetic parameters observed for
methionine to alanine mutants was a dramatic increase in the apparent Km values for the
physiological substrates. The double mutant (Met187Ala/Met192Ala) of R-HPCDH1 showed
minimal catalytic activity with negligible kcat and Km values. In contrast, kinetic parameters for
methionine to leucine mutants were similar to those obtained for the wild-type enzyme, but with
some differences. For example, Met187Leu and Met192Leu of R-HPCDH1 showed a substrate
dependent increase of kcat values, while Met194Leu of S-HPCDH3 showed a substrate dependent
increase in Km values. The primary alcohol 2-hydroxyethyl-CoM (HEC) was a substrate for the
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wild-type enzyme and Met to Leu mutants of both R-HPCDH1 and S-HPCDH3 with similar Km
values (except for Met192Leu of R-HPCDH1). Interestingly, Met192Leu mutant showed 42%
increase in kcat value and over seven-fold increase in the Km value. The apparent kcat and apparent
Km values exhibited by Met187Leu mutant and wild-type rR-HPCDH1 were identical and
suggested that Met187 plays an important role in binding and catalysis of the physiological
substrates (R- and S-HPC), but not substrates analogs lacking the terminal methyl group (e.g.,
HEC). Inhibition studies show that the tertiary alcohol, 2-methyl-2-hydroxypropyl-CoM (MHPC) is a competitive inhibitor of R-HPC oxidation by Met187Leu and Met192Leu of RHPCDH1, with a Kis similar to the Km values for R-HPC. No inhibition of S-HPC oxidation by MHPC was detected for any of Met mutants of S-HPCDH3. The X-ray structures for Met187Ala
and Met192Ala of R-HPCDH1 were determined to 1.5 Å and 2.0 Å, respectively. A large solvent
accessible pocket near the CoM binding site was revealed in the Met187Ala mutant structure. The
sulfonate moiety of the substrate was not visible in this region, thus suggesting non-productive
interaction of the arginine residues involved in the sulfonate binding with the surrounding solvent
molecules. The Met192Ala mutant structure revealed electron density for the sulfonate moiety.
The Met192 is in close proximity to the chiral carbon of the substrate molecule where chemistry
occurs and appears to be shielding the interactions of the substrate with the active site residues
from the surrounding environment. These results highlight the important role of the substrate
flanking methionines in the active site of enzymes involved in the epoxide carboxylase pathway.
Additionally a general architecture of the active site with the substrate flanking methionines and
positively charged amino acids interacting with the sulfonate moiety, observed in R- and SHPCDH, and 2-KPCC, may prove useful in identifying new CoM-dependent enzymes. On the
basis of the kinetic analysis it is proposed that steric clashes of the terminal methyl group of the
HPC substrates with the nicotinamide ring of NAD+ are a major determinant of the
enantioselectivity in rS-HPCDH3.
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INTRODUCTION
In the three-step mechanism of epoxide degradation in X. autotrophicus Py2 an
enantiomeric mixture of R- and S-epoxypropane is converted into a common metabolite
acetoacetate by the action of four enzymes (1, 2). Integral to the versatility of this four-enzyme
pathway are two enantioselective R- and S-dehydrogenases that individually allow for the
oxidation of a single epoxypropane enantiomer (3). Collectively, however, these enzymes enable
X. autotrophicus Py2 to utilize enantiomeric mixtures of epoxypropane, including those produced
in vivo by an alkene monooxygenase during growth on gaseous propylene (4). The (R)- and (S)hydroxypropyl-CoM dehydrogenases (R-HPCDH and S-HPCDH) are highly homologous
enzymes catalyzing the reversible oxidation of (R)- and (S)-hydroxypropyl-CoM (R- and S-HPC)
to an achiral product 2-ketopropyl-CoM (2-KPC) (3). Based on BLAST analysis and the amino
acid

sequence

alignment,

both

enzymes

belong

to

the

class

of

short-chain

dehydrogenase/reductase super-family (SDR). Analogous to other members of SDR family, Rand S-HPCDH enzymes are about 250 amino acids in length and carry out catalysis in the
absence of a metal cofactor (2). Site-directed mutagenesis studies allowed for the identification of
the catalytic triad residues (Ser, Tyr and Lys) in both enzymes (5, 6). Kinetic analysis of R- and
S-HPCDH homologs (namely R-HPCDH1 and S-HPCDH3) revealed that both are highly
enantioselective in discriminating their respective enantiomeric substrates. In R-HPCDH1 this
enantioselectivity was shown to be mostly dictated by changes in kcat while in S-HPCDH3
enantioselectivity was dictated largely by differences in Km (6). Analysis of the X-ray structure of
R-HPCDH1 along with a homology model of S-HPCDH3 shed light on the structural basis for
stereoselectivity (7). In order for the alcohol to be effectively oxidized by HPCDH enzymes its
hydroxyl group and the hydrogen atom have to be properly aligned with respect to the general
base (Tyr155 or Tyr156) and the nicotinamide ring of NAD+, respectively. In R-HPCDH1 the
positively charged side chains of Arg152 and Arg196 were shown to coordinate the negatively
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charged sulfonate group of the substrate (5, 7, 8). These strong electrostatic interactions are
thought to be largely responsible for proper binding and positioning of the "business end" of the
substrate with respect to the active site tyrosine and the NAD+ cofactor. When the opposite
enantiomer (S-HPC) was modeled in the active site of R-HPCDH1 by superimposing its hydroxyl
group with that of R-HPC, the hydrogen atom of S-HPC was pointing away from the
nicotinamide ring of NAD+. This shows that binding of S-HPC in the same mode as R-HPC
cannot support its proper orientation for catalysis (7). Indeed, kinetic analysis of S-HPC oxidation
by R-HPCDH1 corroborates this observation, revealing that S-HPC is a strong competitive
inhibitor of R-HPCDH1 with Kis close to the Km of R-HPC (5). Together, these data suggested
that binding of the substrate sulfonate via positively charged residues is crucial to orienting
substrate for effective hydride transfer and provides the "switch" necessary for chiral
discrimination in R-HPCDH1. Comparison of the X-ray structure of R-HPCDH1 with a
homology model of S-HPCDH3 indicated different special orientation of the sulfonate binding
site in S-HPCDH3 and suggested that Arg211 and Lys214 could be involved in binding of the
CoM moiety (7). Site-directed mutagenesis studies confirmed this prediction, however kinetic
analysis showed that enantioselectivity of S-HPCDH3 is not entirley controlled by the proper
positioning of the substrate brought about by the electrostatic interactions with the positively
charged residues in the CoM binding pocket. In contrast to R-HPCDH1, S-HPCDH3 was shown
to catalyze oxidation of the opposite enantiomer (R-HPC) with only 4.5-times lower kcat (as
opposed to 402-times lower kcat for R-HPCDH1) but with 290-times higher Km (6). Based on
these data and the results of the inhibition studies with the substrate analogs (M-HPC and HEC) it
was proposed that the steric constraints in the active site of S-HPCDH3 prevent R-HPC from
proper binding due to clashes of the terminal methyl group of the substrate with the active site
residues. This could explain a different mechanism for controlling substrate specificity and
enantioselectivity than that observed in R-HPCDH1 (6).
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Despite a relatively low amino acid homology (41%), R-HPCDH and S-HPCDH reveal
high structural similarities. Both enzymes share several important features that facilitate specific
interactions with the substrate functional groups in order to bring about proper orientation of the
substrate for catalysis. Common to both enzymes is a compact structure of the substrate binding
region, which effectively isolates the active site residues from the immediate surroundings of the
solvent environment. Moreover, one side of the binding pocket contains the catalytic triad
residues (Ser, Tyr and Lys), while the opposite side of the pocket is lined with two arginine
residues (in R-HPCDH1) or arginine and lysine residues (in S-HPCDH3), which again were
shown to be important in binding of the substrate sulfonate group. In addition, the CoM binding
pocket of R-HPCDH1 is typified by the presence of a tryptophan residue (Trp195), which
appears to act as a "backstop" preventing movement of the substrate during catalysis (5, 7). Two
substrate flanking methionines are another interesting feature common to both HPCDH enzymes.
In R-HPCDH1 these are Met187 and Met192, while in S-HPCDH3 these are Met153 and Met194.
Strikingly similar architecture of the active site is seen in the subsequent enzyme in the epoxide
degradation pathway, namely 2-KPCC. This enzyme catalyzes the reductive cleavage and
carboxylation of 2-ketopropyl-CoM to acetoacetate and CoM. Likewise, the compact substrate
binding pocket of 2-KPCC is composed of the active site residues (Cys82 and Cys87) on one end,
and arginines along with adjacent phenylalanine on the other end of the pocket. The crystal
structure of 2-KPCC revealed that while Arg56 and Arg365 side chains are involved in binding of
the CoM moiety, phenylalanine acts as a "backstop" restraining further translation of the substrate
(9). Additionally two methionines (Met140 and Met361) flanking the sides of the pocket were
identified in the active site of 2-KPCC (9). While the role of the active site residues and positively
charged residues coordinating the sulfonate moiety is pretty evident based on the available
biochemical data, the role of the methionines remains unknown and requires further investigation.
Unique properties of methionine residues make them useful building blocks in biological
systems, as they are commonly found in practically all proteins. Despite this widespread
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occurrence few studies have been done to investigate the importance of methionines in cellular
processes and particularly in enzymatic reactions. Recent reports provide an increasing body of
evidence suggesting that methionines might be critically important in facilitating specific
functions of enzymes. The following literature review highlights only the most important findings
in order to introduce the relevance of this research and orient the reader on the work that has
previously been conducted, thus providing a context for understanding the possible roles of the
substrate flanking methionines in HPCDH enzymes.
Methionine (Met) is one of the most readily oxidized amino acid constituents of proteins.
Considering the reversibility of Met oxidation and the functional changes associated with its
oxidation, it has been proposed that Met oxidation/reduction in proteins may be one of the means
to control homeostasis in biological systems (10). Moreover, methionine residues may act as
catalytic antioxidants, protecting both the protein where they are located and other
macromolecules against oxidative stress (11). Oxidation of a single active site methionine to
methionine sulfoxide can also result in a significant increase in the catalytic activity of an
enzyme, as observed for α-galactosidase (12-fold increase) (12). Recently, a role of the
methionine residues has also been proposed in substrate recognition. In a study investigating the
structural basis of broad spectrum of specificity of the mammalian signal-recognition particle
(SRP54), it was proposed that the clusters of methionine residues are essential in a recognition
process of a wide variety of nonpolar peptide sequences. Similar mechanism has been suggested
for other proteins interacting with a broad spectrum of substrates e.g., calmodulin (a calciumbinding regulatory protein), which contains eight methionines at the binding site, thus providing a
plastic surface compatible with structurally diverse nonpolar surfaces on binding partners (13).
This unique role of methionine residues was rationalized by the conformational flexibility of the
Met side chain, which cannot be provided by other residues of similar polarity. For example
leucine or isoleucine as the closest analogs of methionine, are branched and thus more rigid. This
hypothesis was further modified by Gellman (14), who suggested that the structural flexibility of

125
methionines arises more from the presence of the sulfur atom rather than the lack of branching. A
statistical survey of crystallized proteins showed that the distribution of the methionine torsion
angles is practically flat over the entire range of possible values, in contrast to the periodicities
observed for all other amino acids side chains (15). Thus small enthalpic discrimination among
possible methionine rotamers could explain considerable freedom of adjusting themselves to
accommodate nonpolar binding partners of different structures. Additionally, the significantly
larger polarizability of sulfur in methionine, as compared to other hydrocarbon moieties, makes
methionine residues even better candidates for binding extensive nonpolar surfaces. Based on the
observed proximity of cysteine (Cys) and methionine (Met) to aromatic side chains in protein
crystal structures (16) it has been proposed that the aryl–sulfur interactions are among the most
favorable interactions. It has been further reported that Met and the phenylalanine aryl ring
interactions are especially important and frequently observed. Substitution with Lys or Ile were
shown to result in a less favorable value of the corresponding interactions (17). Furthermore, one
study proposed that Met with Trp and Phe clusters are so important for protein-protein
interactions (e.g., in p53, HIV transcriptase) that they should be considered as a target for drug
design (18). Important roles of Met interactions with aromatic residues in a recognition process
was further highlighted by the recent structural and functional studies on the influenza virus strain
H5N1 (19). It was shown that Met54 was a key residue of hemagglutimin (H5) of the virus,
making two aromatic interactions with Trp21 of the cell receptor via its sulfur atom.
Together, unique properties of methionine residue suggest that the thioether sulfur atom
in the methionine side chain is more than a methylene equivalent. The conformational properties
of thioether fragments and the unusually large polarizability of the sulfur atom itself prove to be
useful in producing binding sites that are tailored for strong interactions with nonpolar surfaces of
various shapes.
One example of an enzyme which utilizes Met residues to control substrate specificity is
α-Lytic protease (20). Simple substitution of Met192 and Met213 to Ala in one of the substrate
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binding pockets resulted in significant changes in the specificity profiles of the protease due to
the reduction of unfavorable steric constraints. Further, Met213 was implied to play a significant
role in effecting the precise positioning of substrates for optimal interactions with the enzyme.
Another study shows that the presence of a single methionine residue in the binding pocket of a
glutamate transporter is capable of controlling substrate selectivity (21). In particular, it is
proposed that the side-chain of Met367 plays a steric role in the positioning of the substrate in a
step subsequent to its initial binding.
In the present work, the role of active site methionines was investigated in a pair of
enantioselective dehydrogenases (R- and S-HPCDH) involved in aliphatic epoxide carboxylation.
Site-directed mutagenesis was carried out to convert each of the methionines in R-HPCDH1
(Met187 and Met192) and in S-HPCDH3 (Met153 and Met194) to alanine or leucine. As a result,
nine different mutants were isolated and kinetically characterized to shed light on the effect of
each of the methionines on the substrate binding and catalysis.

EXPERIMENTAL PROCEDURES
Materials. All commercially available chemicals were of analytical grade (Sigma-Aldrich
Chemicals, Acros Organics, and Fisher Scientific). 2-KPC, R-HPC S-HPC, HEC and M-HPC
were synthesized as described previously (5, 8). Chemical structures of the compounds were
confirmed using 1H NMR. The spectra of HPC enantiomers and 2-KPC were identical to those
reported previously (5, 22). Purity of the synthesized chemicals as determined by reverse-phase
HPLC was estimated to be ≥98%.
Cloning of the HPCDH Genes (xecD1 and xecE3). Three sets of genes encoding R- and
S-HPCDH enzymes were identified on the linear megaplasmid of X. autotrophicus Py2 (6).
These gene clusters are designated with numbers 1, 2 and 3, respectively, in the order in which
they were discovered and subsequently studied. Thus, xecD1 encodes R-HPCDH1 and refers to
the first operon, whereas xecE3 encodes S-HPCDH3 found in the third operon, downstream from
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the first operon on the megaplasmid. Genes xecD1 and xecE3 were cloned in pET28-b (Novagen)
and pRSFDuet-1 (Novagen) expression vectors to yield pXD28 and pDS53 vectors, respectively.
All procedures were performed as described previously (6).
Site-Directed Mutagenesis (SDM). Site-directed mutagenesis of xecD1 (in pXD28) and
xecE3 (in pDS53) were carried out utilizing the QuickChange site-directed mutagenesis kit
(Stratagene) according to the manufacturer’s protocols. All mutations were confirmed by DNA
sequencing. The sequences of the mutagenic primer pairs (purchased from IDT) used for each
codon substitution in xecD1 are as follows:
M187A, GCGGTCTGTCCGGGCGCCATCGAGACGCCCATG and
CATGGGCGTCTCGATGGCGCCCGGACAGAC; M192A,
CATGATCGAGACGCCCGCCACCCAGTGGCGCCTCG and
CGAGGCGCCACTGGGTGGCGGGCGTCTCGATCATG; M187L,
GCGGTCTGTCCGGGCCTGATCGAGACGCCCATG and
GTACCCGCAGAGCTAGTCCGGGCCTGTCTGGCG; M192L,
CATGATCGAGACGCCCCTGACCCAGTGGCGCCTCG and
GCTCCGCGGTGACCCAGTCCCCGCAGAGCTAGTAC.
Primers used for SDM of xecE3 are as follows:
M153A, CGGCATCCCGACCGCGGCGGCCTACTGC and
GCAGTAGGCCGCCGCGGTCGGGATGCCG; M194A,
ACACCTCGACCGGCGCGGGGCAGCAGCTG and
CAGCTGCTGCCCCGCGCCGGTCGAGGTG; M153L,
GGCATCCCGACCTTGGCGGCCTACT and AGTAGGCCGCCAAGGTCGGGATGCC;
M194L, CCTCGACCGGCTTGGGGCAGCAG and CTGCTGCCCCAAGCCGGTCGAGG;
DNA Sequencing. Sequencing was performed on an AB 3730 DNA Analyzer at the Utah
State University CIB DNA sequencing laboratory. The following sequencing primers were used
to confirm all mutations in pXD28: T7 promoter primer, TAATACGACTCACTATAGGG
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(Novagen), and T7 terminator primer, GCTAGTTATTGCTCAGCGG (Novagen). Primers used
to confirm all mutations in pDS53 were as follows: ACYCDuetUP1 Primer (Novagen),
GGATCTCGACGCTCTCCCT

and

DuetDOWN1

Primer

(Novagen),

GATTATGCGGCCGTGTACAA.
Media and Growth of Bacteria. E. coli BL21- (DE3) CodonPlus with pXD28 or pDS53
plasmids was grown in a 15L semicontinuous microferm fermenter with LB media supplemented
with kanamycin (50 µg mL-1) and chloramphenicol (50 µg mL-1). All other procedures were
performed as described previously (5, 6).
Preparation of Cell-Free Extracts. On average about 60 grams of frozen cell paste was
thawed at room temperature in two volumes of lysis buffer (20 mM Tris, 20% glycerol, 500 mM
NaCl, 20 mM imidazole, 0.03 mg mL-1 DNase I, at pH 8.0). For purification of S-HPCDH3 lysis
buffer also contained 0.1% (w/v) Tween20. Homogenized cell suspension was subjected to two
passes through a French pressure cell at 15000 psi and the crude lysate was clarified by
centrifugation at 244,717g for 45 min. The supernatant was further retained for purification.
Purification of rR-HPCDH1, rR-HPCDH1 Mutants, rS-HPCDH3 and rS-HPCDH3
Mutants. All purification procedures were performed in identical conditions, as described
previously (5, 6). All steps were carried out at 4 °C. All used buffers had the pH adjusted at 4 °C.
Dialyzed proteins were concentrated over a 30000 MW cutoff membrane, flash frozen and stored
in liquid nitrogen for future use. Protein concentrations were determined on a NanoDrop
spectrophotometer using theoretical extinction coefficients (ϵ280 = 10033 M-1 cm-1 for rSHPCDH3 and ϵ280 = 18512.5 M-1 cm-1 for rR-HPCDH1), with dialysis flow-through buffers as
blanks.
SDS-PAGE and Native PAGE Analysis. SDS-PAGE (12% T) and native PAGE (4-20% T
BioRad) were performed according to the Laemmli procedure (23). The apparent molecular
masses of polypeptides on a SDS-PAGE gel were determined by comparison to Rf values of
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standard proteins. Migration of rS-HPCDH3 mutants and rR-HPCDH1 mutants were also
compared directly to wild-type rS-HPCDH3 and wild-type rR-HPCDH1.
Spectrophotometric Enzyme Assays. All enzymes assays were performed in 50 mM
glycine, 50 mM NaH2PO4, and 50 mM Tris base (GPT buffer mix) at a pH of 7.5 (adjusted at 30
°C), as described previously (5). Assays were performed at 30 °C in a Shimadzu model UV160U
spectrophotometer equipped with a water-jacketed cuvette holder for thermal control. Alcohol or
ketone production was correlated to micromoles of NADH appearance or disappearance,
respectively, measured at 340 nm using the extinction coefficient for NADH (ϵ340 = 6.22 mM-1
cm-1). In determining kinetic constants for R-HPC oxidation by rR-HPCDH1 the following ranges
of alcohol concentration were used in the assays: 0.025 – 1.0 mM (WT); 0.75 – 24 mM (M187A
and M192A); 0.75 – 75 mM (M187A/M192A); 0.050 – 20 mM (M187L); 0.10 – 81 mM
(M192L). For S-HPC oxidation the concentrations were: 0.078 – 7.8 mM (WT); 14 – 52 mM
(M187A); 3.5 – 87 mM (M192A); 0.035 – 14 mM (M187L); 0.078 – 7.8 mM (M192L). For HEC
oxidation the concentrations were: 0.20 – 16 mM (WT); 0.40 – 16 mM (M187L); 0.80 – 30 mM
(M192L). In the assay of S-HPC oxidation by rS-HPCDH3 the following ranges of alcohol
concentrations were used: 0.030 – 3.8 mM (WT); 3.5 – 87 mM (M153A); 1.6 – 52 mM (M194A);
0.21 – 6.7 mM (M194L). For R-HPC oxidation the concentrations were: 1.5 – 3.8 mM (WT); 12
– 45 mM (M153A); 30 – 121 mM (M194A); 1.5 – 3.8 mM (M194L). For HEC oxidation the
concentrations were: 0.20 – 16 mM (WT); 0.40 – 16 mM (M194L). The concentration of NAD+
for all assays was 10 mM (22 x value of KmNAD+ for rR-HPCDH1 and 52 x value of KmNAD+ for rSHPCDH3). For assays of ketone reduction by rR-HPCDH1, the following ranges of 2-KPC
concentration were used in determining kinetic constants: 0.016 – 0.50 mM (WT); 0.36 – 36 mM
(M187A); 0.7 – 17 mM (M192A); 1.4 – 36 mM (M187A/M192A); 0.016 – 1.0 mM (M187L);
0.033 – 2.1 mM (M192L). In the assay of 2-KPC reduction by rS-HPCDH3 the following ranges
of concentration were used: 0.10 – 32 mM (WT); 6.2 – 34 mM (M153A); 1.4 – 21 mM (M194A);
0.69 – 22 mM (M194L); The concentration of NADH for these assays was 0.16 mM, (4.4 x value
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of KmNADH for rR-HPCDH1 and 19 x value of KmNADH for rS-HPCDH3). On an average, six
concentrations of substrates within the ranges indicated were chosen for the kinetic analyses. All
samples were degassed/flushed with nitrogen and incubated at 30 ºC water-bath for 5 min prior to
the enzyme addition. To determine kinetic parameters (apparent Km and Vmax) initial rate values
were plotted as a function of substrate concentration and data points were fitted to the MichaelisMenten equation using SigmaPlot 11.0.
Standardization of Stock Solutions. Stock solutions of synthesized R-HPC and 2-KPC
were standardized using wild-type rR-HPCDH1, whereas stock solutions of synthesized S-HPC
were standardized with wild-type rS-HPCDH3. Standardization assays for R-HPC and S-HPC
oxidation were performed in GPT buffer (50 mM glycine, 50 mM NaH2PO4, and 50 mM Tris
base) at pH 11.0 with 50 μg of enzyme and 10 mM of NAD+. Standardization assay for 2-KPC
reduction was performed in GPT buffer at pH 7.5 with 50 μg of enzyme and 0.2 mM of NADH.
All assays were repeated three to six times depending on the value of standard deviation obtained
from triplicate experiments. Reactions were carried out at 30 ºC for 2 min. The average
absorbance measured at 340 nm was correlated with micromoles of the substrate used in the assay
using the extinction coefficient for NADH (ϵ340 = 6.22 mM-1 cm-1). Calculations of the final stock
concentration of 2-KPC were done using the equilibrium constant determined from the Haldane
equation, as described previously (5). Calculations of the final stock concentration of R-HPC and
S-HPC were based on assumption that the reactions went to completion, since pH 11.0 renders
both enzymes irreversible. Stock solutions of NAD+ and NADH were standardized by measuring
absorbance of aliquoted solutions at 260 nm and 340 nm, respectively, using corresponding
extinction coefficients (NAD+ ϵ260 = 18.0 mM-1 cm-1).
Inhibition Studies. All assays were performed in GPT buffer mix at pH 7.5 with
saturating concentration of NAD+ (10 mM). Inhibition assays for wild-type rR-HPCDH1 were
performed at the following variable concentrations of R-HPC: 31, 72, 144, 287 and 615 µM. For
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rR-HPCDH1 M187L concentrations of R-HPC were: 48, 96, 240, 480, 960 and 1920 µM,
whereas for rR-HPCDH1 M192L concentrations of R-HPC were: 246, 491, 982, 1960, 3920 and
7840 µM. Each assay was performed at several fixed concentrations of M-HPC: 0, 0.2, 0.4, 0.8
and 1.6 mM. Inhibition assays for wild-type rS-HPCDH3 were performed at the following
variable concentrations of S-HPC: 16, 31, 62, 155 and 310 µM and three fixed concentrations of
M-HPC (0, 1.2 and 4.9 mM). Similar assays for rS-HPCDH3 methionine mutants were performed
at the following concentrations of S-HPC: 0.10, 0.21, 0.42, 0.83, 17 and 34 mM and five fixed
concentrations of M-HPC (0, 1.2, 2.4, 4.9 and 9.8 mM). Initial rate data were fit to a rectangular
hyperbola described by the standard form of the Michaelis-Menten equation.
Crystallization Data for the Met187Ala and Met192Ala Mutants of rR-HPCDH1. The
structural studies described below were conducted in collaboration with Dr. John Peters from
Montana State University. Crystalization conditions for the Met187Ala and Met192Ala mutants
were identical to those used for the wild-type enzyme (7). Crystal trays were set up with both
substrates NAD+ and R-HPC present at a concentration of 15 and 20 mM, respectively. After 2
weeks crystals of the average size of 0.2 x 0.3 x 0.2 mm were obtained. These crystals were
harvested and flash frozen in liquid nitrogen. Diffraction data was collected at SSRL beam line 92 and further processed using HKL2000. Table 4-1 and 4-2 summarize data statistics obtained for
each of the mutants. Both crystals were assigned to the space group P21 and revealed identical
cell parameters as previously characterized crystals of the wild-type R-HPCDH (7, 24). The
molecular replacement method was applied for solving the Met187Ala and Met192Ala mutant
structures with the wild-type structure as the starting model. The refinement of these structures
was carried out. Several cycles of refinement using the CNS suite of programs along with model
building using the program O resulted in final models with 100% residues occupying allowed
regions of a Ramachandran Plot, as calculated by PROCHECK. The refinement statistics are
presented in Tables 4-3 and 4-4.
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Table 4-1. Data statistics for the R-HPCDH mutant Met187Ala co-crystallized with R-HPC.
Adopted from Krishnakumar (25).
Space group
Cell dimensions

P21
a = 64.678 Å

Resolution (Å)
Completeness (%)
Observed reflections
Unique reflections
I/σ
Rmerge a

20.00-1.46
97.9(93.7)
1163058
161616
48 (7.5)
0.042(0.301)

b = 110.176 Å

c = 68.894 Å

α = γ = 90o

β = 93.855o

Numbers in parentheses indicate values for the highest resolution bin.
a
Rmerge = ΣhklΣi|Ii - >|/ΣhklΣi|<I>|, where Ii is the intensity for the ith measurement of an equivalent
reflection with indices h, k, l.

Table 4-2. Data statistics for the R-HPCDH mutant Met192Ala co-crystallized with R-HPC.
Adopted from Krishnakumar (25).
Space group
Cell dimensions
Resolution (Å)
Completeness (%)
Observed reflections
Unique reflections
I/σ
Rmerge a

P21
a = 64.720 Å
20.00-2.08
98.9(96.7)
503556
65222
30.1(15.5)
0.111(0.264)

b = 110.812 Å

c = 68.866 Å

α = γ = 90o

β = 93.710o

Numbers in parentheses indicate values for the highest resolution bin.
a
Rmerge = ΣhklΣi|Ii - >|/ΣhklΣi|<I>|, where Ii is the intensity for the ith measurement of an equivalent
reflection with indices h, k, l.

Table 4-3. Refinement statistics for the R-HPCDH mutant Met187Ala co-crystallized with RHPC. Adopted from Krishnakumar (25).
Resolution (Å)
Rfree
Rcryst
No. Non hydrogen atoms
Protein
Cofactor
Solvent
RMSD from target values
Bond lengths (Å)
Bond angles (º)
Average isotropic B factor
All atoms
Protein main chain
Protein side chain
NAD+
Water

20.00-1.46
0.201
0.181
4004
176
419
0.012
1.55
18.71
13.71
18.41
47.25
19.05
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Table 4-4. Refinement statistics for the R-HPCDH mutant Met192Ala co-crystallized with RHPC. Adopted from Krishnakumar (25).
Resolution (Å)
Rfree
Rcryst
No. Non hydrogen atoms
Protein
Cofactor
Solvent
RMSD from target values
Bond lengths (Å)
Bond angles (º)
Average isotropic B factor
All atoms
Protein main chain
Protein side chain
NAD+
Water

20.00-2.08
0.201
0.231
4004
176
243
0.014
1.59
15.39
19.66
17.33
50.25
15.05

RESULTS AND DISCUSSION
The Overall Structure of the Met187Ala and Met192Ala Mutants of rR-HPCDH1. The
overall structure of the mutants is analogous to that of the wild-type rR-HPCDH1 (PDB ID 2cfc).
The Met187Ala mutant structure was determined at resolution up to 1.46 Å and resulted in
calculating high quality electron density maps. These maps indicate that the NAD+ molecule is
well ordered (Figure 4-1). In contrast to the previously determined structure of rR-HPCDH1, the
present structure reveals clear electron density for the entire ribose molecule, thus confirming its
positioning in the previously determined wild-type structure (7). Site directed mutagenesis studies
of Met187 and Met192 in rR-HPCDH1 have revealed the importance of these residues for
catalysis. Kinetic analysis, discussed in detail further in the text, revealed that substitution of the
methionines to alanine significantly altered both kcat and Km in the reaction with all tested
substrates. To gain further insigh into the role of the active site methionines in the substrate
binding and catalysis crystal structures of the methionine mutants were determined.
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Figure 4-1. Electron density contoured at 1σ cutoff around NAD+ in the structure of R-HPCDH1
Met187Ala mutant.

Structural Analysis of the Role of Met187 Residue in rR-HPCDH1. The X-ray structure
of Met187Ala shows clear density of an alanine rather than a methionine residue at position 187,
thus confirming the mutation. No electron density corresponding to the sulfonate group at the
sulfonate binding site could be seen in the initial density maps. Instead, this position is occupied
by what seems like solvent molecules, present in the electron density maps in form of disordered
"blobs" (Figure 4-2). Comparison of the wild-type rR-HPCDH1 structure with the Met187Ala
mutant structure reveals structural implications in the substrate binding pocket brought about by
the mutation. Based on the structural data it is proposed that the Met187 plays a role in shielding
the sulfonate moiety of the substrate from the ambient solvent and in separating/shielding charges
of the sulfonate moiety from the charges developing in the active site during catalysis. The
Met187 residue in the wild-type rR-HPCDH1 is positioned close to the sulfonate moiety of the
substrate and forms a part of the solvent protected substrate binding pocket. Superimposition of
the wild-type rR-HPCDH1 and the Met187Ala mutant structures reveals a large solvent
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Figure 4-2. Electron density contoured at 1σ cutoff at the sulfonate biding region in the
Met187Ala mutant structure of R-HPCDH1. Adopted from Krishnakumar (25).

accessible pocket created around the sulfonate binding pocket. As a result non-productive
interactions of the solvent molecules with the arginine residues impair/prevent interactions of
these residues with the sulfonate moiety of the substrate (Figure 4-3). Another important
difference is the altered conformation of the side chain of Phe149 in the mutant structure.
Analysis of the wild-type structure revealed that the side chain of Phe149 forms several
hydrophobic interactions with the C1, C2 and C3 carbons of the product 2-KPC (Figure 4-4)
clearly contributing to its binding. Also, a terminal methyl group of Met187 side chain is oriented
towards Phe149 making a single hydrophobic contact. Position and orientation of Met187 and
Phe149 in the wild-type structure suggest that both residues contribute to the compact active site
architecture and appear to be shielding the substrate from behind. Substitution of Met187 to
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Figure 4-3. Superimposed structures of the Met187Ala mutant (grey) and wild-type rR-HPCDH1
(green) highlighting alignment of NAD+ and the active site residues, and showing a position of
Met187 in a channel leading to the active site cavity. Surface representation of Met187Ala mutant
(yellow) shows a large opening of the active site as a result of Met187 to Ala substitution.

smaller in size alanine allows the side chain of Phe149 to assume a different conformation, thus
creating a large solvent accessible pocket. Superimposition of Met187Ala mutant and the wildtype enzyme structures reveals that the phenolic ring of Phe149 in Met187Ala structure clashes
with the product 2-KPC present in the wild-type structure (Figure 4-4). It is plausible that
different confirmation of Phe149 side chain might be a direct result of the product absence, as
observed for Met187Ala mutant. Lack of hydrophobic interactions between Phe149 and both the
product and Met187 residue could provide the phenolic ring of Phe149 with more conformational
freedom. Another important observation is that the catalytic triad residues of Ser142, Y155 and
Lys159 along with the NAD+ cofactor are well aligned with respect to each other in both the
wild-type and the mutant structures (Figure 4-3). This is despite the fact that the Met187Ala
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Figure 4-4. Superimposed structures of the Met187Ala mutant (green) and the wild-type rRHPCDH1 (grey) highlighting hydrophobic interactions (dashed lines) of Phe149 with C1-C3
carbons of 2-KPC in the wild-type enzyme structure, and different conformation of Phe149 and
Met192 residues in the Met187Ala mutant structure relative to that of the wild-type rR-HPCDH1.
mutant structure lacks the substrate R-HPC and thus represents an enzyme•NAD+ binary
complex, whereas the wild-type structure with the product 2-KPC bound represents
enzyme•NAD+•2-KPC ternary complex. Together it may suggest that there is no conformational
change induced by the substrate binding to the enzyme•NAD+ binary complex with respect to the
active site residues. However the cofactor-induced conformational change reported for some
members of the SDR family cannot be rule out at this point (26).
Structural Analysis of the Role of Met192 Residue in rR-HPCDH1. The crystal structure
of Met192Ala determined at 2.08Å resolution clearly shows lack of the methionine residue at
position 192, thus confirming the mutation (Figure 4-5). An electron density of the substrate
bound in the active site is only observed for the sulfonate moiety. Lack of good electron density
for the remaining part of the substrate prevents from its precise postioning relavite to the catalytic
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Figure 4-5. Superimposed structures of the Met192Ala mutant (grey) and the wild-type rRHPCDH1 (green) highlighting alignment of NAD+ and the active site residues, and showing a
position of Met187 in a channel leading to the active site cavity. Surface representation of
Met192Ala mutant (yellow) shows a large opening of the active site as a result of Met192 to Ala
substitution.
triad residues. Nevertheless, the fact that the sulfonate group is present in these initial maps is
somewhat surprising considering that the Km value for R-HPC exhibited by Met192Ala mutant is
higher than that for the Met187Ala mutant, which did not show electron density corresponding to
the bound substrate. Superimposition of the Met192Ala mutant and the wild-type rR-HPCDH1
structures highlights further differences in the architechture of the two active sites thus providing
insight into the possible role of Met192. The crystal structure of the wild-type enzyme reveals
that Met192 is positioned in close proximity of the hydroxyl group and the hydrogen atom
involved in the oxidation/reduction chemistry. This suggests a possible role of this residue in
shielding the negative charge on the catalytic triad tyrosine from the non-productive interactions
with the solvent molecules. The comparison of both structures corroborates with this prediction
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and reveals a large solvent accessible pocket around the active site as a result of the Met192
substitiution to Ala (Figure 4-5).
Kinetic Analysis of Met187Ala and Met192Ala Mutants of rR-HPCDH1. The apparent kcat
and Km values determined for R-HPC and S-HPC oxidation, and 2-KPC reduction, by rRHPCDH1 were similar to those reported previously (6). In contrast, kinetic parameters of rRHPCDH1 methionine mutants were significantly altered, suggesting an important role of Met187
and Met192 in substrate binding and/or catalysis. Specifically, in R-HPC oxidation catalyzed by
Met187Ala and Met192Ala mutants the apparent Km values increased by 18- and 24-fold,
respectively, as compared to the wild-type rR-HPCDH1. These results are in agreement with the
structural data showing that the substitution of Met187 and Met192 to alanine creates a large
solvent accessible pocket, thus permitting non-productive interactions of the active site residues
with the solvent molecules. The significance of both methionines was also reflected in the two- to
four-fold decrease of the apparent turnover number (kcat) exhibited by Met187Ala and Met192Ala
mutants, respectively. The most substantial changes were observed for Met192Ala mutant
suggesting a special role of Met192 in the catalytic activity of rR-HPCDH1. Indeed
crystallographic data shows that Met192 in the wild-type enzyme shields the negative charge on
Tyr155 of the catalytic triad from ambient solvent molecules, thereby bringing about effective
catalysis. The trend of an increasing Km and a decreasing kcat was dramatically intensified in a
double mutant of rR-HPCDH1 (Met187Ala/Met192Ala) where the apparent Km was 876-fold
higher and the apparent kcat 22-fold lower than for the wild-type enzyme, thereby making the
mutant enzyme practically inactive at the cellular concentration of R-HPC. A combined effect of
the changes in Km and kcat was well reflected in the catalytic efficiencies (kcat/Km) of the analyzed
mutants, which values decreased by 43-fold (Met187Ala), 96-fold (Met192Ala) and over 19,000fold (Met187Ala/Met192Ala). Significant changes in kinetic parameters were also observed in 2KPC reduction, where the apparent kcat values decreased four-fold (Met187Ala), five-fold
(Met192Ala) and 196-fold (Met187Ala/Met192Ala). This in turn translates to a further

Table 4-5. Kinetic parameters for rR-HPCDH1 WT and its Met187Ala and Met192Ala mutants at 30°C and
pH 7.5a
Enzyme
Km
Change in
Vmax
kcat
Change in
kcat /Km
(units•mg-1)
(s-1)
kcat (x-fold)
(M-1 s-1)
Km (x-fold)
Substrate: R-HPC
WT
82.7 ± 6.8
1.00
83.2 ± 1.9
41.2
1.0
4.98 x 105
M187A
1510 ± 92
18.3
35.2 ± 0.54
17.4
0.42
1.15 x 104
M192A
2020 ± 210
24.4
21.0 ± 0.61
10.4
0.25
5.16 x 103
M187/192A
72500 ± 10500
876
3.82 ± 0.33
1.89
0.046
2.61 x 101
Substrate: S-HPC
WT
265 ± 72
1.00
0.226 ± 0.014
0.112
1.0
4.22 x 102
M187A
NDb
NDb
NDb
NDb
M192A
4840 ± 280
18.3
0.165 ± 0.0021
0.0815
0.73
1.68 x 101
NDc
NDc
NDc
M187/192A
NDc
Substrate: 2-KPC
WT
72.4 ± 12
1.00
55.7 ± 2.9
27.6
1.0
3.81 x 105
M187A
1160 ± 120
16.0
12.5 ± 0.37
6.19
0.22
5.33 x 103
M192A
1890 ± 220
26.1
10.5 ± 0.34
5.20
0.19
2.75 x 103
M187/192A
8470 ± 1260
117
0.28 ± 0.015
0.141
0.0051
1.66 x 101
a
Assay for R-HPC and S-HPC oxidation by rR-HPCDH1 WT, M187A and M192A mutants contained 1.0 µg
and 46 µg of enzyme, respectively. Assay for R-HPC and S-HPC oxidation by M187A/M192A mutant
contained 46 µg and 100 µg of enzyme, respectively. Assay for 2-KPC reduction by rR-HPCDH1 WT,
M187A and M192A mutants contained 2.0 μg of enzyme and 70 μg of M187A/M192A mutant. Apparent
kcat and Km values are reported as means ± standard deviations. All assays were performed at 30 ˚C with
fixed concentrations of NAD+ (10 mM) or NADH (0.16 mM). Apparent kinetic constants were determined
by fitting experimental data to the standard form of the Michaelis-Menten equation. bND, not determined;
accurate steady-state kinetic data were unobtainable due to lack of saturation up to 52 mM of S-HPC. cND –
no detectable activity at concentrations up to 28 mM of S-HPC and 100 µg of enzyme.
(μM)

140

141
decline in the kcat/Km values, which were 71-fold, 139-fold and 23,000-fold lower, respectively,
than the corresponding values for the wild-type rR-HPCDH1. As previously demonstrated, rRHPCDH1 enzyme is highly specific towards R-HPC, exhibiting only 0.5% activity with the
opposite enantiomer (5, 6). It was further shown that enantioselectivity of rR-HPCDH1 enzyme is
mostly controlled by kcat values, while Km values for both enantiomers remain similar. Results
presented in Table 4-5 confirm this finding, showing 370-times lower kcat for the opposite
enantiomer (S-HPC) of rR-HPCDH1 and similar Km values for both isomers. The reaction of SHPC oxidation by Met192Ala mutant was characterized by 18-fold increase in the apparent Km
value, as compared to the wild-type rR-HPCDH1, and was analogous to the corresponding
increase of the apparent Km values (24-fold) for R-HPC oxidation. When enantioselectivity (E) is
defined as the ratio of kcat/Km for the natural enantiomer to kcat/Km for the opposite enantiomer, the
following values were obtained: ERHPCDH1 = 1182 and ERHPCDH1_M192A = 307. Thus, the Met192Ala
mutant of rR-HPCDH1 is about four times less efficient in discriminating between the HPC
enantiomers than its wild-type counterpart.
Although the enantioselectivity of both enzymes is still controlled largely by the
differences in kcat values for the reaction with R-HPC vs. S-HPC, this difference is significantly
smaller for the Met192Ala mutant (∆kcat = 130 vs. ∆kcat = 370 for rR-HPCDH1). Similar activity
assays with S-HPC performed for Met187Ala / Met192Ala mutant showed no detectable activity,
whereas accurate steady-state kinetic data for S-HPC oxidation by Met187Ala mutant were
unobtainable due to lack of enzyme saturation. Interestingly, however, the Met187Ala mutant
showed a specific activity which was four times lower than for Met192Ala mutant at 14 mM of
the substrate and remained fairly constant with increasing concentrations of S-HPC (up to 52
mM).
Structural Analysis of Met187Leu and Met192Leu Mutants of rR-HPCDH1. To further
investigate the importance of the substrate flanking methionines in the active site of rR-HPCDH1,
Met187 and Met192 were substituted with leucines. This substitution was rationalized by the fact
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Figure 4-6. Superimposed structures of Met187Ala rR-HPCDH1 (grey) and wild-type rRHPCDH1 (green) showing positions of Met187 and Met192 residues on the loop connecting βF
sheet and αFF1 helix (Met187Ala rR-HPCDH1 loop – red, WT rR-HPCDH1 loop-blue).

Figure 4-7. Structure of the wild-type rR-HPCDH1 showing a channel leading to the active site
cavity. Positions of Met187 and Met192 residues (green) were superimposed on the modeled in
PyMol Leu187 and Leu192 residues (red). Electron density around residues 187 and 192
highlights differences in shape of the occupied volume.
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that the van der Waals volume occupied by leucine is the same as for methionine (27) and that the
substitution of methionines with leucines within the interior of a enzyme has been reported to
increase stability of the resulting mutants (28). If the methionines of interest had any role in the
catalytic mechanism of the enzyme, these substitutions would allow us to test their contribution,
at the same time preserving the compact and solvent protected structure of the active site.
Analysis of the X-ray structure of the wild-type rR-HPCDH1 shows that methionines 187 and
192 are located on a loop between βF sheet and αFF1 short helix (Figure 4-6) in such a way that
they approach the substrate from opposite sides. Additionally, Met192 is strategically positioned
on a side of a channel leading to the active site cavity, which may suggest its role as a "gate
keeper" (Figure 4-7). In the absence of the X-ray structures for Leu187 and Leu192 mutants,
modeling studies were done in PyMol 1.2 to visualize possible structural changes resulting from
these substitutions. Both residues (Met187 and Met192) were converted to leucines and the most
plausible rotamers (in terms of steric clashes) were selected. Superimposition of the methionines
with the corresponding leucines revealed noticeable differences in the shape of their electron
density clouds. Although the overall volume occupied by leucine and methionine residues is the
same (27), differences in its distribution, as seen in Figure 4-7, could potentially have some
structural consequences. These could include enlargement of the channel leading to the active
site, thus making it more accessible to solvent. It could also cause some small but noticeable
rearrangement of the neighboring residues in order to accommodate the differently shaped
residue, thereby remodeling the active site cavity and introducing different steric constrains posed
on the substrate. All of the above could result in alteration of the kinetic parameters and thus
should be considered for Met153Leu and Met194Leu mutants.
Analysis of the structural data for the wild-type rR-HPCDH1 shows that Met192 is in
close proximity of the chiral carbon of the substrate and as such could impose steric constrains
favoring only certain orientations of the terminal methyl group (Figure 4-8). This in turn would

144

Figure 4-8. Active site of the wild-type rR-HPCDH1 with the substrate flanking Met187 and
Met192. Superimposed are methionine 192 (green) and leucines 192 (red) to show differences in
their electron density and possible interactions with the substrates: (A) R-HPC or (B) S-HPC.
Alignment of the hydroxyl group and hydrogen atom of the substrate with respect to Tyr155 and
the nicotinamide ring of NAD+ is depicted in dashed lines.

determine orientation of the hydroxyl group and the hydrogen atom with respect to Tyr155 and
the nicotinamide ring of NAD+. It was reported previously and again confirmed in this study
(Table 4-5), that even though rR-HPCDH1 enzyme binds both enantiomers of HPC with similar
affinity, only R-HPC can be efficiently oxidized to 2-KPC, outcompeting S-HPC oxidation with
over 400-fold higher kcat (6). This difference in kcat values results from a misalignment of the
hydrogen atom on C2 carbon of S-HPC with respect to the nicotinamide ring of NAD+, where it
gets transferred in form of a hydride ion. Additionally, altered orientation of the hydrogen on SHPC increases the distance of the hydride transfer to NAD+ as compared to the corresponding
distance for R-HPC (Figure 4-8).
Two enantiomers were modeled in the active site of rR-HPCDH1 in such a way that their
hydroxyl groups were identically oriented with respect to the general base Tyr155. As a result,
the terminal methyl group and the hydrogen atom at the chiral center switched their positions.
When R-HPC is present at the active site its methyl group is located between residues 187 and
192, while the hydrogen atom points directly at Met192 (Figure 4-8A). The orientation of the

145
substrate is proper for catalysis and no steric clashes occur. In contrast, when S-HPC is bound in
the active site (with identical orientation of the hydroxyl group), its methyl group assumes the
position of the hydrogen atom in R-HPC which in turn may cause unfavorable steric clashes with
Met192 (Figure 4-8B). With regard to Met192Leu mutant it is possible that the substitution of
Met192 for shorter leucine could enlarge an otherwise compact active site and thus provide more
room for the substrate to assume a proper orientation for catalysis (Figure 4-8). Accordingly,
when S-HPC is bound in the active site with its terminal methyl group pointing at residue 192,
leucine residue in place of methionine could lower steric hindrance necessary for the proper
alignment of the hydroxyl group and the hydrogen atom with respect to Tyr155 and the
nicotinamide ring of NAD+. To visualize differences in the special orientation of the chiral center
substituents with respect to Met187 and Met192, both enantiomers of HPC alcohol were modeled
in the active site of R-HPCDH1 (Figure 4-8 and 4-9). Corresponding Leu residues were
superimposed on Met residues to envision possible changes in steric constrains imposed on the
substrate. Likewise, the achiral product of HPC alcohols oxidation (2-KPC) was analyzed in the
active site of R-HPCDH1 to visualize possible interactions with methionines and leucines at
positions 187 and 192 (Figure 4-10). The binding mode of 2-KPC is displayed as in the X-ray
structure of R-HPCDH1. The carbonyl group of 2-KPC is shifted away from Tyr155 and the
nicotinamide ring of NAD+ in direction of Phe149 residue, with which it forms several
hydrophobic interaction (Figure 4-4). As a result, this orientation brings 2-KPC close to Met187
and suggests that mutagenesis at this position could have a significant effect on the kinetic
parameters of 2-KPC reduction catalyzed by R-HPCDH1.
Kinetic Analysis of Met187Leu and Met192Leu Mutants of rR-HPCDH1. Enzymatic
assays with Met187Leu and Met192Leu mutants were performed in identical conditions as for the
corresponding alanine mutants and the wild-type rR-HPCDH1. In general, kinetic parameters
determined for R-HPC and S-HPC oxidation as well as for 2-KPC reduction were similar to those
obtained for the wild-type enzyme, but with few potentially important differences. As shown
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Figure 4-9. Active site of the wild-type rR-HPCDH1 with the substrate flanking Met187 and
Met192. Superimposed are methionine 187 (green) and leucine 187 (red) to show differences in
their electron density and possible interactions with the substrates: (A) R-HPC or (B) S-HPC.
Alignment of the hydroxyl group and hydrogen atom of the substrate with respect to Tyr155 and
the nicotinamide ring of NAD+ is depicted in dashed lines.

Figure 4-10. Active site of the wild-type rR-HPCDH1 with nicotinamide ring of NAD+ and the
substrate flanking Met187 and Met192. Superimposed are methionine 187 (green) and leucine
187 (red) to show differences in their electron density and possible interactions with 2-KPC.
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in Table 4-6, the apparent Km values for Met187Leu mutant with all tested substrates remained
fairly similar to those of the wild-type enzyme, implying a structural role of Met187. It is
speculated that alternative hydrophobic residues of similar volume (e.g., leucine, norleucine)
could effectively substitute the role of Met187 in preserving a compact and solvent free
environment of the active site. With respect to the kinetic parameters exhibited by Met192Leu
mutant, the apparent Km values increased three- to five-fold. Although this change was much less
dramatic than for the corresponding Met192Ala mutant (18- to 26-fold), it suggested an important
role for Met192 at its strategic position, susceptible to even small changes. This observation is
supported by the structural data suggesting that differences in shape of the electron density of
methionine and leucine at position 192 could result in a larger opening of the channel leading to
the active site (Figure 4-7). This in turn would provide easier access for solvent molecules to
enter the active site and competitively interact with charged residues otherwise involved in the
substrate binding/catalysis. The overall comparison of the apparent Km values for R-HPC, S-HPC
and 2-KPC displayed by Met187Leu and Met192Leu mutants with respect to the wild-type rRHPCDH1 implies that observed variations in Km are not substrate dependent, but rather arise from
changes inherited by the active site, as a consequence of the mutagenesis. For example, the
increase in Km for Met187Leu mutant is consistent across all tested substrates (1.4- to 1.7-fold),
similar to the increase in Km for Met192Leu mutant (3.3- to 5.2-fold). Surprisingly, in the reaction
of R-HPC oxidation catalyzed by Met187Leu and Met192Leu mutants, the apparent kcat values
increased by 42% and 59%, respectively, as compared to the wild-type enzyme. However, the
most significant change in kcat was observed for S-HPC oxidation by Met192Leu mutant, where
its value increased by almost three-fold. Interestingly, this enhancement of activity was abolished
for 2-KPC reduction where the apparent kcat value remained fairly similar to the corresponding
value of the wild-type enzyme (Table 4-6). These results may suggest that chirality and/or
oxidation state of the substrate are important factors in determining kcat values exhibited by
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Table 4-6. Kinetic parameters for rR-HPCDH1 WT and its Met187Leu and Met192Leu mutants
at 30°C and pH 7.5a
Enzyme
Km
Change in
Vmax
kcat
Change in
kcat /Km
(μM)

Km (x-fold)

(units•mg-1)

(s-1)

kcat (x-fold)

(M-1 s-1)

Substrate: R-HPC
R-HPCDH1

82.7 ± 6.8

1.0

83.2 ± 1.9

41.2

1.0

4.98 x 105

M187L

144 ± 10

1.7

118 ± 2.1

58.3

1.4

4.05 x 105

M192L

431 ± 14

5.2

132 ± 1.1

65.4

1.6

1.52 x 105

Substrate: S-HPC
R-HPCDH1

265 ± 72

1.0

0.226 ± 0.014

0.112

1.0

4.22 x 102

M187L

434 ± 69

1.6

0.195 ± 0.006

0.097

0.87

2.23 x 102

M192L

881 ± 54

3.3

0.632 ± 0.011

0.313

2.8

3.55 x 102

Substrate: 2-KPC
R-HPCDH1

72.4 ± 12

1.0

55.7 ± 2.9

27.6

1.0

3.81 x 105

M187L

104 ± 11

1.4

72.2 ± 2.4

35.8

1.3

3.43 x 105

M192L

341 ± 38

4.7

48.0 ± 1.9

23.8

0.86

6.99 x 104

a

Assay for R-HPC and S-HPC oxidation by rR-HPCDH1 WT and Met mutants contained 1.0 µg
and 46 µg of enzyme, respectively. Assay for 2-KPC reduction contained 1.0 µg of enzyme.
Apparent kcat and Km values are reported as means ± standard deviations. All assays were
performed at 30 ˚C with fixed concentrations of NAD+ (10 mM) or NADH (0.16 mM). Apparent
kinetic constants were determined by fitting experimental data to the standard form of the
Michaelis-Menten equation.

Met192Leu. Analysis of the structural data supports this observation showing that the steric
constrains of Met192 in the active site of rR-HPCDH1 with the terminal methyl group of S-HPC
might be involved (Figure 4-8). Accordingly it is speculated that the observed three-fold increase
in kcat exhibited by the Met192Leu mutant is caused by the substitution of Met192 with a shorter
leucine which in turn could provide more degrees of freedom for S-HPC to assume proper
orientation for catalysis (Figure 4-8). Lack of the similar increase in kcat for the oxidation of SHPC by the Met187Leu mutant seems to further support this hypothesis (Table 4-6). The same
rationale is believed to apply in the case of the Met187Leu mutant catalyzed R-HPC oxidation
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where the terminal methyl group of the substrate is oriented towards residue 187 (Figure 4-9).
Substitution to leucine at this position would remove excessive steric restrictions and thus allow
the enzyme to orient R-HPC in a fashion more favorable for catalysis. This could explain an
increase in kcat value revealed by Met187Leu (Table 4-6). Unexpectedly a similar increase in the
kcat value is observed for R-HPC oxidation by the Met192Leu mutant. Although this increase can
be regarded as moderate compared to the corresponding increase in kcat observed for S-HPC
oxidation (59% vs. 280%, respectively), nevertheless this observation suggests an important role
of Met192 in the catalytic function of rR-HPCDH1, which cannot be explained strictly in terms of
steric effects. This increase in the apparent kcat value is accompanied by over five-fold increase in
the apparent Km value. Consequently, despite the positive effect of Met192 to leucine substitution
on the turnover number, the overall catalytic efficiency for R-HPC oxidation decreased by more
than three-fold relative to the wild-type enzyme. Thus, choice of methionine in this particular
position appears to be optimal and perfectly tuned by many rounds of evolutionary selection. It
should be noted at this point that the Met192 residue is located only 4.6 Å away from the general
acid/base residues (Tyr155) and thus any changes made to its closest environment could
potentially have significant implications on the enzyme’s catalytic activity (e.g., increase in kcat).
Once available, the X-ray structure of the Met192Leu mutant will undoubtedly aid in a better
understanding of the observed changes in the kinetic parameters. Also, additional kinetic assays
with other chiral alcohols (e.g., R- and S-2-hexanol or 3-hexanol) and their corresponding ketones
as substrates for the Met192Leu mutant may prove useful.
With regard to the 2-KPC reduction catalyzed by rR-HPCDH1 Met192Leu mutant, the
most interesting observation was the 30% increase in the apparent kcat value exhibited by
Met187Leu. It is speculated that in the ketone reduction catalyzed by rR-HPCDH1 steric factors
associated with the differences in shape of leucine and methionine residues play an important role
in positioning of the substrate for catalysis (Figure 4-9). These, together with the differences in
geometry between the ketone and alcohol functional groups (trigonal planer vs. tetrahedral) and
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the occupied volume might by a reason why the kcat values for the ketones are less altered than
those observed for the alcohols (Table 4-6).
Finally, since enantioselectivity of rR-HPCDH1 is largely controlled by kcat (6), it is not
surprising that differences in the apparent kcat values for the Met187Leu and Met192Leu mutants
relative to the wild-type enzyme had a direct effect on their enantioselectivity. For the
Met187Leu mutant enantioselectivity increased by 53% (ER-HPCDH1 = 1182 vs. ER-HPCDH1_M187L =
1813), whereas for the Met192Leu mutant it decreased by almost three-fold (ER-HPCDH1_M192L =
428). The latter change resulted from an increase in catalytic efficiency exhibited by the
Met192Leu mutant in an oxidation of the opposite enantiomer (S-HPC), which was mostly
dictated by a three-fold increase in the apparent kcat value. Based on the presented herein data it is
proposed that the methionines at position 187 and 192 are involved in modulating the
enantioselectivity of the rR-HPCDH1 enzyme towards the HPC enantiomers. This hypothesis
could be further tested through the additional kinetic analysis of the new site-directed mutants
such as Met187Ile or Met192Ile.
Structural Analysis of Met153Ala and Met194Ala Mutants of rS-HPCDH3. As revealed
by the homology model, a characteristic feature of rS-HPCDH3 active site is the presence of two
methionine residues situated on both sides of the substrate binding pocket. These are Met153 and
Met194. Both residues appear 41 residues apart in the amino acid sequence of S-HPCDH3 and
are located on two separate loops dividing β sheets and α helixes (Figure 4-11). In the homology
model however they are oriented in a similar way to the corresponding methionines in RHPCDH1, namely flanking the substrate from both sides (Figure 4-6 and 4-12). By comparison,
Met187 and Met192 in R-HPCDH1 are located on the same loop, separated by only four residues.
To investigate the role of Met153 and Met194 in S-HPCDH3 in substrate binding and catalysis,
both residues were mutated to alanines. The kinetic studies of the site-directed mutants of SHPCDH3, supported by the structural analysis, complement those of R-HPCDH1 and thus
provide an insight to the importance of the active site methionines in controlling the
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Figure 4-11. Structural representation of the active site of rS-HPCDH3 based on the homology
model, with highlighted positions of Met153 and Met194 (cyan) located on the separate loops
connecting β sheets and α helixes.

enantioselectivity of the HPCDH enzymes. The X-ray structure of R-HPCDH1 reveals that
Met192 is involved in binding of the NAD+ cofactor. As shown in Figure 4-12A possible
interactions include: hydrogen bonding with the phosphate groups and hydrophobic interactions
with the ribose ring of the cofactor. Superimposition of the homology model of S-HPCDH3 with
the X-ray structure of R-HPCDH1 suggests a similar role of Met194 in S-HPCDH3 (Figure 412A). In contrast Met187 of R-HPCDH1 is positioned around the CoM moiety of the substrate.
Similar orientation of Met153 with respect to the general base (Tyr156) and the CoM moiety of
the substrate is predicted for S-HPCDH3 as indicated by the homology model (Figure 4-12B).
Similar to R-HPCDH1, Met153 and Met194 in S-HPCDH3 are situated at the entrance of
a channel leading to the active site, suggesting that both methionines may play a role of "gate
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Figure 4-12. Superimposed structure of rR-HPCDH1 (green) and the homology model of rSHPCDH3 (grey). (A) Superimposed are Met192 of rR-HPCDH1 (green) and Met194 of rSHPCDH3 (grey) to show possible interactions with NAD+ cofactor. Distances are shown in Å.
(B) Superimposed are Met187 of rR-HPCDH1 (green) and Met153 of rS-HPCDH3 (grey) to
show their orientation relative to each other and the respective substrates.
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Figure 4-13. Homology model of rS-HPCDH3 with the substrate S-HPC and the cofactor NAD+
bound. Superimposed are Met153 and Met194 residues (green) with Ala187 and Ala192 residues
(red) shown with their predicted electron density to highlight differences in shape and occupied
volume. (A) Position of Met153 and Met194 with respect to two channels leading to the active
site cavity. (B): Alternative view on Met153 and Met194 in the active site highlighting strategic
position of Met194 at the interface of two channels.

keepers" (Figure 4-13). Since no X-ray structures are available for Met153Ala and Met194Ala
mutants, modeling studies were conducted using PyMol 1.2 to visualize possible structural
changes introduced by the substitution. Superimposition of Met153 and Met194 on the
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corresponding alanine residues (Ala153 and Ala194) reveals a large solvent accessible pocket
created around the active site, which was previously well shielded from the surroundings (Figure
4-13). This could allow non-specific interactions of the critical active site residues with the
solvent thus significantly altering binding and catalysis of the physiological substrates. It appears
that Met194, at its bridging position between two channels, might be susceptible to minor
changes which would likely affect the binding affinity of the substrate and the cofactor.
Kinetic Analysis of Met153Ala and Met194Ala Mutants of rS-HPCDH3. Table 4-7
summarizes the effect of methionine to alanine substitutions at positions 153 and 194 on the
kinetic parameters of rS-HPCDH3, when R-HPC, S-HPC and 2-KPC were variable substrates and
NAD+/NADH was the fixed saturating substrate. The kinetic analyses of wild-type rS-HPCDH3
were also performed in identical conditions for side by side comparison with the mutated
variants. The apparent kcat and Km values determined for R-HPC and S-HPC oxidation, and 2KPC reduction, by rS-HPCDH3 were comparable to those reported previously (6). The most
significant changes for rS-HPCDH3 methionine mutants were observed in the apparent Km values
(Table 4-7). Specifically, in S-HPC oxidation catalyzed by Met153Ala and Met194Ala mutants
the apparent Km values increased by about 100-fold, as compared to the wild-type enzyme. At the
same time, the apparent Km values for R-HPC oxidation and 2-KPC reduction by Met194Ala
mutant increased by seven- and 24-fold, respectively. These results are analogous to the
Met187Ala and Met192Ala mutants of rR-HPCDH1 and suggest a similar role for both
methionine residues in protecting the active side from non-productive interactions with the
solvent molecules. Structural analysis of the homology model of rS-HPCDH3 shows that Met153
and Met194 are lining a small channel leading to the active site cavity, and thus could serve a role
of "gate keepers" (Figure 4-13). The corresponding kinetic parameters for Met153Ala mutant
with R-HPC and 2-KPC could not be determined due to the lack of detectable activity. This is not
surprising considering that in the reaction of S-HPC oxidation Met153Ala mutant showed
minimal activity, exhibiting five-orders of magnitude decrease in catalytic efficiency (kcat/Km).
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Table 4-7. Kinetic Parameters for rS-HPCDH3 WT and its Methionine Mutants at 30°C and
pH 7.5a
Enzyme
Km
Change in
Vmax
kcat
Change in
kcat /Km
(μM)

Km (x-fold)

(units•mg-1)

(s-1)

kcat (x-fold)

(M-1 s-1)

Substrate: S-HPC
135.2 ± 9.7

1.00

57.1 ± 1.0

25.8

1.0

1.91 x 105

M153A

13990 ± 1100

103

0.188 ± 0.0048

0.0848

0.0033

6.06 x 100

M194A

13440 ± 850

99.4

93.2 ± 2.3

42.1

1.6

3.13 x 103

M194L

381 ± 54

2.82

12.3 ± 0.43

5.53

0.21

1.45 x 104

4.18 ± 0.10

1.89

1.0

2.29 x 102

NDb

NDb

WT

Substrate: R-HPC
WT

8217 ± 570

1.00

M153A

NDb

NDb

M194A

57060 ± 4500

6.94

0.677 ± 0.025

0.310

0.16

5.35 x 100

M194L

15360 ± 2449

1.87

1.30 ± 0.091

0.585

0.31

3.81 x 101

24.3 ± 0.42

11.0

1.0

4.89 x 104

NDb

NDb

Substrate: 2-KPC
WT

223.8 ± 17

1.00

M153A

NDb

NDb

M194A

5367 ± 860

24.0

11.7 ± 0.71

5.30

0.48

9.87 x 102

M194L

2229 ± 423

9.96

6.16 ± 0.38

2.78

0.25

1.25 x 103

a

Assay for S-HPC oxidation contained the following amounts of enzyme: 1.0 μg of rSHPCDH3 WT and M194L, 118 μg of M153A and 1.5 μg of M194A. Assay for R-HPC
oxidation contained the following amounts of enzyme: 5 μg of rS-HPCDH3 WT, 29 μg of
M194L, 118 μg of M153A and 100 μg of M194A. Assay for 2-KPC reduction contained the
following amounts of enzyme: 1.0 μg of rS-HPCDH3 WT, 2.0 μg of M194L, 118 μg of
M153A and 1.5 μg of M194A. Apparent kcat and Km values are reported as means ± standard
deviations. All assays were performed at 30 ˚C with fixed concentrations of NAD+ (10 mM).
Apparent kinetic constants were determined by fitting experimental data to the standard form
of the Michaelis-Menten equation. bND – no detectable activity at concentrations up to 34 mM.

Therefore by analogy to the wild-type enzyme the reaction of R-HPC and 2-KPC
catalyzed by the Met153Ala mutant would be expected to proceed with even lower values of
kcat/Km, possibly below detectable levels. The dramatic decrease in kcat/Km observed for
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Met153Ala mutant is a result of over 100-fold higher Km value and over 300-fold lower kcat value,
relative to wild-type rS-HPCDH3. Substitution of Met153 to Ala renders an enzyme practically
inactive at the physiological concentrations of substrates and cofactors, thus suggesting that this
residue is especially important in substrate binding and catalysis. The homology model of rSHPCDH3 shows that Met153 is in a close proximity of the general acid/base (Tyr156). This
suggests that it might participate in its positioning for catalysis and/or in protecting Tyr156 from
the solvent. With respect to the apparent kcat values, Met194Ala mutant revealed two- to six-fold
decrease in its value for 2-KPC and R-HPC as substrates, respectively. Interestingly however, in
S-HPC oxidation the apparent kcat value increased by 63%, implying that similar to Met192Leu
mutant of rR-HPCDH1 some steric restrictions imposed by Met194 could be involved in the
improved substrate positioning for catalysis. It is speculated that substitution of Met194 to alanine
(significantly smaller in volume) could enlarge the active site and provide the substrate with more
conformational freedom to assume the most suitable position for catalysis. Despite the increased
apparent kcat value, the overall catalytic efficiency for the Met194Ala mutant decreased over 60fold compared to wild-type rS-HPCDH3, due to the highly elevated apparent Km value. Finally,
an intriguing observation coming from the kinetic data is the disproportionately high increase in
the apparent Km values for S-HPC oxidation, as compared to the corresponding increase for 2KPC and R-HPC displayed by the same mutants (Table 4-7).
Structural Analysis of Met153Leu and Met194Leu Mutant of rS-HPCDH3. To further
investigate the role of the substrate flanking methionines in the active site of rS-HPCDH3,
methionines 153 and 194 were substituted with leucines. This substitution was chosen based on
the similarities of both the residues and was intended to preserve the compact and solvent
inaccessible structure of the active site. Modeling studies (in PyMol) where Met153 and Met194
were converted to leucines and then superimposed on the homology model of the wild-type rSHPCDH3, revealed noticeable differences in the shape of their electron density clouds.
Specifically, the side chain of Met153 in its most favorable conformation is oriented towards the
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opening of the channel thus determining its diameter. When shorter in length Leu153 was
modeled at the same position, it became clear that this substitution will likely result in a wider
opening of the channel (Figure 4-14). A similar effect is believed to apply in the case of Met194,
which is bridging the two channels leading to the active site cavity. Together, the Met to Leu
substitutions could grant an easier access of the surrounding solvent into an otherwise compact
active site of rS-HPCDH3, thus permitting non-productive interactions with charged amino acids
(e.g., Tyr156, Arg211 or Lys214). Therefore, as stated for methionine to alanine mutants and
observed again here, one of the proposed functions for Met153 and Met194 is to serve a role of
"gate keepers" in sealing the active site from the immediate solvent environment.

Figure 4-14. Homology model of rS-HPCDH3 showing the active site cavity with S-HPC and
NAD+ bound. Superimposed are Met153 and Met194 residues (green) with Leu187 and Leu192
residues (red) shown with their predicted electron density to highlight differences in shape and
occupied volume.
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To shed more light on the possible involvement of both methionines in controlling
enantioselectivity of rS-HPCDH3, two PyMol models were built with R-HPC and S-HPC bound
in the active site. Both enantiomers were positioned in such a way that their hydroxyl groups
were identically oriented with respect to the general base Tyr156. It has been proposed that the
enantioselectivity of rS-HPCDH3 is largely dictated by changes in Km values (over 60-fold
difference in Km for S- and R-enantiomers) as a result of steric clashes imposed by the presence of
the methyl group on the chiral carbon of R-HPC (6). It was therefore intriguing to test the
possiblilty of the substrate flanking methionines being involved in chiral discrimination. When SHPC is bound in the active site with its hydroxyl group and the hydrogen atom in the proper
orientation with respect to Tyr156 and the nicotinamide ring of NAD+, the terminal methyl group
points towards Met153 (Figure 4-17A). No steric clashes are observed for this enantiomer.
However, when R-HPC is present in the active site (with the identical orientation of the hydroxyl
group) its hydrogen atom becomes misaligned relative to the nicotinamide ring of NAD+, while
the terminal methyl group (now in the position of the hydrogen atom of S-HPC) clashes with the
nicotinamide ring of NAD+ (Figure 4-17B). Moreover, any rotation of the chiral center around C2
– C3 bond to lessen the observed steric hindrance would result in further clashes of the hydroxyl
group with the nicotinamide ring plus, even greater misalignment of both: the hydroxyl group and
the hydrogen atom of the substrate. Clearly only S-HPC can be effectively bound in the active site
of rS-HPCDH3 to fulfill the required alignment for catalysis and avoid unfavorable steric clashes.
As shown in Figure 4-17A, a compact structure of the active site imposes steric restrictions on SHPC to bind in the specific manner.
Structural analysis of Met153 and Met194 substitution to leucines (in PyMol) suggests
some minor changes to the active site environment directly involved in catalysis. Specifically, the
shorter in length Leu153 residue is likely to remove extensive steric hindrance imposed on the
terminal methyl group of S-HPC (Figure 4-15A and 4-17A). It is speculated that the ethyl group
substituent at the chiral center could probably be accommodated as a result of the enlarged
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Figure 4-15. Active site of rS-HPCDH3 highlighting an orientation of the substrates with respect
to Met153. Superimposed are Met153 (green) and Leu153 (red) to show differences in their
electron density and possible interactions with substrates: S-HPC (Panel A) or R-HPC (Panel B).
Alignment of the hydroxyl group and the hydrogen atom of the substrate with respect to Tyr156
and nicotinamide ring of NAD+ are depicted in dashed lines.

Figure 4-16. Active site of rS-HPCDH3 highlighting an orientation of the substrates with respect
to Met194. Superimposed are Met194 (green) and Leu194 (red) to show differences in their
electron density and possible interactions with substrates: S-HPC (Panel A) or R-HPC (Panel B).
Alignment of the hydroxyl group and the hydrogen atom of the substrate with respect to Tyr156
and nicotinamide ring of NAD+ are depicted in dashed lines.
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Figure 4-17. Active site of rS-HPCDH3 (homology model) highlighting steric effects of docking
two enantiomeric forms of HPC alcohol. Superimposed are Met153 (green) and Leu153 (red) to
show differences in their electron density and possible interactions with the substrates: S-HPC
(Panel A) or R-HPC (Panel B). Alignment of the hydroxyl group and the hydrogen atom of the
substrate with respect to Tyr156 and nicotinamide ring of NAD+ are depicted in dashed lines.

"methyl binding pocket". The position of Met194 further away from the "business" end of the
substrate does not seem to have any direct influence on the enantioselectivity of rS-HPCDH3
(Figure 4-16). Accordingly, Met194 to leucine substitution is not expected to significantly alter
the enantioselectivity of rS-HPCDH3, which as noted before is controlled by means of Km. On the
other hand, the close proximity of Met194 to NAD+ suggests its role in the cofactor binding
through hydrophobic and hydrogen bond interactions. If this hypothesis holds true, one would
expect noticable changes in binding affinity for NAD+ exhibited by the Leu194 mutant. This
however requires additional kinetic analysis and has not been further pursued in this study.
Kinetic Analysis of Met194Leu Mutant of rS-HPCDH3. The substrate flanking
methionines (Met153 and Met194) in the active site of rS-HPCDH3 were substituted with
leucines. Although Met194Leu mutant was cloned and expressed in a fully active form, numerous
efforts to isolate Met153Leu were unsuccessful due to low expression level of the mutant protein.
In general, the kinetic parameters for Met194Leu mutant of rS-HPCDH3 were fairly similar to
the corresponding parameters exhibited by the wild-type rS-HPCDH3, however with some
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interesting differences (Table 4-7). Specifically, the apparent kcat values for all substrates used in
the assay decreased by three- to five-fold. Simultaneously, the apparent Km values for the
oxidation of S-HPC and R-HPC increased by two- to three-fold, while the apparent Km value for
the reduction of 2-KPC increased by 10-fold. Differences in Km values could suggest that the
oxidation state (ketone vs. alcohol) and geometry (trigonal planar vs. tetrahedral) of the substrate
might be important in determining its binding affinity. Analysis of the homology model of rSHPCDH3 corraborate an important role of Met194 located on the surface between two channels
leading to the active site (Figure 4-13). Based on this model Met194 is proposed to form part of a
lining of the active site and contributes to NAD+ binding (Figure 4-12A). Superimposition of the
homology model of rS-HPCDH3 and the X-ray structure of rR-HPCDH1 suggests that Met194 of
rS-HPCDH3 is positioned in the similar fashion to Met192 of rR-HPCDH1 and may form
hydrogen bond interaction with the phosphate groups and hydrophobic interactions with the
ribose ring of NAD+.
Initial

Velocity

Studies

with

a

Substrate

Analogue.

2-(2-hydroxyethylthio)

ethanesulfonate (HEC) is an achiral mimic of both R-HPC and S-HPC in which the terminal
methyl group is replaced by hydrogen. HEC was previously shown to be a substrate for both the
R- and S-HPCDH enzymes with identical Km values, suggesting that for this substrate the CoM
moiety and hydroxyl group have become equal determinants in binding affinity (assuming Km
approximates affinity). Structural and kinetic analysis of the methionine mutants presented above
suggested that these residues might be involved in modulating enantioselectivity of the enzyme
through steric interactions with the C2 methyl group of the substrate. To test this hypothesis HEC
was used as a substrate for Met187Leu and Met192Leu mutants of rR-HPCDH1 along with
Met194Leu mutant of rS-HPCDH3. Presented in Table 4-8 are kinetic parameters for HEC
oxidation determined at a fixed saturating concentration of NAD+ (10 mM) and a variable
concentration of HEC at pH 7.5. For comparison purposes and to better visualize the effect of the
terminal methyl group on the biding affinity of the analyzed substrates secondary tables were
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assembled (Table 4-9 and 4-10). The first important observation coming out from the data
presented here is a significantly higher Km for HEC as compared to Km values for the
corresponding natural substrates of R- and S-HPCDH enzymes, thus highlighting the contribution
of the C2 methyl group to substrate binding (Table 4-9 and 4-10). These differences range from
two-fold for rS-HPCDH3 Met194Leu mutant to 16-fold for rR-HPCDH1 Met192Leu mutant.
Similar comparison of kcat values (Table 4-6 and 4-8) also suggests an important role of the
methyl group in determining proper orientation of the substrate for catalysis. This was especially
articulated for the rR-HPCDH1 enzyme where the apparent kcat value for HEC oxidation
decreased by 75-fold with respect to R-HPC oxidation, while the corresponding decrease of kcat
value in rS-HPCDH3 was only seven-fold. This corroborates well with the previous results
showing that the enantioselectivity of rR-HPCDH1 is controlled by kcat, while in rS-HPCDH3 it is
dictated in terms of Km (6). The oxidation of HEC by Met187Leu mutant and wild-type rRHPCDH1 shows identical values of apparent kcat and apparent Km thus suggesting that Met187
plays an important role in the binding and catalysis of the physiological substrates (R- and SHPC), but not substrates analogs lacking the terminal methyl group (e.g., HEC). Activity assays
of Met187Leu mutant with R-HPC and S-HPC revealed 74% and 64% increase in the apparent
Km values, respectively, compared to wild-type rR-HPCDH1 (Table 4-6). Kinetic parameters for
HEC oxidation by Met192Leu mutant were significantly different from those of the wild-type
enzyme. In particular, the values of apparent Km and apparent kcat increased by seven- and 1.4fold, respectively. Especially dramatic change in Km value exhibited by Met192Leu mutant
relative to the corresponding values of Km exhibited by Met187Leu mutant and the wild-type
enzyme are nicely visualized by the saturation curves of steady-state kinetics in Figure 4-18A.
Interestingly also the oxidation of R- and S-HPC by the Met192Leu mutant was characterized by
highly elevated Km values and a concomitant increase in kcat values (Table 4-6). Similar trends
observed for substrates differing in a substitution at C2 carbon imply that the presence of the
terminal methyl group on the substrate may not be responsible for the increased Km values
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exhibited by Met192Leu mutant. Accordingly, higher turnover may not be substrate dependent,
but rather a result of some rearrangement of the active site architecture induced by Met192
substitution to leucine. This is an important observation suggesting a critical role of Met192
strategically positioned at the entrance to active site and in a close proximity of the general
acid/base residue (Tyr155).

Table 4-8. Kinetic parameters for the oxidation of HEC by R-HPCDH, S-HPCDH and their
methionine mutants at pH 7.5a
Enzyme
Km
Change in
Vmax
kcat
Change in
kcat /Km
(μM)

Km (x-fold)

(units•mg-1)

(s-1)

kcat (x-fold)

(M-1 s-1)

R-HPCDH1
WT

958.7 ± 107

1.0

1.10 ± 0.03

0.55

1.00

5.70 x 102

M187L

1020 ± 81.7

1.1

1.09 ± 0.02

0.54

0.93

5.28 x 102

M192L

6841 ± 608

7.1

1.58 ± 0.05

0.78

1.4

1.15 x 102

S-HPCDH3
WT

974.7 ± 248

1.0

8.34 ± 0.6

3.8

1.00

3.86 x 103

M194L

674.1 ± 65.5

0.7

5.36 ± 0.1

2.4

0.93

3.59 x 103

a

Assay for HEC oxidation by rR-HPCDH1 WT and Met mutants contained 20 µg and 34 µg of
enzyme, respectively. Assay for HEC oxidation by rS-HPCDH3 WT and Met mutant contained
4.0 µg of enzyme. Apparent kcat and Km values are reported as means ± standard deviations. All
assays were performed at 30 ˚C with fixed concentrations of NAD+ (10 mM). Apparent kinetic
constants were determined by fitting experimental data to the standard form of the MichaelisMenten equation.

The kinetic parameters for HEC oxidation by Met194Leu mutant of rS-HPCDH3
revealed that although values of the apparent kcat and the apparent Km changed noticeably
compared to the wild-type enzyme, the overall catalytic efficiency (kcat/ Km) remained the same.
Specifically, a 31% increase in binding affinity (expressed in terms of Km) was compensated by a
similar decrease in value of the kcat (37%). In contrast the kcat/ Km for oxidation of S-HPC and R-
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HPC decreased dramatically (13- and six-fold, respectively) for the same mutant enzyme (Table
4-7). As mentioned before, rS-HPCDH3 is believed to discriminate between the two enantiomeric
forms of HPC by means of steric effects that reflect on their Km values. Accordingly, catalysis of
the opposite enantiomer is characterized by over 60-times higher Km value. Since the steric
clashes with the terminal methyl group of the substrate are at the origin of the enantioselectivity
of rS-HPCDH3, it is likely that removal of this methyl group from the chiral center of the
substrate could alter its binding affinity for the enzyme. Indeed, when HEC (a substrate analogue
in which the terminal methyl group is replaced by hydrogen) is a substrate for rS-HPCDH3, the
apparent Km value decreases by over eight-fold, as compared to R-HPC (Table 4-10). Although
the same holds true for the Met194Leu mutant of rS-HPCDH3 this increase is much more
dramatic (23-fold). A distinct trend can be observed in the data presented in Table 4-10, the Km
values displayed by both the wild-type and mutant rS-HPCDH3 increase in the following order:
S-HPC, HEC and R-HPC. An important and somewhat surprising result is that the substitution of
Met194 to leucine produces an enzyme with a greater binding affinity for HEC than that of the
wild-type rS-HPCDH3. The homology model of rS-HPCDH3 indicates that Met194 is located
further away from the "business end" of the substrate (6.2 Å from the C2 carbon) thereby making
it less likely to clash with the methyl group of the substrate (Figure 4-16A). It remains unclear at
this point why the Met194Leu mutation has a positive effect on the Km for HEC oxidation. It can
be speculated that the Met to Leu substitution could cause some small but sufficient
rearrangements of the neighboring residues (due to differences in shape), thereby remodeling the
active site cavity and introducing novel steric constrains on the substrate. Although the presented
results suggest that Met194 is important in modulating binding affinity and possibly
enantioselectivity of the physiological substrates in rS-HPCDH3, this hypothesis requires further
investigation (e.g., solving of Met194Leu mutant X-ray structure).

Table 4-9. Comparison of the apparent Km values for R-HPC, S-HPC and HEC oxidation by rR-HPCDH1 WT, Met187Leu
and Met192Leu mutants of rR-HPCDH1
Substrate

WT
Km (µM)

Change
(x-fold)

M187L
Km (µM)

Change
(x-fold)

change (x-fold)
relative to WT

M192L
Km (µM)

Change
(x-fold)

change (x-fold)
relative to WT

R-HPC

82.7 ± 6.8

1.0

144 ± 10

1.0

1.7

431± 14

1.0

5.2

S-HPC

265 ± 72

3.2

434 ± 69

3.0

1.6

881 ± 54

2.0

3.3

HEC

958 ± 110

11.6

1020 ± 82

7.1

1.1

6840 ± 610

15.9

7.1

Table 4-10. Comparison of the apparent Km values for S-HPC, R-HPC and HEC oxidation by
rS-HPCDH3 WT and Met194Leu mutant of rS-HPCDH3
Substrate

rS-HPCDH3 WT
Km (µM)

Change
(x-fold)

M194L
Km (µM)

Change
(x-fold)

change (x-fold)
relative to WT

S-HPC

135 ± 9.7

1.0

381 ± 54

1.0

2.8

HEC

975 ± 250

7.2

674 ± 66

1.8

0.7

R-HPC

8220 ± 570

60.8

15400 ± 2400

40.3

1.9
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Figure 4-18. Catalytic activity of rR-HPCDH1 and rS-HPCDH3 enzymes in oxidation of 2-(2hydroxyethylthio) ethanesulfonate (HEC), an achiral substrate homolog. Panel A: v vs. S plots for
HEC oxidation by (●) wild-type rR-HPCDH1, (○) Met187Leu rR-HPCDH1 and (▼) Met192Leu
rR-HPCDH1 at variable concentrations of HEC (0.2 mM – 30 mM). Panel B: v vs. S plots for
HEC oxidation by (●) wild-type rS-HPCDH3 and (○) Met194Leu rS-HPCDH3 at variable
concentrations of HEC (0.2 mM – 16 mM). The solid lines were generated by fitting data points
from each assay to a rectangular hyperbola described by a standard form of the Michaelis-Menten
equation using SigmaPlot 11.0. Data points represent the average of duplicate experiments.
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Rapid Equilibrium Inhibition Studies with a Substrate Analogue. 2-(2-methyl-2hydroxypropylthio) ethanesulfonate (M-HPC) is an achiral analog of both R-HPC and S-HPC
where the hydrogen atoms of each alcohol are replaced by a methyl group. Thus, M-HPC is a
tertiary alcohol that cannot be oxidized due to lack of an abstractable hydride. As shown in Table
4-5 and Table 4-7, the Km values for S-HPC and R-HPC oxidation exhibited by rR-HPCDH1 are
in the same range, whereas Km values exhibited by rS-HPCDH3 for R-HPC were 60-times higher
than for S-HPC. These results are similar to those reported previously (6) and suggest that
enantioselectivity of rS-HPCDH3 is brought about by steric constraints with the misaligned
methyl group of the opposite enantiomer. Subsequent inhibition studies revealed that M-HPC is a
competitive inhibitor for R-HPC oxidation by rR-HPCDH1 but not for S-HPC oxidation by rSHPCDH3, thereby confirming an important role of the terminal methyl group in modulating
binding affinity of enantiomeric substrates for the R- and S-specific dehydrogenases. Inhibition
studies with M-HPC were further extended to methionine mutants of HPCDH enzymes to shed
light on a possible role of the substrate flanking methionines in controlling enantioselectivity.
Kinetic analysis of R-HPC oxidation in the presence of variable concentrations of M-HPC
revealed competitive inhibition for the Met187Leu and Met192Leu mutants of rR-HPCDH1 with
Kis values comparable to the corresponding Km values for R-HPC (Table 4-11). The Kis values for
M-HPC were also similar to the Km values for S-HPC, demonstrating that all three compounds
bind to R-HPCDH1 with comparable affinities and substitution of the active site methionines to
leucines has no significant effect on M-HPC binding. As shown in Figure 4-20, the double
reciprocal plots showed a clear competitive inhibition pattern for both Met187Leu mutant and the
wild-type enzyme. An ambiguous line pattern was observed for Met192Leu mutant. However, the
theoretical data calculations using equations 1 – 3 confirmed the competitive model. In contrast,
no detectable inhibition was observed for M-HPC vs. the natural substrate S-HPC with any of rSHPCDH3 methionine mutants (Table 4-11). This is in agreement with the results of the kinetic
assays presented in Table 4-7, showing that R-HPC binds to rS-HPCDH3 with a 60-fold lower
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Table 4-11. Summary of the inhibition studies performed for the rR-HPCDH1 and rSHPCDH3 enzymes and their methionine mutants in the oxidation of R- and S-HPC,
respectively, in the presence of M-HPC at pH 7.5a
Enzyme
Km
Change in
Kis
Change in
Inhibition
(μM)

Km (x-fold)

(μM)

Kis (x-fold)

R-HPCDH1
WT

82.7 ± 6.8

1.0

290 ± 14

1.00

Competitive

M187L

144 ± 10

1.7

269 ± 12

0.93

Competitive

M192L

431 ± 14

5.2

714 ± 46

2.46

Competitive

S-HPCDH3
WT
M153A
M194A
M194L

135 ± 9.7
14000 ± 1100
13400 ± 850
381 ± 54

1.00

NDb

None

103

ND

b

None

ND

b

None

ND

b

None

99.4
2.82

a

Assay for R-HPC oxidation at different constant concentrations of M-HPC (0 – 1.6 mM) by
rR-HPCDH1 WT and Met mutants contained 1.0 µg of enzyme. Assay for S-HPC oxidation
contained: 1.0 µg of rS-HPCDH3 WT and M194L mutant, 1.5 µg of M194A and 118 µg of
M153A mutant. Apparent Km values were determined by fitting experimental data to the
standard form of the Michaelis-Menten equation and are reported as means ± standard
deviations. All assays were performed at 30 ˚C with fixed concentrations of NAD+ (10 mM).
b
ND – no detectable inhibition at concentrations up to 10 mM of M-HPC.

affinity than the native enantiomer S-HPC presumably due to the steric clashes of the misaligned
methyl group on R-HPC with the nicotinamide ring of NAD+. It is plausible that the addition of
the methyl group on C2 carbon of the substrate could cause further steric constrains thereby
enabling such a substrate to bind in the active site of rS-HPCDH3.
Lack of inhibition by M-HPC in oxidation of S-HPC exhibited by methionine mutants of
rS-HPCDH3 confirms this prediction. Structural analysis of rS-HPCDH3 with M-HPC modeled
in the active site suggests extensive steric clashes of the methyl groups with the nicotinamide ring
of NAD+ and to some extent with Tyr156 (Figure 4-19). The fact that none of the tested
methionine mutants showed any inhibition in the presence of M-HPC suggests that Met153 and
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Met194 are not involved in imposing those steric clashes. Moreover, expanding the active site
cavity in the direct proximity of the "business end" of the substrate by substitution of either of the
methionines with much smaller alanine residues does not release the steric restriction imposed
upon binding of M-HPC. Together, these results further support the hypothesis that steric clashes
of the terminal methyl group of the HPC substrates with the nicotinamide ring of NAD+ are a
major determinant of the enantioselectivity in rS-HPCDH3.

Figure 4-19. The active site of rS-HPCDH3 showing steric effects of the nicotinamide ring of
NAD+ with M-HPC inhibitor (modeled in PyMol).
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Figure 4-20. Effects of 2-(2-methyl-2-hydroxypropylthio)ethanesulfonate (M-HPC) on R- and SHPC oxidation by wild-type rR-HPCDH1, and Met187Leu and Met192Leu mutants of rRHPCDH1. Panel A: Competitive inhibition of wild-type rR-HPCDH1-catalyzed R-HPC oxidation
by M-HPC. Panel B: Competitive inhibition of Met187Leu mutant-catalyzed R-HPC oxidation by
M-HPC. Panel C: Competitive inhibition of Met192Leu mutant-catalyzed R-HPC oxidation by
M-HPC. The double reciprocal plots for assays performed in the presence of different
concentrations of M-HPC are shown in the main diagram. The solid lines were generated by
nonlinear least-square fits of the v vs. S data, shown in the inset, to the equation for a rectangular
hyperbola using SigmaPlot. M-HPC concentrations: (●) 0 mM, (○) 0.2 mM, (▼) 0.4 mM, (∆) 0.8
mM, (■) 1.6 mM.

CONCLUSIONS
Structural analysis of the enzymes involved in the epoxide carboxylase pathway found in
X. autotrophicus Py2 revealed striking similarities in their active site architecture. Highly
conserved positively charged residues (Arg and/or Lys) lining the CoM binding pocket and two
methionine residues flanking the substrate were common to three of the four enzymes of the
pathway (R-HPCDH, S-HPCDH and 2-KPCC). This intriguing observation prompted the study
aimed at elucidating a possible role of the substrate flanking methionines. The subject of
investigation presented in this chapter is a pair of enantiocomplementary R- and S-HPC
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dehydrogenases. A series of site-directed mutants were made to substitute specific methionines to
alanine and subsequently to leucine. A total of nine mutants were obtained and subjected to
kinetic analysis with various substrates. The most significant change in the kinetic parameters
observed for the methionine to alanine mutants of rR-HPCDH1 and rS-HPCDH3 was a dramatic
increase in the apparent Km values for the physiological substrates. As a result the catalytic
efficiency for these mutants was significantly impaired, especially for the double mutant of rRHPCDH1. The X-ray structures for Met187Ala and Met192Ala of rR-HPCDH1 were determined
in support of the kinetic and mechanistic studies. The Met187Ala mutant structure revealed a
large solvent accessible pocket near the CoM binding site. The lack of the sulfonate moiety of the
substrate in this region suggested non-productive interaction of the arginine residues (involved in
the sulfonate binding) with the surrounding solvent molecules. Although, the sulfonate moiety
was visible in the structure of the Met192Ala mutant, the kinetic analysis showed a dramatic
increase in the apparent Km values for this mutant (24-fold), also suggesting opening of the active
site to the solvent. Based on these results the Met187 and Met192 residues are proposed to play
an important role in shielding the active site from the surrounding solvent. Additionally, because
Met192 is in close proximity to the chiral carbon of the substrate molecule where chemistry
occurs, it is also speculated that Met192 might be shielding charges on both ends of the substrate
during catalysis. When Met187 and Met192 residues were changed to leucine, the resulting
mutants displayed kinetic parameters similar to the wild-type enzyme, which suggested a
structural, rather than catalytic function of the methionines. Comparison of the leucine mutants of
both dehydrogenases revealed some interesting and potentially important differences. Namely,
the Met187Leu and Met192Leu mutants of rR-HPCDH1 showed a substrate dependent increase
in the kcat values, while the Met194Leu mutant of rS-HPCDH3 revealed a substrate dependent
increase in the Km values. This corroborates with the previous study (6) where rR-HPCDH1 and
rS-HPCDH3 were demonstrated to control their enantioselectivity via changes in kcat and Km,
respectively. Surprisingly, in the reaction of R-HPC oxidation catalyzed by Met187Leu and
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Met192Leu mutants of rR-HPCDH1, the apparent kcat values increased by 42% and 59%,
respectively, as compared to the wild-type enzyme. In the reaction of S-HPC oxidation by rRHPCDH1 this increase was almost three-fold. Interestingly however, this enhancement of activity
was abolished for 2-KPC reduction and the apparent kcat value remained fairly similar to the
corresponding value of the wild-type enzyme. These results suggest that chirality and/or
oxidation state of the substrate might be important determinants of the enzyme’s activity. Based
on the structural and kinetic analysis presented herein, it is proposed that the methionines at
position 187 and 192 may be also involved in modulating the enantioselectivity of the rRHPCDH1. With respect to the Met153 and Met194 residues in S-HPCDH3, their strategic
position at the entrance of a channel leading to the active site suggests a role of "gate keepers",
protecting the active site from non-productive interactions with the ambient solvent. The natural
substrate analogue HEC (2-hydroxyethyl-CoM) was used as a substrate for the leucine mutants of
rR-HPCDH1 and rS-HPCDH3. Similar values of Km were obtained in all enzymes (except for
Met192Leu of rR-HPCDH1). Interestingly, Met192Leu mutant showed 42% increase in kcat value
and over seven-fold increase in the Km value. The apparent kcat and apparent Km values exhibited
by Met187Leu mutant and wild-type rR-HPCDH1 were identical and suggested that Met187
plays an important role in binding and catalysis of the physiological substrates (R- and S-HPC),
but not substrate analogs lacking the terminal methyl group. Inhibition studies show that the
tertiary alcohol, 2-methyl-2-hydroxypropyl-CoM (M-HPC) is a competitive inhibitor of R-HPC
oxidation by Met187Leu and Met192Leu of rR-HPCDH1, with a Kis similar to the Km values for
R-HPC. No inhibition of S-HPC oxidation by M-HPC was observed for any of Met mutants of rSHPCDH3, thus suggesting that Met153 and Met194 are not directly involved in the steric clashes
with the terminal methyl group of the substrate. As proposed in Chapter 2, these steric clashes are
believed to prevent proper binding of R-HPC and M-HPC and result in a different mechanism for
controlling substrate specificity and enantioselectivity. Structural and kinetic analysis of the rSHPCDH3 mutants with M-HPC suggests that the steric clashes of the terminal methyl group of
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the HPC substrates with the nicotinamide ring of NAD+ are a major determinant of the
enantioselectivity in rS-HPCDH3. Based on the structural data Met192 of rR-HPCDH1 is
proposed to be involved in the NAD(H) cofactor binding. The homology model of rS-HPCDH3
suggests a similar role for the Met194 residue. An importance of the active site methionine in
orienting the cofactor nicotinamide ring with respect to the substrate has been previously reported
for 6-phosphogluconate dehydrogenase enzyme (29). As mentioned earlier, methionine is one of
the most readily oxidized amino acid constituents of proteins. Considering the reversibility of Met
oxidation followed by its functional changes, it is speculated that the presence of the substrate
flanking methionines might crucial in protecting enzymes involved in the propylene and epoxide
degradation pathway from the oxidative stress. However, this hypothesis requires more research
and was not further explored in the current study.
Together, the presented results provide evidence for the importance of the substrate
flanking methionines in the active site of the R- and S-HPCDH enzymes. Furthermore, it is
proposed that the high enantioselectivity of rS-HPCDH3 is due to the steric clashes of the NAD+
cofactor with the improperly aligned methyl group on the C2 carbon of the substrate.
Finally, a general architecture of the active site with the substrate flanking methionines
and positively charged amino acids interacting with the sulfonate moiety observed in 2-KPCC, RHPCDH and S-HPCDH may prove useful in identifying new CoM-dependent enzymes.
REFERENCES
1.

Ensign, S. A., and Allen, J. R. (2003) Aliphatic epoxide carboxylation. Annu. Rev.
Biochem. 72, 55-76.

2.

Allen, J. R., and Ensign, S. A. (1998) Identification and characterization of epoxide
carboxylase activity in cell extracts of Nocardia corallina B276. J. Bacteriol. 180, 20722078.

3.

Allen, J. R., and Ensign, S. A. (1999) Two short-chain dehydrogenases confer
stereoselectivity for enantiomers of epoxypropane in the multiprotein epoxide
carboxylating systems of Xanthobacter strain Py2 and Nocardia corallina B276.
Biochemistry 38, 247-256.

175
4.

Small, F. J., and Ensign, S. A. (1997) Alkene monooxygenase from Xanthobacter strain
Py2. J. Biol. Chem. 272, 24913.

5.

Clark, D. D., and Ensign, S. A. (2002) Characterization of the 2-[(R)-2hydroxypropylthio]ethanesulfonate dehydrogenase from Xanthobacter strain Py2:
product inhibition, pH dependence of kinetic parameters, site-directed mutagenesis, rapid
equilibrium inhibition, and chemical modification. Biochemistry 41, 2727-2740.

6.

Sliwa, D. A., Krishnakumar, A. M., Peters, J. W., and Ensign, S. A. (2010) Molecular
basis for enantioselectivity in the (R)- and (S)-hydroxypropylthioethanesulfonate
dehydrogenases, a unique pair of stereoselective short-chain dehydrogenases/reductases
involved in aliphatic epoxide carboxylation. Biochemistry 49, 3487-3498.

7.

Krishnakumar, A. M., Nocek, B. P., Clark, D. D., Ensign, S. A., and Peters, J. W. (2006)
Structural basis for stereoselectivity in the (R)- and (S)-hydroxypropyl
thioethanesulfonate dehydrogenases. Biochemistry 45, 8831-8840.

8.

Clark, D. D., Boyd, J. M., and Ensign, S. A. (2004) The stereoselectivity and catalytic
properties of Xanthobacter autotrophicus 2-[(R)-2-Hydroxypropylthio]ethanesulfonate
dehydrogenase are controlled by interactions between C-terminal arginine residues and
the sulfonate of coenzyme M. Biochemistry 43, 6763-6771.

9.

Nocek, B., Jang, S. B., Jeong, M. S., Clark, D. D., Ensign, S. A., and Peters, J. W. (2002)
Structural basis for CO2 fixation by a novel member of the disulfide oxidoreductase
family of enzymes, 2-ketopropyl-coenzyme M oxidoreductase/carboxylase. Biochemistry
41, 12907-12913.

10.

Vogt, W. (1995) Oxidation of methionyl residues in proteins: tools, targets, and reversal.
Free Radic. Biol. Med. 18, 93-105.

11.

Luo, S., and Levine, R. L. (2009) Methionine in proteins defends against oxidative stress.
The FASEB Journal 23, 464.

12.

Kachurin, A., Golubev, A., Geisow, M., Veselkina, O., Isaeva-Ivanova, L., and
Neustroev, K. (1995) Role of methionine in the active site of alpha-galactosidase from
Trichoderma reesei. Biochem. J. 308, 955.

13.

O'Neil, K. T., and DeGrado, W. F. (1990) How calmodulin binds its targets: sequence
independent recognition of amphiphilic [alpha]-helices. Trends Biochem. Sci. 15, 59-64.

14.

Gellman, S. H. (1991) On the role of methionine residues in the sequence-independent
recognition of nonpolar protein surfaces. Biochemistry 30, 6633-6636.

15.

Janin, J., Wodak, S., Levitt, M., and Maigret, B. (1978) Conformation of amino acid sidechains in proteins. J. Mol. Biol. 125, 357-386.

16.

Pal, D., and Chakrabarti, P. (2001) Non-hydrogen bond interactions involving the
methionine sulfur atom. J. Biomol. Struct. Dyn. 19, 115-128.

17.

Tatko, C. D., and Waters, M. L. (2004) Investigation of the nature of the methionine–
interaction in -hairpin peptide model systems. Protein Sci. 13, 2515.

176
18.

Ma, B., and Nussinov, R. (2007) Trp/Met/Phe hot spots in protein-protein interactions:
potential targets in drug design. Curr. Top. Med. Chem. 7, 999-1005.

19.

Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L., Santelli, E., Stec, B.,
Cadwell, G., and Ali, M. (2009) Structural and functional bases for broad-spectrum
neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265273.

20.

Bone, R., Fujishige, A., Kettner, C. A., and Agard, D. A. (1991) Structural basis for
broad specificity in. alpha.-lytic protease mutants. Biochemistry 30, 10388-10398.

21.

Rosental, N., and Kanner, B. I. (2010) A conserved methionine residue controls the
substrate selectivity of a neuronal glutamate transporter. J. Biol. Chem.285, 21241-21248.

22.

Allen, J. R., Clark, D. D., Krum, J. G., and Ensign, S. A. (1999) A role for coenzyme M
(2-mercaptoethanesulfonic acid) in a bacterial pathway of aliphatic epoxide
carboxylation. Proc. Natl. Acad. Sci. U.S.A. 96, 8432-8437.

23.

Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of
bacteriophage T4. Nature 227, 680-685.

24.

Nocek, B., Clark, D. D., Ensign, S. A., and Peters, J. W. (2002) Crystallization and
preliminary X-ray analysis of an R-2-hydroxypropyl-coenzyme M dehydrogenase. Acta
Crystallogr. D. Biol. Crystallogr. 58, 1470-1473.

25.

Krishnakumar, A. M. (2007) Structural studies of enzymes involved in propylene and
acetone metabolism in Xanthobacter autotrophicus, Thesis, Montana State University,
Bozeman.

26.

Price, A. C., Zhang, Y. M., Rock, C. O., and White, S. W. (2004) Cofactor-induced
conformational rearrangements establish a catalytically competent active site and a
proton relay conduit in FabG. Structure 12, 417-428.

27.

O.B. Ptitsyn, T. E. C. (1992) Protein Folding, W.H. Freeman, New York.

28.

Lipscomb, L. A., Gassner, N. C., Snow, S. D., Eldridge, A. M., Baase, W. A., Drew, D.
L., and Matthews, B. W. (1998) Context-dependent protein stabilization by methionineto-leucine substitution shown in T4 lysozyme. Protein Sci. 7, 765-773.

29.

Cervellati, C., Dallocchio, F., Bergamini, C. M., and Cook, P. F. (2005) Role of
methionine-13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from
sheep liver. Biochemistry 44, 2432-2440.

177
CHAPTER 5
SUMMARY
The SDR superfamily has very few enzymes that can be characterized by their unique
ability to discriminate or produce enantiomeric alcohols. Even more unusual are
enantiocomplementary dehydrogenases present in a common metabolic pathway that would
catalyze the same reaction but with the opposite enantioselectivity. The R- and S-HPCDH possess
these characteristics, and thus provide an excellent model for studying features controlling
enantioselectivity among SDR enzymes. Although R-HPCDH has been extensively characterized,
very little is known about S-HPCDH due to the solubility problems encountered in expressing its
recombinant form. Herein, we report a heterologous expression of an active form of rS-HPCDH
and its kinetic and mechanistic characterization (Chapter 2). Although both R- and S-HPCDH are
highly homologous and highly enantioselective for their respective substrates, they reveal some
significant differences. The most significant difference is observed in the inhibition studies and in
the reaction with the non-physiological substrates (aliphatic alcohols and ketones lacking the
CoM moiety). Most importantly, they employ different mechanisms of controlling their
enantioselectivity. Although both enzymes are highly enantioselective and hold high potential for
the biocatalytic production of optically pure alcohols, the rS-HPCDH3 makes an especially
noteworthy candidate for a biocatalyst, considering its near absolute stereoselectivity for some
aliphatic (S)-alcohols (Chapter 3). The results presented herein provide a further evidence for the
importance of the positively charged residues (Arg and/or Lys) in the active site of R- and SHPCDH. It was demonstrated that strong ionic interactions of these residues with the sulfonate
moiety of the substrate are essential for the high binding affinity and proper orientation of the
substrate.
In Chapter 4, a role of the active site methionines was investigated for the R- and SHPCDH enzymes. Nine site-directed mutants were produced where specific methionines were
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replaced with either alanine or leucine. Subsequently, all the mutants were subjected to kinetic
and mechanistic analysis with various substrates. Analogous of the natural substrate HEC and MHPC were used in the activity assay. No inhibition was observed for any of Met mutants of rSHPCDH3 in the oxidation of S-HPC in the presence of M-HPC. This suggests that Met153 and
Met194 are not directly involved in the steric clashes with the terminal methyl group of the
substrate. As proposed in Chapter 2, these steric clashes in the active site of rS-HPCDH3 are
believed to prevent proper binding of R-HPC and M-HPC and result in a different mechanism for
controlling enantioselectivity. The substrate flanking methionines in R- and S-HPCDH enzymes
were shown to play a role of "gate keepers" in shielding the active site from the non-productive
interactions with the surrounding solvent. Additionally, they might be important in modulating
enantioselectivity of both enzymes by imposing specific steric constrains in the direct vicinity of
the substrate binding site, thus facilitating selection of the proper enantiomeric substrate. The
Met192 of rR-HPCDH1 and by analogy Met194 of rS-HPCDH3 are also involved in the cofactor
binding. It is proposed that the high enantioselectivity of rS-HPCDH3 is dictated by the steric
clashes of the nicotinamide ring of NAD+ with the improperly aligned methyl group on the C2
carbon of the substrate. To our knowledge, this dissertation provides the first side by side
characterization of a pair of SDR enzymes expressed simultaneously to act on two enantiomers of
the same alcohol produced in a metabolic pathway. These dehydrogenases are distinguished from
all other known members of the SDR family in using the novel sulfonate functional group of
coenzyme M as a handle for chiral discrimination. The differential control of enantioselectivity
by means of kcat vs. Km is a surprising yet explainable result in the context of cellular metabolism.
These results provide a standard for examining the molecular basis of stereoselectivity in other
such enzyme pairs.
More work still has to be done in order to confirm the hypothesis proposed above. For
example, the X-ray structure of rS-HPCDH3 will undoubtedly aid in better understanding of the
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observed results and provide further insight into the mechanism of high degree of chiral
discrimination exhibited by R- and S-HPCDH.
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